<SEC-DOCUMENT>0001193125-16-533218.txt : 20160407
<SEC-HEADER>0001193125-16-533218.hdr.sgml : 20160407
<ACCEPTANCE-DATETIME>20160407105402
ACCESSION NUMBER:		0001193125-16-533218
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		28
CONFORMED PERIOD OF REPORT:	20160518
FILED AS OF DATE:		20160407
DATE AS OF CHANGE:		20160407
EFFECTIVENESS DATE:		20160407

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MACROGENICS INC
		CENTRAL INDEX KEY:			0001125345
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36112
		FILM NUMBER:		161559127

	BUSINESS ADDRESS:	
		STREET 1:		9640 MEDICAL CENTER DRIVE
		CITY:			Rockville
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301-251-5172

	MAIL ADDRESS:	
		STREET 1:		9640 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d172766ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed&nbsp;by&nbsp;the&nbsp;Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed&nbsp;by&nbsp;a&nbsp;Party&nbsp;other&nbsp;than&nbsp;the&nbsp;
Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only&nbsp;(as permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material under &#167;&nbsp;240.14a-12</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>MACROGENICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount Previously Paid:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MacroGenics,&nbsp;Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9704 Medical Center Drive </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Rockville, Maryland 20850 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD ON MAY 18, 2016 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders of MacroGenics,&nbsp;Inc.: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOTICE IS HEREBY GIVEN</B> that the Annual Meeting of Stockholders (&#147;Annual Meeting&#148;) of MacroGenics,&nbsp;Inc., a Delaware
corporation (the &#147;Company&#148;), will be held on May&nbsp;18, 2016, at 9:00&nbsp;a.m. local time, at the Hilton Garden Inn Rockville-Gaithersburg, 14975 Shady Grove Road, Rockville, Maryland 20850, for the following purposes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">1. To elect two Class III directors listed in these proxy materials to hold office until the 2019 Annual Meeting of Stockholders or until their
successors are elected; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">2. To ratify the selection by the Audit Committee of our Board of Directors of Ernst&nbsp;&amp; Young&nbsp;LLP as
the independent registered public accounting firm of the Company for its fiscal year ending December&nbsp;31, 2016; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">3. To approve, on
an advisory basis, the compensation of our named executive officers as disclosed in these proxy materials. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">4. To approve, on an advisory
basis, the frequency of future advisory votes on executive compensation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">5. To transact such other business as may properly come before
the Annual Meeting or any adjournment or postponement thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing items of business are more fully described in the Proxy
Statement accompanying this Notice. Only stockholders who owned our common stock at the close of business on March&nbsp;29, 2016, the record date, can vote at this meeting or any adjournments that take place. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors recommends that you vote <B>FOR</B> the election of the director nominees and <B>FOR</B> the Proposals 2 and 3. Our
Board of Directors is not making a recommendation with respect to Proposal 4 and currently intends to hold future advisory votes on executive compensation with the frequency option that receives the most stockholder support. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Your vote is important. Whether or not you plan to attend the meeting in person, please vote by internet, by telephone or by completing,
signing and dating the accompanying proxy card and returning it as soon as possible. If you have received and are using an enclosed return envelope, no postage need be affixed if it is mailed in the United States. If you receive more than one notice
or more than one proxy card because your shares are registered in different names or addresses, you should vote each set of shares separately to ensure that all of your shares will be voted. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held on May&nbsp;18, 2016. Our proxy
materials and annual report to shareholders are available at www.investorvote.com/MGNX. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">By Order of the Board of
Directors </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">James Karrels </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><I>Corporate Secretary </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rockville, Maryland </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;7, 2016</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="96%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_1">Information about the Proxy Process and Voting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_2">Proposal No.&nbsp;1. Election of Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_9">Director Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_3">Proposal No.&nbsp;2. Ratification of Selection of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_4">Report of the Audit Committee of the Board of Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_5">Proposal No.&nbsp;3. Advisory Vote on Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_6">Proposal No.&nbsp;4. Advisory Vote on the Frequency of Future Advisory Votes on Executive
Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_7">Corporate Governance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_8">Certain Relationships and Related Party Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_10">Executive Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_11">Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc172766_12">Security Ownership</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MacroGenics,&nbsp;Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9704 Medical Center Drive </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Rockville, Maryland 20850 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT FOR THE 2016 ANNUAL MEETING </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF STOCKHOLDERS TO BE HELD MAY 18, 2016 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have sent you or made available this proxy statement and the accompanying proxy card because the Board of Directors (the &#147;Board&#148;)
of MacroGenics,&nbsp;Inc. (referred to herein as the &#147;Company&#148;, &#147;MacroGenics&#148;, &#147;we&#148;, &#147;us&#148; or &#147;our&#148;) is soliciting your proxy to vote at our 2016 Annual Meeting of Stockholders (the &#147;Annual
Meeting&#148;) to be held on Wednesday, May&nbsp;18, 2016, at 9:00&nbsp;a.m. local time, at the Hilton Garden Inn Rockville-Gaithersburg, 14975 Shady Grove Road, Rockville, Maryland 20850. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">This proxy statement summarizes information about the proposals to be considered at the Annual Meeting and other information you may find useful in determining how to vote. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The proxy card is the means by which you actually authorize another person to vote your shares in accordance with your instructions. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to solicitations by mail, our directors, officers and regular employees, without additional remuneration, may solicit proxies by
telephone, e-mail and personal interviews. All costs of solicitation of proxies will be borne by us. Brokers, custodians and fiduciaries will be requested to forward proxy soliciting material to the owners of stock held in their names, and we will
reimburse them for their reasonable out-of-pocket expenses incurred in connection with the distribution of proxy materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are
mailing the Notice of Annual Meeting of Stockholders, this proxy statement and the accompanying proxy card to our stockholders of record as of March&nbsp;29, 2016, the record date, for the first time on or about April&nbsp;7, 2016. In this mailing,
we are also including our Annual Report on Form&nbsp;10-K (&#147;Form&nbsp;10-K&#148;) for the year ended December&nbsp;31, 2015, which Form&nbsp;10-K, together with the additional cover materials, constitutes our 2015 Annual Report to Stockholders
(&#147;2015 Annual Report&#148;). In addition, we have provided brokers, dealers, banks, voting trustees and their nominees, at our expense, with additional copies of our proxy materials and the 2015 Annual Report so that our record holders can
supply these materials to the beneficial owners of shares of our common stock as of the record date upon request. The Form&nbsp;10-K is also available in the &#147;Financials&nbsp;&amp; Filings&#148; section of our website at
http://ir.macrogenics.com/financials.cfm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The only voting securities of MacroGenics are shares of common stock, $0.01 par value per share
(the &#147;common stock&#148;), of which there were 34,536,521 shares outstanding as of the record date (excluding any treasury shares). We need the holders of a majority in voting power of the shares of common stock issued and outstanding and
entitled to vote, present in person or represented by proxy, to hold the Annual Meeting. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_1"></A>INFORMATION ABOUT THE PROXY PROCESS AND VOTING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why am I receiving these materials? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You
are receiving this annual meeting information and proxy from us because you owned shares of common stock of MacroGenics, Inc. as of March&nbsp;29, 2016, the record date for the 2016 Annual Meeting of Stockholders (the &#147;Annual Meeting&#148;).
The MacroGenics Board of Directors has made these materials available to you in connection with the Board&#146;s solicitation of proxies for use at our Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement describes matters on which you may vote and provides you with other important information so that you can make informed
decisions. You are requested to vote on the proposals described in this proxy statement and are invited to attend the annual meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
intend to mail our Annual Report, this proxy statement and accompanying proxy card on or about April&nbsp;7, 2016, to all stockholders of record entitled to vote at the Annual Meeting.&nbsp;Beneficial owners will receive notice and electronic access
to these materials, and may request physical copies from their respective brokers, custodians or fiduciaries who are holding the shares on their behalf. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who can vote at the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only
stockholders of record at the close of business on March&nbsp;29, 2016, the record date, will be entitled to vote at the Annual Meeting. At the close of business on the record date, there were 34,536,521 shares of our common stock issued and
outstanding and entitled to vote. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder of Record: Shares Registered in Your Name </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, on the record date, your shares were registered directly in your name with the transfer agent for our common stock, Computershare Trust
Company, N.A., then you are a stockholder of record. As a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting, we urge you to fill out and return the enclosed
proxy card or vote by proxy over the telephone or on the internet as instructed below to ensure your vote is counted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Beneficial
Owner: Shares Registered in the Name of a Broker, Bank or Other Agent </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, on the record date, your shares were held in an account
at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and these proxy materials are being forwarded to you by that organization. The organization holding your
account is considered the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account. You are also invited to attend
the Annual Meeting. However, since you are not the stockholder of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy card from your broker or other agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are the voting requirements to elect directors and approve the other proposals described in the proxy
statement? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The vote required to elect directors and approve each of the matters scheduled for a vote at the annual meeting is set
forth below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:30.20pt; font-size:8pt; font-family:Times New Roman"><B>Proposal</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vote Required</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Board Recommendation</B></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Election of directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Plurality&nbsp;of&nbsp;votes&nbsp;cast</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ratification of appointment of Ernst&nbsp;&amp; Young LLP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Majority&nbsp;of&nbsp;votes&nbsp;cast</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advisory vote to approve compensation of named executive officers as disclosed in this proxy
statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Majority of votes cast</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advisory vote on the frequency of future advisory votes on executive compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Plurality of votes cast</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>NOT&nbsp;APPLICABLE</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares voted &#147;Abstain&#148; will be counted for the purposes of determining whether quorum has been
reached, but will have no effect on the approval of matters considered at the annual meeting. Votes may be cast by proxy or in person. A &#147;plurality&#148; of the votes cast at the meeting for the election of directors means that the nominees who
receive the most votes will be the nominees elected by stockholders. A &#147;plurality&#148; of the votes cast at the meeting for the advisory vote on the frequency of future advisory votes on executive compensation means that the frequency that
receives the most votes will be the frequency adopted by us. In addition, you are entitled to vote on any other matters that are properly brought before the Annual Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if you plan to
attend the Annual Meeting, we recommend that you vote before the meeting, as described below, so that your vote will be counted if you later decide not to attend the meeting. Voting by internet or by telephone is fast and convenient and your vote is
immediately confirmed and tabulated. Submitting a proxy by internet, telephone or mail prior to the annual meeting will not affect your right to attend the Annual Meeting and vote in person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>If you hold shares in your own name as a stockholder of record</I>, regardless of whether you received your annual meeting materials
through the mail or via the internet, you may vote before the annual meeting: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>By Internet</B>.&nbsp;To vote by internet, go to www.investorvote.com/MGNX and follow the instructions you find on this website. Your proxy will be voted according to your instructions. If you vote by internet, you
do not need to mail in a proxy card. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>By Telephone</B>.&nbsp;To vote by phone, call 1-800-652-VOTE (8683)&nbsp;toll-free from the United States and follow the instructions. If you vote by telephone, you do not need to mail in a proxy card.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>By Mail</B>.&nbsp;If you received your proxy materials by mail, you may vote by completing, signing and returning your proxy card in the enclosed postage-paid envelope. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you vote by internet or by telephone, please do not mail in your proxy card (unless you intend for it to revoke your prior internet or
telephone vote). Your internet or telephone vote will authorize the named proxies to vote your shares in the same manner as if you completed, signed and returned your proxy card. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Agent </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you hold shares in your name through a bank, broker or other nominee, please refer to the information provided by that entity regarding how
to provide them with voting instructions. If you beneficially hold your shares in street name through a bank, broker or other nominee and you do not submit specific voting instructions to your broker, your broker may generally vote your shares in
its discretion on matters designated as &#147;routine&#148; under rules applicable to broker-dealers. However, a broker cannot vote shares held in street name on matters designated by these rules as &#147;non-routine,&#148; unless the broker
receives specific voting instructions from the beneficial holder. Please see below for a description of which of this year&#146;s proposals are considered &#147;routine&#148; or &#147;non-routine&#148; for this purpose. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who counts the votes? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Computershare Trust Company, N.A. (&#147;Computershare&#148;) has been engaged as our independent agent to tabulate stockholder votes as the
Inspector of Elections. If you are a stockholder of record, your executed proxy card should be returned directly to Computershare for tabulation. As noted above, if you hold your shares through a broker, your broker will return one proxy card to
Computershare on behalf of all its clients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How are votes counted? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Votes will be counted by the Inspector of Election appointed for the Annual Meeting, who will separately count &#147;For&#148; and
&#147;Against&#148; votes, abstentions and broker non-votes. In addition, with respect to the election of directors, the Inspector of Election will count the number of &#147;Withheld&#148; votes received for the nominees. If your shares are held by
a bank or broker as your nominee (that is, in &#147;street name&#148;), you will need to obtain a voting instruction form from the institution that holds your shares and follow the instructions included on that form regarding how to instruct your
bank or broker to vote your shares. If you do not give instructions to your bank or broker, your bank or broker can vote your shares with respect to &#147;routine&#148; items, but not with respect to &#147;non-routine&#148; items. Please see below
for more information regarding: &#147;What are &#145;broker non-votes&#146;?&#148; and &#147;Which ballot measures are considered &#145;routine&#146; and &#145;non-routine&#146;?&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are &#147;broker non-votes&#148;? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Broker non-votes occur when a beneficial owner of shares held in &#147;street name&#148; does not give instructions to the broker or nominee
holding the shares as to how to vote on matters deemed &#147;non-routine.&#148; Generally, if shares are held in street name, the beneficial owner of the shares is entitled to give voting instructions to the broker or nominee holding the shares. If
the beneficial owner does not provide voting instructions, the broker or nominee can still vote the shares with respect to matters that are considered to be &#147;routine,&#148; but not with respect to &#147;non-routine&#148; matters. In the event
that a broker, bank, custodian, nominee or other record holder of common stock indicates on a proxy that it does not have discretionary authority to vote certain shares on a particular proposal, then those shares will be treated as broker non-votes
with respect to that proposal. Accordingly, if you own shares through a nominee, such as a broker or bank, please be sure to instruct your nominee how to vote to ensure that your vote is counted on each of the proposals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Which ballot measures are considered &#147;routine&#148; or &#147;non-routine&#148;? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ratification of the appointment of Ernst&nbsp;&amp; Young&nbsp;LLP as our independent registered public accounting firm for the year ending
December&nbsp;31, 2016 (Proposal 2)&nbsp;is considered routine under applicable rules. A broker or other nominee may generally vote on routine matters, and therefore no broker non-votes are expected to exist in connection with Proposal 2. The
election of directors (Proposal 1), the advisory vote approving compensation of the named executive officers (Proposal 3) and the advisory vote on the frequency of future advisory votes approving compensation of named executive officers (Proposal 4)
are considered non-routine under applicable rules. A broker or other nominee cannot vote without instructions on non-routine matters, and therefore there may be broker non-votes on Proposals&nbsp;1, 3 and 4. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes do I have? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On each matter
to be voted upon, you have one vote for each share of common stock you own as of the record date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if I return a proxy card but do not make
specific choices? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we receive a signed and dated proxy card or receive your instructions by internet or by telephone and your
instructions do not specify how your shares are to be voted, your shares will be voted &#147;For&#148; the election of each </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the two nominees for director, &#147;For&#148; the ratification of the appointment of Ernst&nbsp;&amp; Young&nbsp;LLP as our independent registered public accounting firm and &#147;For&#148;
the approval of the compensation of named executive officers. If any other matter is properly presented at the Annual Meeting, your proxy (one of the individuals named on your proxy card) will vote your shares using his or her best judgment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who is paying for this proxy solicitation? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay for the entire cost of soliciting proxies. In addition to these mailed proxy materials, our directors, officers and employees may
also solicit proxies in person, by telephone or by other means of communication. Directors, officers and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for
the cost of forwarding proxy materials to beneficial owners. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What does it mean if I receive more than one notice or more than one set of materials?
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It means that you have more than one account for your MacroGenics, Inc. shares. Please vote by internet or telephone using each of the
identification numbers, or complete and submit all proxies to ensure that all of your shares are voted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Can I change my vote after submitting my
proxy? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your
shares, you may revoke your proxy in any one of three ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may submit another properly completed proxy with a later date. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may send a written notice that you are revoking your proxy to our Corporate Secretary at 9704&nbsp;Medical Center Drive, Rockville, Maryland 20850. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may attend the Annual Meeting and vote in person. Please note, however, that simply attending the Annual Meeting will not, by itself, revoke your proxy. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held by your broker, bank or other agent, you should follow the instructions provided by them. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When are stockholder proposals due for next year&#146;s annual meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be considered for inclusion in the proxy materials for the 2017 annual meeting of stockholders, your proposal must be submitted in writing
by December&nbsp;31, 2016, to our Corporate Secretary at 9704 Medical Center Drive, Rockville, Maryland 20850. However, if the date of the 2017 annual meeting is more than 30&nbsp;days from May&nbsp;19, 2017, the deadline is a reasonable time before
we begin to print and send our proxy materials for next year&#146;s annual meeting. If you wish to submit a proposal that is not to be included in our proxy materials for next year&#146;s annual meeting or to nominate a director pursuant to our
current by-laws, you must do so not less than 90&nbsp;days and no more than 120 days prior to the first anniversary of the preceding year&#146;s annual meeting; provided, that if the date of that annual meeting is more than 20&nbsp;days before or
more than 60&nbsp;days after the first anniversary of the preceding year&#146;s annual meeting, you must give notice not earlier than the 120th day prior to such annual meeting and not later than the close of business on the later of (a)&nbsp;the
90th day prior to such annual meeting and (b)&nbsp;the tenth day following the day on which notice of the date of such annual meeting was mailed or public disclosure of the date of such annual meeting was made, whichever first occurs. You are also
advised to review our by-laws, which contain additional requirements about advance notice of stockholder proposals and director nominations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is the quorum requirement? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A quorum of stockholders is necessary to hold a valid meeting. Our amended and restated bylaws provide that a quorum will exist if stockholders
holding a majority of the shares of stock issued and outstanding and entitled to vote are present at the meeting in person or by proxy. Abstentions and broker non-votes count as present for establishing a quorum but will not be counted as votes
cast. Broker non-votes occur when your broker or other nominee submits a proxy for your shares (because the broker or other nominee has received instructions from you on one or more proposals, but not all, or has not received instructions from you
but is entitled to vote on a particular &#147;discretionary&#148; matter) but does not indicate a vote for a particular proposal because the broker or other nominee either does not have the authority to vote on that proposal and has not received
voting instructions from you or has discretionary authority but chooses not to exercise it. If a quorum is not present, the meeting may be adjourned until a quorum is obtained. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I find out the results of the voting at the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Voting results will be announced by the filing of a Current Report on Form&nbsp;8-K within four business days after the Annual Meeting. If
final voting results are unavailable at that time, we will file an amended Current Report on Form&nbsp;8-K within four business days of the day the final results are available. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_2"></A>PROPOSAL NO. 1 ELECTION OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Background </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the 2016 Annual Meeting,
stockholders will have an opportunity to vote for the election of Messrs. Paulo Costa and Edward Hurwitz to serve as Class&nbsp;III directors. If elected, the terms of each of these two director nominees will expire at the 2019 annual meeting of
stockholders. The persons named in our proxy card will vote to elect these two nominees as Class&nbsp;III directors, unless you withhold authority to vote for the election of any or all of these nominees by indicating as such in your proxy. Each of
the nominees has indicated his willingness to serve, if elected. However, if either of the nominees should be unable or unwilling to serve, the proxies may be voted for a substitute nominee designated by our Board, or our Board may reduce the number
of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Recommendation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Board of Directors recommends a vote </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#147;FOR&#148; the election of each of the Class&nbsp;III director nominees. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTORS AND NOMINEES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following paragraphs provide information as of the date of this proxy statement about each Class&nbsp;III director nominee and each member
of our Board of Directors whose term continues after the 2016 Annual Meeting. The information presented includes information about each such director, including age, all positions and offices held with us, length of service as a director, principal
occupation and employment for the past five years and the names of other publicly held companies of which he has served as a director during the past five years. For information about the number of shares of common stock beneficially owned by our
directors as of March&nbsp;29, 2016, please see &#147;Information About Stock Ownership&#148; beginning on page 41. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each director to be
elected at the 2016 Annual Meeting will hold office from the date of their election by the stockholders until the third subsequent annual meeting of stockholders or until his successor is elected and has been qualified, or until such director&#146;s
earlier death, resignation or removal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares represented by executed proxies will be voted, if authority to do so is not withheld, for
the election of the two nominees named below. In the event that any nominee should be unavailable for election as a result of an unexpected occurrence, such shares will be voted for the election of such substitute nominee as the Board may propose.
Each person nominated for election has agreed to serve if elected, and management has no reason to believe that any nominee will be unable to serve. Directors are elected by a plurality of the votes cast at the meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nominees for Election to a Three-Year Term Expiring at the 2019 Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Paulo Costa, age 65 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Costa has served as a director since June 2009. Mr.&nbsp;Costa served as President and Chief Executive Officer of Novartis U.S.
Corporation, from October 2005 to August 2008. Prior to that Mr.&nbsp;Costa was President and CEO of Novartis Pharmaceuticals, US from July 1999 to September 2005. From August 2009 to August 2012, Mr.&nbsp;Costa served as chairman of the Board of
Directors of Amylin Pharmaceuticals Inc., a publicly held company, and currently serves as a director of two privately-held companies. Based on Mr.&nbsp;Costa&#146;s diverse experience in the pharmaceutical industry, ranging from successful product
development, launch and commercialization and his extensive senior management experience within the industry, our Board believes Mr.&nbsp;Costa has the appropriate set of skills to serve as a member of our Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Edward Hurwitz, age 52 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Hurwitz has served as a director since October 2004. Mr.&nbsp;Hurwitz is a Managing Director of Precision BioVentures, LLC, a
consulting and investment advisory firm. He was a Director of Alta BioPharma III, L.P., and Alta Partners VIII, funds affiliated with Alta Partners, a venture capital firm, from 2002 through December 2014. Mr.&nbsp;Hurwitz also serves as a director
of Applied Genetic Technologies Corporation, a publicly held company. The Board believes that Mr.&nbsp;Hurwitz&#146;s financial and scientific expertise, as well as his deep understanding of the biotechnology industry, makes him an important
resource for the Board as it assesses both financial and strategic decisions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors Continuing in Office Until the 2017 Annual Meeting of
Stockholders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Scott Koenig, M.D., Ph.D., age 63 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Koenig has been our President and Chief Executive Officer and a director since September 2001 and was one of our co-founders. Prior to
joining us, Dr.&nbsp;Koenig served as Senior Vice President of Research at MedImmune, Inc., where he participated in the selection and maturation of their product pipeline. From 1984 to 1990, he worked in the Laboratory of Immunoregulation at the
National Institute of Allergy and Infectious Diseases at the National Institutes of Health, where he investigated the immune response to retroviruses and studied the pathogenesis of AIDS. Dr.&nbsp;Koenig currently serves as Chairman of the Board of
Directors of Applied Genetic Technologies Corporation, a publicly held company, and the Children&#146;s Research Institute. Additionally, Dr.&nbsp;Koenig serves on the Board of Directors of Children&#146;s National Medical Center, the International
Biomedical Research Alliance, and the Biotechnology Innovation Organization (BIO). We believe that Dr.&nbsp;Koenig&#146;s detailed knowledge of our company and his over 29 years in research and the biotechnology industry provide a valuable
contribution to our Board.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Matthew Fust, age 51 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Matthew Fust has served as a director since 2014. He was most recently Executive Vice President and Chief Financial Officer of Onyx
Pharmaceuticals, Inc., an oncology-focused biopharmaceutical company, where he served from January 2009 until its acquisition by Amgen Inc. in October 2013. From May 2003 to December 2008, Mr.&nbsp;Fust served as Chief Financial Officer of Jazz
Pharmaceuticals, Inc. From 2002 to 2003, Mr.&nbsp;Fust served as Chief Financial Officer of Perlegen Sciences, a biopharmaceutical company. Previously, he was Senior Vice President and Chief Financial Officer of ALZA Corporation, where he was an
executive from 1996 until 2002.&nbsp;Mr.&nbsp;Fust serves as a director of Atara Biotherapeutics, Inc., Dermira, Inc., Sunesis Pharmaceuticals and Ultragenyx Pharmaceutical, which are publicly held companies.&nbsp;Based on Mr.&nbsp;Fust&#146;s depth
of experience in the biotechnology industry, ranging from executive officer to director roles, the Board of Directors believes Mr.&nbsp;Fust has the appropriate set of skills to serve as a member of the Board of Directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors Continuing in Office Until the 2018 Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Kenneth Galbraith, age 53 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Galbraith has served as a director since July 2008. Mr.&nbsp;Galbraith joined Ventures West Capital in 2007 and founded Five Corners
Capital Inc., in 2013 to manage the continued operations of the Ventures West Investment Funds. Mr.&nbsp;Galbraith has over 25 years of experience acting as an executive, director, investor and advisor to companies in the biotechnology, medical
device, pharmaceutical and healthcare sectors. In addition, Mr.&nbsp;Galbraith serves as a director of several privately-held companies. Based on Mr.&nbsp;Galbraith&#146;s depth of experience in the biotechnology industry, ranging from executive
officer to director roles, the Board believes Mr.&nbsp;Galbraith has the appropriate set of skills to serve as a member of the Board.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>David Stump, M.D., age 66 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Stump has served as a director since September 2013. Dr.&nbsp;Stump was most recently Executive Vice President, Research and
Development at Human Genome Sciences, Inc., where he was employed from November 1999 until his retirement in December 2012. Dr.&nbsp;Stump also serves as a director of Sunesis Pharmaceuticals, Inc., Portola Pharmaceuticals, Inc., and REGENXBIO,
Inc., which are publicly-held companies. The Board believes that Dr.&nbsp;Stump&#146;s medical training and 23 years of experience in research and development and operations in the biotechnology industry qualify him to serve as a member of our
Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_9"></A>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Director Compensation Program (the &#147;Director Plan&#148;) for our non-employee directors. Pursuant to the Director Plan,
our non-employee directors receive an annual retainer of $35,000. The Chairman receives an additional annual retainer of $27,500. In addition, all non-employee directors who serve on one or more committees are eligible to receive the following
committee fees: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt ;border-bottom:1.00pt solid #000000; width:35.45pt; font-size:8pt; font-family:Times New Roman">Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Member&nbsp;Annual<BR>Retainer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Chair&nbsp;Additional<BR>Retainer</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt ;margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt ;margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt ;margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our directors may elect to receive these retainer amounts in cash or stock options based on the Black-Scholes
value of the dollar amount of the retainer as of the date of grant. Other than the annual retainers and committee fees paid pursuant to our Director Plan described above, non-employee directors are not entitled to receive any cash fees in connection
with their service on our Board. In addition, non-employee directors are entitled to receive an option to purchase 17,000 shares of our common stock upon initial election or appointment to the Board (the &#147;Initial Option&#148;) and an option to
purchase 8,500 shares of our common stock annually thereafter (the &#147;Annual Option&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Options granted to non-employee directors
have a per share exercise price equal to the per share fair market value of our common stock as of the date of grant and vest as to 1/12<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the shares of our common stock underlying such option
monthly, beginning on the first monthly anniversary of the applicable grant date, subject to the director&#146;s continued service on our Board through each vesting date. The Initial Option will be granted on the date the director first joins the
Board and the Annual Option will be granted on the date of the first Board meeting held after each annual meeting of stockholders. Our directors who are employees are compensated for their service as employees and do not receive any additional
compensation for their service on our Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning the compensation earned by our
non-employee directors during the year ended December&nbsp;31, 2015. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt ;border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Fees&nbsp;Earned&nbsp;or<BR>Paid in Cash</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Option&nbsp;Awards&nbsp;(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt ;margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paulo Costa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">255,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">289,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt ;margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Fust</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">183,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">245,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt ;margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kenneth Galbraith</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">183,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">237,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt ;margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward Hurwitz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">183,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">241,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt ;margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Stump, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">183,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">223,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Amount reflects the aggregate grant date fair value of options granted during 2015 computed in accordance with ASC Topic 718 <I>Stock Compensation</I>, as used by analogy for non-employees. The assumptions used in the
valuation of these awards are set forth in Note&nbsp;5 to our financial statements, which are included in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2015. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2015, each of our non-employee directors held the following outstanding
options: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Shares<BR>Subject to<BR>Outstanding<BR>Options</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paulo Costa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Fust</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kenneth Galbraith</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward Hurwitz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Stump M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_3"></A>PROPOSAL NO. 2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP currently serves as our independent registered public accounting firm. After consideration of the firm&#146;s
qualifications and past performance, the Audit Committee of our Board of Directors has appointed Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the rules of the Securities and Exchange Commission, and our Audit Committee&#146;s charter, the Audit Committee is
directly responsible for the selection, appointment, compensation, and oversight of the Company&#146;s independent registered public accounting firm and is not required to submit this appointment to a vote of the stockholders. The Board, however,
considers the appointment of the independent registered public accounting firm to be an important matter of stockholder concern and is submitting the appointment of Ernst&nbsp;&amp; Young for ratification by our stockholders as a matter of good
corporate practice. One or more representatives of Ernst&nbsp;&amp; Young is expected to be present at the Annual Meeting and will have an opportunity to make a statement and respond to appropriate questions from stockholders. In the event that our
stockholders fail to ratify the appointment of Ernst&nbsp;&amp; Young, it will be considered as a direction to the Audit Committee to consider the appointment of a different firm. Even if the appointment is ratified, the Audit Committee in its
discretion may select a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and its stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Required Vote and Board Recommendation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ratification of the appointment of Ernst&nbsp;&amp; Young as the Company&#146;s independent registered public accounting firm requires the
affirmative vote of a majority of the votes cast on the matter. Abstentions are not considered votes cast and, therefore, will have no effect on the voting outcome. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Board of Directors recommends a vote </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#147;FOR&#148; the ratification of the appointment of Ernst&nbsp;&amp; Young LLP. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Principal Accountant Fees and Services</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the fees paid to Ernst&nbsp;&amp; Young&nbsp;LLP during the years ended December&nbsp;31,
2015 and 2014. All fees described below were approved by the Audit Committee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Year Ended December&nbsp;31,</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2015</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2014</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">843,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">440,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">289,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,053,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">969,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Audit fees for 2015 and 2014 were for professional services rendered for the audits of our financial statements, reviews of quarterly financial statements and consents related to regulatory filings. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Audit-related fees for 2015 and 2014 were for services associated with our follow-on offerings, consultations concerning financial accounting and other audit requirements. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Tax fees for 2015 consist of $64,500 for tax compliance, including the preparation, review and filing of tax returns, and $29,799 for tax advice and planning. Tax fees for 2014 consist of $143,387 for tax compliance,
including the preparation, review and filing of tax returns, and $145,723 for tax advice and planning. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pre-Approval Policies and Procedures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee pre-approves all audit and non-audit services provided by its independent registered public accounting firm. This policy is
set forth in the charter of the Audit Committee and available on the Corporate Governance section of our website at http://ir.macrogenics.com/corporate-governance.cfm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee approved all audit, audit-related, tax and other services provided by Ernst&nbsp;&amp; Young&nbsp;LLP for 2015 and 2014
and the estimated costs of those services. Actual amounts billed, to the extent in excess of the estimated amounts, were periodically reviewed and approved by the Audit Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_4"></A>REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC, and is not to be incorporated by
reference into any filing by MacroGenics under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary purpose of the Audit Committee is to oversee the Company&#146;s financial reporting processes on behalf of the Board. The Audit
Committee&#146;s functions are more fully described in its charter, which is available on the Corporate Governance section of the Company&#146;s website at http://ir.macrogenics.com/corporate-governance.cfm. Management has the primary responsibility
for the Company&#146;s financial statements and reporting processes, including the Company&#146;s systems of internal controls. In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed with management
MacroGenics&#146; audited financial statements and the effectiveness of the Company&#146;s internal controls over financial reporting as of and for the year ended December&nbsp;31, 2015. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has discussed with Ernst&nbsp;&amp; Young&nbsp;LLP, the Company&#146;s independent registered public accounting firm, the
matters required to be discussed by Statement on Auditing Standards No.&nbsp;61, as amended (AICPA, Professional Standards, Vol. 1. AU section&nbsp;380) as adopted by the Public Company Accounting Oversight Board (&#147;PCAOB&#148;) in
Rule&nbsp;3200T. In addition, the Audit Committee discussed with Ernst&nbsp;&amp; Young&nbsp;LLP their independence, and received from Ernst&nbsp;&amp; Young&nbsp;LLP the written disclosures and the letter required by Ethics and Independence
Rule&nbsp;3526 of the PCAOB. Finally, the Audit Committee discussed with Ernst&nbsp;&amp; Young&nbsp;LLP, with and without management present, the scope and results of Ernst&nbsp;&amp; Young&nbsp;LLP&#146;s audit of such financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on these reviews and discussions, the Audit Committee recommended to the Board that such audited financial statements be included in the
Company&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2015, for filing with the SEC. The Audit Committee also has engaged Ernst&nbsp;&amp; Young&nbsp;LLP as the Company&#146;s independent registered public accounting
firm for the fiscal year ending December&nbsp;31, 2016, and is seeking ratification of such selection by the Company&#146;s stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Audit Committee </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Matthew Fust, Chairman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Kenneth Galbraith </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Edward Hurwitz </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_5"></A>PROPOSAL NO. 3 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;14A of the Securities Exchange Act, our Board of Directors is asking stockholders to approve an advisory vote on the
following resolution: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>RESOLVED</B>, that the compensation paid to MacroGenics&#146; named executive officers, as disclosed pursuant to
the compensation disclosure rules of the Securities and Exchange Commission, including the compensation discussion and analysis, the compensation tables and any related material disclosed in this proxy statement, is hereby approved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As an advisory vote, this proposal is not binding.&nbsp;Although the vote is non-binding, our compensation committee and Board of Directors
value the opinions expressed by our stockholders in their vote on this proposal and will consider the outcome of the vote when making future compensation decisions for our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our executive compensation programs are designed to attract, motivate, and retain executive officers who are critical to our success. Under
these programs, our named executive officers are rewarded for the achievement of our near-term and longer-term financial and strategic goals and for driving corporate financial performance and stability.&nbsp;The programs contain elements of cash
and equity-based compensation and are designed to align the interests of our executives with those of our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
&#147;Executive Compensation&#148; section of this proxy statement beginning on page 24, including &#147;Compensation Discussion and Analysis&#148; beginning on page 24 describes in detail our executive compensation programs and the decisions made
by the Compensation Committee with respect to 2015.&nbsp;Highlights of our executive compensation philosophy include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">A significant portion of each senior executive&#146;s compensation should be variable, based on a combination of individual and corporate performance; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Compensation opportunities should be competitive with clinical-stage biopharmaceutical companies of similar size and comparable stage of development, but also should be designed to be flexible enough to attract talent
as needed from larger biopharmaceutical companies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The equity compensation program should align executive interests with those of stockholders; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Supplemental benefits and perquisites should be limited and used selectively in specific circumstances to attract and retain executives. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As we describe in the &#147;Compensation Discussion and Analysis&#148; section of this proxy statement, our executive compensation program
embodies a pay-for-performance philosophy that supports our business strategy and aligns the interests of our executives with those of our stockholders.&nbsp;The Board of Directors believes this link between compensation and the achievement of our
near- and long-term business goals has helped drive our performance over time. At the same time, we believe our program does not encourage excessive risk-taking by management. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required and Board Recommendation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of Proposal No.&nbsp;3 requires the affirmative vote of a majority of the votes cast on the proposal. Abstentions are not considered
votes cast and, therefore, will have no effect on the vote outcome. If you own shares through a bank, broker or other holder of record, you must instruct your bank, broker or other holder of record how to vote on this proposal for your shares to be
counted on this proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The Board of Directors recommends a vote &#147;FOR&#148; the approval of the advisory vote on the
compensation of our named executive officers. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_6"></A>PROPOSAL NO.&nbsp;4 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this Proposal No.&nbsp;4, we are asking our stockholders to cast a non-binding advisory vote regarding the frequency of future advisory
votes on executive compensation. Stockholders may vote for a frequency of every one, two, or three years, or may abstain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of
Directors will take into consideration the outcome of this vote in making a determination about the frequency of future advisory votes on executive compensation. However, because this vote is advisory and non-binding, the Board of Directors may
decide that it is in the best interest of our stockholders and the company to hold future advisory votes on executive compensation more or less frequently. In the future, we will propose an advisory vote on the frequency of future advisory votes on
executive compensation at least once every six calendar years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Our Board of Directors acknowledges that there are a number of points
of view regarding the relative benefits of the frequency of advisory votes on executive compensation. Accordingly, our Board of Directors is not making a recommendation on this Proposal 4 and currently intends to hold future advisory votes on
executive compensation in accordance with the frequency option that receives the most stockholder support. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_7"></A>CORPORATE GOVERNANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a
code of business conduct and ethics that applies to all of our employees, officers and directors, including those officers responsible for financial reporting. The code of business conduct and ethics is available under the Corporate Governance
section of our website at http://ir.macrogenics.com/corporate-governance.cfm. We expect that any amendments to the code, or any waivers of its requirements, will be disclosed on our website or in a Current Report on Form 8-K. The references to our
web address in this proxy statement do not constitute incorporation by reference of the information contained at or available through our website. In addition, we have adopted a corporate insider trading policy that establishes procedures regulating
the trading of the Company&#146;s securities by directors and employees. This policy restricts trading during specified blackout periods, establishes procedures for directors, executive officers and certain other employees to obtain pre-approval for
market trades and prohibits these individuals from engaging in certain types of transactions involving Company securities such as short sales, open market trading of options or derivatives, trading on margin and any hedging, monetization or similar
arrangements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Independence of the Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under NASDAQ rules and regulations, a majority of the members of a listed company&#146;s Board of Directors must qualify as
&#147;independent,&#148; as affirmatively determined by the Board. The Board consults with the Company&#146;s counsel to ensure that the Board&#146;s determinations are consistent with all relevant securities and other laws and regulations regarding
the definition of &#147;independent,&#148; including those set forth in pertinent NASDAQ listing standards, as in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent with these considerations, our Board has determined that all of our directors, other than Dr.&nbsp;Koenig, qualify as
&#147;independent&#148; directors in accordance with the NASDAQ listing requirements. Dr.&nbsp;Koenig is not considered independent because he is an employee of MacroGenics. The NASDAQ independence definition includes a series of objective tests,
such as that the director is not, and has not been for at least three years, one of our employees and that neither the director nor any of his family members has engaged in various types of business dealings with us. In addition, as required by
NASDAQ rules, our Board has made a subjective determination as to each independent director that no relationships exist, which, in the opinion of our Board, would interfere with the exercise of independent judgment in carrying out the
responsibilities of a director. In making these determinations, our Board reviewed and discussed information provided by the directors and us with regard to each director&#146;s business and personal activities and relationships as they may relate
to us and our management. There are no family relationships among any of our directors or executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under NASDAQ
rules and regulations, our independent directors meet in regularly scheduled executive sessions at which only independent directors are present. All of the committees of our Board are comprised entirely of directors determined by the Board to be
independent within the meaning of NASDAQ rules and regulations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Leadership Structure of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors does not have a policy regarding whether the roles of Chief Executive Officer and Chairman of the Board should be
separate and, if they are to be separate, whether the Chairman of the Board should be a non-employee director. The Board will continue to periodically review our leadership structure and may make such changes in the future as it deems appropriate
and in the best interests of the Company and its stockholders. However, the Board believes that separation of the roles of Chief Executive Officer and Chairman of the Board is currently the most appropriate structure for the Company because that
structure is consistent with best corporate governance practices and may enhance the independence of the Board. Currently, Mr.&nbsp;Costa, a non-employee director, serves as the Chairman of the Board and Dr.&nbsp;Koenig serves as a director and
Chief Executive Officer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Role of Board in Risk Oversight Process </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Risk assessment and oversight are an integral part of our governance and management processes. Our Board encourages management to promote a
culture that incorporates risk management into our corporate strategy and day-to-day business operations. Management discusses strategic and operational risks at regular management meetings, and conducts specific strategic planning and review
sessions during the year that include a focused discussion and analysis of the risks facing us. Throughout the year, senior management reviews these risks with the Board at regular Board meetings as part of management presentations that focus on
particular business functions, operations or strategies, and presents the steps taken by management to mitigate or eliminate such risks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board does not have a standing risk management committee, but rather administers this oversight function directly through our Board as a
whole, as well as through various standing committees of our Board that address risks inherent in their respective areas of oversight. In particular, our Board is responsible for monitoring and assessing strategic risk exposure, our Audit Committee
is responsible for overseeing our major financial risk exposures and the steps our management has taken to monitor and control these exposures. The Audit Committee also monitors compliance with legal and regulatory requirements and considers and
approves or disapproves any related-person transactions. Our Nominating and Governance Committee monitors the effectiveness of our corporate governance guidelines. Our Compensation Committee assesses and monitors whether any of our compensation
policies and programs has the potential to encourage excessive risk-taking. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Audit
Committee oversees our corporate accounting and financial reporting process. Among other matters, the Audit Committee: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">appoints our independent registered public accounting firm;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">evaluates the independent registered public accounting firm&#146;s qualifications, independence and performance;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">determines the engagement of the independent registered public accounting firm;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviews and approves the scope of the annual audit and the audit fee;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">discusses with management and the independent registered public accounting firm the results of the annual audit and the review of our quarterly financial statements;</TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">approves the retention of the independent registered public accounting firm to perform any proposed permissible non-audit services;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">monitors the rotation of partners of the independent registered public accounting firm on our engagement team as required by law; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">is responsible for reviewing our financial statements and our management&#146;s discussion and analysis of financial condition and results of operations to be included in our annual and quarterly reports to be filed
with the SEC;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviews our critical accounting policies and estimates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviews our approach to compliance with legal and regulatory requirements; and</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">annually reviews the Audit Committee charter and the committee&#146;s performance. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
current members of our Audit Committee are Matthew Fust, Kenneth Galbraith and Edward Hurwitz. Mr.&nbsp;Fust serves as the chair of the Audit Committee. All members of our Audit Committee meet the requirements for financial literacy under the
applicable rules and regulations of the SEC and NASDAQ. Our Board has determined that each of Messrs. Fust, Galbraith and Hurwitz qualifies as an &#147;audit committee financial expert&#148; as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
defined under the applicable rules of the SEC and has the requisite financial sophistication as defined under the applicable rules and regulations of NASDAQ. Our Board has determined that each of
Messrs. Fust, Galbraith and Hurwitz are independent under the applicable rules of NASDAQ and under the applicable rules of the SEC, in particular, Rule&nbsp;10A-3 of the Exchange Act. The Audit Committee operates under a written charter that
satisfies the applicable standards of the SEC and NASDAQ and the committee reviews compliance with its charter annually. A copy of the Audit Committee charter is available to security holders on the Corporate Governance section of the Company&#146;s
website at http://ir.macrogenics.com/corporate-governance.cfm. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee reviews and recommends policies relating to compensation and benefits of our officers and employees. The
Compensation Committee reviews and recommends to our Board corporate goals and objectives relevant to compensation of our Chief Executive Officer, evaluates the performance of the Chief Executive Officer in light of those goals and objectives and
determines his compensation based on such evaluations. The Compensation Committee also reviews and approves the corporate goals and objectives relevant to the executive officer compensation other than the Chief Executive Officer and evaluates the
performance and determines all compensation for those individuals. The Compensation Committee also determines the issuance of stock options and other awards under our stock plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The current members of our Compensation Committee are Edward Hurwitz, Paulo Costa and David Stump, M.D. Mr.&nbsp;Hurwitz serves as the chair
of the Compensation Committee. Each of the members of our Compensation Committee is independent under the applicable rules and regulations of NASDAQ, is a &#147;non-employee director&#148; as defined in Rule&nbsp;16b-3 promulgated under the Exchange
Act and is an &#147;outside director&#148; as that term is defined in Section&nbsp;162(m) of the U.S. Internal Revenue Code of 1986, as amended, or Section&nbsp;162(m). The Compensation Committee operates under a written charter and the committee
reviews compliance with its charter annually. A copy of the Compensation Committee charter is available on the Corporate Governance section of the Company&#146;s website at http://ir.macrogenics.com/corporate-governance.cfm. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee is responsible for making recommendations to our Board regarding candidates for directorships
and the size and composition of our Board. In addition, the Nominating and Corporate Governance Committee is responsible for overseeing our corporate governance policies and reporting and making recommendations to our Board concerning governance
matters. The current members of our Nominating and Corporate Governance committee are Kenneth Galbraith, Paulo Costa and Matthew Fust. Mr.&nbsp;Galbraith serves as the chair of the Nominating and Corporate Governance Committee. Each of the members
of our Nominating and Corporate Governance Committee is an independent director under the applicable rules and regulations of NASDAQ relating to Nominating and Corporate Governance Committee independence. The Nominating and Corporate Governance
Committee operates under a written charter and the committee reviews compliance with its charter annually. A copy of the Nominating and Corporate Governance Committee charter is available to security holders on the Corporate Governance section of
the Company&#146;s website at http://ir.macrogenics.com/corporate-governance.cfm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In recommending candidates for election to the Board,
the independent members of the Nominating and Corporate Governance Committee may consider the following criteria, among others: personal and professional integrity, ethics and values; experience in corporate management, such as serving as an officer
or former officer of a publicly held company; experience in the industries in which we compete; experience as a Board member or executive officer of another publicly held company; diversity of expertise and experience in substantive matters
pertaining to our business relative to other Board members; conflicts of interest; and practical and mature business judgment. The Board evaluates each individual in the context of the Board as a whole, with the objective of assembling a group that
can best maximize the success of the business and represent stockholder interests through the exercise of sound judgment using its diversity of experience in these various areas. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee will consider director candidates recommended
by stockholders. For a stockholder to make any nomination for election to the Board at an annual meeting, the stockholder must provide notice to the Company, which notice must be delivered to, or mailed and received at, the Company&#146;s principal
executive offices not less than 90&nbsp;days and not more than 120&nbsp;days prior to the one-year anniversary of the preceding year&#146;s annual meeting; provided, that if the date of the annual meeting is more than 20&nbsp;days before or more
than 60&nbsp;days after such anniversary date, the stockholder&#146;s notice must be delivered, or mailed and received, not earlier than the 120th day prior to such annual meeting and not later than the close of business on the later of (a)&nbsp;the
90th day prior to such annual meeting and (b)&nbsp;the tenth day following the day on which notice of the date of such annual meeting was mailed or public disclosure of the date of such annual meeting was made, whichever first occurs. Further
updates and supplements to such notice may be required at the times, and in the forms, required under our bylaws. As set forth in our by-laws, submissions must include the name and address of the proposed nominee, information regarding the proposed
nominee that is required to be disclosed in a proxy statement or other filings in a contested election pursuant to Section&nbsp;14(a) under the Exchange Act, information regarding the proposed nominee&#146;s indirect and direct interests in shares
of the Company&#146;s common stock, and a completed and signed questionnaire, representation and agreement of the proposed nominee. Our bylaws also specify further requirements as to the form and content of a stockholder&#146;s notice. We recommend
that any stockholder wishing to make a nomination for director review a copy of our bylaws, as amended and restated to date, which is available, without charge, from our Corporate Secretary, at 9704 Medical Center Drive, Rockville, Maryland 20850.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Meetings of the Board of Directors, Board and Committee Member Attendance and Annual Meeting Attendance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board met seven times during the last year. The Audit Committee met seven times, the Compensation Committee met seven times and the
Nominating and Corporate Governance Committee met four times during last year. Additionally, all of our Board members attended our 2015 Annual Meeting of Shareholders. During 2015, each Board member attended 75% or more of the meetings of the Board
and of the committees on which he served. We encourage all of our directors and nominees for director to attend our annual meeting of stockholders, but attendance is not mandatory. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Communications with the Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should stockholders wish to communicate with the Board or any specified individual directors, such correspondence should be sent to the
attention of the Corporate Secretary at 9704 Medical Center Drive, Rockville, Maryland 20850. The Corporate Secretary will forward the communication to the Board members. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the members of our Compensation Committee has at any time been one of our officers or employees. None of our executive officers
currently serves, or in the past fiscal year has served, as a member of the Board of Directors or compensation committee of any entity that has one or more executive officers on our Board or Compensation Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_8"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2014, we entered into a collaboration and license agreement with Janssen Biotech, Inc., or Janssen, relating to one of our
programs, designated MGD011, and concurrently entered into a stock purchase agreement and an investor agreement with Johnson&nbsp;&amp; Johnson Innovation&#151;JJDC, Inc., or JJDC, an affiliate of Janssen. The transactions contemplated by these
agreements closed in the first quarter of 2015. Under the terms of this stock purchase agreement, JJDC acquired 1,923,077 shares of our common stock, which is approximately 5.6% of our common stock as of March&nbsp;29, 2016.&nbsp;JJDC has certain
rights and is subject to certain restrictions as set forth in greater detail in the above referenced investor agreement. JJDC does not have any rights to appoint individuals to our Board of Directors or otherwise direct our general
operations.&nbsp;There are on-going rights and obligations set forth in the above referenced collaboration and license agreement with Janssen, under which Janssen can control and direct the MGD011 program subject to the terms of that agreement;
however, Janssen does not have any rights to direct our general operations.&nbsp;The collaboration and license agreement, the stock purchase agreement, and the investor agreement are attached as exhibits to our Annual Report on Form 10-K, filed with
the SEC on March&nbsp;3, 2015. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than the foregoing, since January&nbsp;1, 2013, there has not been, nor is there any proposed
transaction where we were or will be a party in which the amount involved exceeded or will exceed $120,000 and in which any director, executive officer, holder of more than 5% of any class of our voting securities, or any member of the immediate
family of any of the foregoing persons had or will have a direct or indirect material interest, other than the compensation agreements and other agreements and transactions which are described in &#147;Executive Compensation&#151;Employment
Arrangements&#148;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Policies and Procedures for Related Party Transactions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the written charter of our Audit Committee, that committee is responsible for reviewing and approving, prior to our entry into any
such transaction, all related party transactions and potential conflict of interest situations involving a principal stockholder, a member of the Board of Directors or senior management. This policy covers, with certain exceptions set forth in
Item&nbsp;404 of Regulation&nbsp;S-K under the Securities Act of 1933, as amended, any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships in which we were or are to be a participant, where
the amount involved exceeds $120,000 and a related person had or will have a direct or indirect material interest, including, without limitation, purchases of goods or services by or from the related person or entities in which the related person
has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related person. In reviewing and approving any such transactions, our Audit Committee considers all relevant facts and circumstances, including, but not
limited to, whether the transaction is on terms comparable to those that could be obtained in an arm&#146;s length transaction and the extent of the related person&#146;s interest in the transaction. In addition, our Company policies require that
our officers and employees avoid using their positions for purposes that are, or give the appearance of being, motivated by a desire for personal gain, and our policies further require that all officers and employees report any potential related
party transaction prior to entering into such transaction. All such notices concerning related party transactions or conflicts of interest are submitted to, and reviewed by, our general counsel, our chief financial officer and our Audit Committee.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_10"></A>IDENTIFICATION OF EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following sets forth certain information regarding our current executive officers as of March&nbsp;29, 2016: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="71%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Age</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:34.55pt; font-size:8pt; font-family:Times New Roman">Position(s)</P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott&nbsp;Koenig,&nbsp;M.D.,&nbsp;Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Chief Executive Officer and Director</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Chief Financial Officer and Corporate Secretary</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Research</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Risser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Business Development and Portfolio Management</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atul Saran</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President and General Counsel</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Clinical Development and Chief Medical Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lynn Cilinski</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President, Controller and Treasurer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Scott Koenig, M.D., Ph.D., </I></B>President and Chief Executive Officer and a director since September
2001 was one of our co-founders. Prior to joining us, Dr.&nbsp;Koenig served as Senior Vice President of Research at MedImmune, Inc., where he participated in the selection and maturation of their product pipeline. From 1984 to 1990, he worked in
the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, where he investigated the immune response to retroviruses and studied the pathogenesis of AIDS. Dr.&nbsp;Koenig
currently serves as Chairman of the Board of Directors of Applied Genetic Technologies Corporation, a publicly held company,&nbsp;and the Children&#146;s Research Institute. Additionally, Dr.&nbsp;Koenig serves on the Board of Directors of
Children&#146;s National Medical Center, the International Biomedical Research Alliance, and the Biotechnology Innovation Organization (BIO). Dr.&nbsp;Koenig received his A.B. and Ph.D. from Cornell University and his M.D. from the University of
Texas Health Science Center in Houston. We believe that Dr.&nbsp;Koenig&#146;s detailed knowledge of our company and his over 29 years in research and the biotechnology industry provide a valuable contribution to our Board.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>James&nbsp;Karrels,</I></B> Senior Vice President, Chief Financial Officer and Corporate Secretary, joined us in May 2008 and has
approximately 25 years of experience in finance, a significant portion of which he has worked for, or on behalf of, life sciences companies. Prior to joining us, he was at Jazz Pharmaceuticals, Inc., most recently serving as Executive Director of
Finance, where he was responsible for the company&#146;s financial planning and analysis and investor relations activities. Prior to joining Jazz Pharmaceuticals, Mr.&nbsp;Karrels spent 11 years in the Investment Banking Group at Merrill Lynch, most
recently serving as a Director in the Global Healthcare Group. Mr.&nbsp;Karrels holds an M.B.A. from Stanford University and a B.B.A. from the University of Notre Dame. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ezio Bonvini, M.D.</I></B>, Senior Vice President, Research, joined us in June 2003. From 1985 to 2003, Dr.&nbsp;Bonvini was with the
FDA in the Center for Biologics Evaluation and Research, or CBER, which is responsible for regulating therapeutic monoclonal antibodies and other proteins, ultimately serving as Acting Deputy Director, Division of Monoclonal Antibodies and Chief,
Laboratory of Immunobiology. From 1982 to 1984, Dr.&nbsp;Bonvini was a Visiting Fellow at the National Cancer Institute at the National Institutes of Health. Dr.&nbsp;Bonvini received a Diploma in Science from the Scientific Lyceum in Genoa, Italy,
and his M.D. and Specialty Certification in Clinical Hematology from the University of Genoa, School of Medicine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Eric&nbsp;Risser</I></B><I>,</I> Senior Vice President, Business Development and Portfolio Management, joined us in March&nbsp;2009.
Prior to joining us, Mr.&nbsp;Risser held the position of Senior Director, Business Development in the pharmaceutical group at Johnson&nbsp;&amp; Johnson, where he worked from 2003 to 2009. Before Johnson&nbsp;&amp; Johnson, Mr.&nbsp;Risser started
and built a consulting practice that provided counsel to emerging life science companies in the United States and Europe. Earlier in his career, Mr.&nbsp;Risser held venture capital and investment banking positions with BA Venture Partners and
Lehman Brothers Holdings Inc., respectively. Mr.&nbsp;Risser holds an M.B.A. from Stanford University and a B.A. from Yale University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Atul Saran, </I></B>Senior Vice President and General Counsel, joined us in April 2014.&nbsp;Before joining MacroGenics, Mr.&nbsp;Saran
spent over a decade at AstraZeneca and MedImmune. From May 2013 through </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
January&nbsp;2014, Mr.&nbsp;Saran was Vice President, Corporate Development and Ventures for AstraZeneca PLC. During that time, he was responsible for AstraZeneca&#146;s global corporate
development strategies and also chaired the MedImmune Ventures Investment Committee. From January 2011 through May 2013, Mr.&nbsp;Saran was Senior Vice President, Corporate Development and Ventures for MedImmune, the biologics business for
AstraZeneca. During that time, he was responsible for corporate and business development, government contracting and oversight for MedImmune Ventures. From February 2003 through December 2010, Mr.&nbsp;Saran had positions of increasing
responsibility in the MedImmune legal department, both before and after its acquisition by AstraZeneca, culminating as Vice President and Deputy General Counsel, the role he held from September 2008 through December 2010. Before joining MedImmune,
Mr.&nbsp;Saran was a practicing attorney in the private equity/emerging business group at Hogan&nbsp;&amp; Hartson, LLP in Washington, D.C.&nbsp;Mr. Saran holds an M.B.A. from the MIT Sloan School of Management, a J.D. from the University of
Illinois College of Law and a B.S. in biological sciences from Stanford University. He is a member of the bar in the State of California and in the District of Columbia. From August 2011 through January 2014, Mr.&nbsp;Saran served on the Board of
Directors for Xencor, Inc., a company that was publicly held starting in December 2013, and also previously served on the Board of Directors of privately held companies Arriva Pharmaceuticals, Inc. and Inotek Pharmaceuticals Corporation. He is
currently a member of the boards of directors of private companies, VentiRx Pharmaceuticals, Inc. and LogicNets, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Jon&nbsp;Wigginton, M.D.</I></B>, Senior Vice President, Clinical Development and Chief Medical Officer, joined us in August 2013 as
Senior Vice President, Clinical Development and was promoted to Chief Medical Officer in February 2016. Dr.&nbsp;Wigginton was previously the Therapeutic Area Head, Immuno-Oncology, Early Clinical Research and Executive Director, Discovery
Medicine-Clinical Oncology at Bristol-Myers from October&nbsp;2008 to August&nbsp;2013. While there, he led the early clinical development of the Bristol-Myers&#146; Immuno-Oncology portfolio including anti-PD-1 and anti-PD-L1. Prior to joining
Bristol-Myers, Dr.&nbsp;Wigginton was the Director of Clinical Oncology at Merck Research Laboratories from May 2006 to October 2008, where he led early- and late-stage clinical development teams for small molecules and biologics. During his
academic career, Dr.&nbsp;Wigginton held several positions at the National Cancer Institute Center for Cancer Research (NCI-CCR), including Head of Investigational Biologics Section, Pediatric Oncology Branch. Dr.&nbsp;Wigginton received his M.D.
and B.S. in Biology from the University of Michigan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Lynn&nbsp;Cilinski</I></B>, Vice President, Controller and Treasurer, joined
us in October 2003. Prior to joining us, Ms.&nbsp;Cilinski spent a year as a consultant to various companies providing services to the government. Prior to that, she spent more than 20 years with Covanta Energy Inc. (formerly Ogden Corporation)
where she held the position of Corporate Controller for four subsidiary companies that provided services to the federal government. Ms.&nbsp;Cilinski holds a B.S. from Strayer University. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_11"></A>EXECUTIVE COMPENSATION<BR> COMPENSATION DISCUSSION AND ANALYSIS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation
Discussion&nbsp;&amp; Analysis (&#147;CD&amp;A&#148;) considers the Company&#146;s executive compensation philosophy, the objectives and operation of the compensation program, how compensation was set for 2015 and the various elements of
compensation paid to the named executive officers for services during 2015. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2015, MacroGenics&#146; named executive officers consisted
of the following people: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="62%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1.00pt solid #000000; width:35.90pt; font-size:8pt; font-family:Times New Roman"><B>Position(s)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and Director</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(principal executive officer)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Chief Financial Officer and Corporate Secretary (principal financial officer)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Clinical Development (1)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Research</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atul Saran</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President and General Counsel</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:7%;border-bottom:1px solid #000000; width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">In the first quarter of 2016, Dr.&nbsp;Wigginton was promoted to Senior Vice President, Clinical Development and Chief Medical Officer. The compensation information for all named executive officers, including
Dr.&nbsp;Wigginton, is as of and for the year ended December&nbsp;31, 2015. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Compensation Philosophy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MacroGenics&#146; compensation program is designed to attract, retain and reward a strong performing workforce in a highly competitive market
to achieve the Company&#146;s mission, vision, and goals. This philosophy is reflected in the components of the Company&#146;s compensation program, and includes the following principles: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pay should be linked to individual and corporate performance; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">compensation opportunities should be competitive with comparable biopharmaceutical companies, but also should be designed to be flexible enough to attract talent as needed from larger biopharmaceutical companies;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the equity compensation program should align executives&#146; interests with those of stockholders; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">supplemental benefits and perquisites should be limited and used selectively in specific circumstances to attract and retain executives </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee believes that these principles allow for retaining and rewarding high-performing employees while ensuring
individual and corporate accountability. It will also allow MacroGenics to recruit and retain top talent at the senior executive level. This is especially critical at our current size and stage of development, but also for our future growth over the
next several years. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Attract and Retain Highly Qualified Executives </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee believes that the compensation for MacroGenics&#146; named executive officers should be designed to attract,
motivate and retain highly qualified executive officers responsible for the success of MacroGenics and should be determined within a framework that rewards performance and aligns the interests of the named executive officers with the interests of
the Company&#146;s stockholders. Within this overall philosophy, the Compensation Committee&#146;s objectives are to: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">offer a total compensation program that enables MacroGenics to attract, motivate, and retain, from a limited pool of resources, individuals who are highly experienced with a proven track record of success, and to
provide total compensation that is competitive with the Company&#146;s peers within the biotechnology and pharmaceutical industry; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">achieve an equitable balance in the compensation offered to the members of the executive team; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide annual variable cash incentive awards that take into account the achievement of individual performance criteria based on the Company&#146;s performance goals; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">make a significant portion of named executive officers&#146; compensation dependent on MacroGenics&#146; long-term performance and on enhancing stockholder value by providing appropriate long-term, equity-based
incentives and encouraging stock ownership. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Balance Corporate and Individual Performance </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee believes that a significant portion of a named executive officer&#146;s total compensation should be affected by the
overall Company performance as well as that individual&#146;s performance. Incentives are based on meeting criteria in each of these categories and reflect the named executive officer&#146;s overall contribution to the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reward Named Executive Officers for Meeting MacroGenics&#146; Strategic Goals and Objectives </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation program rewards the Company&#146;s named executive officers for achieving specified performance goals, building stockholder
value and maintaining long-term careers with MacroGenics. The compensation program is designed to reward these three aspects because the Compensation Committee believes it will motivate the executive team to make balanced annual and long-term
decisions resulting in financial performance, scientific and product development innovations, and achievement of the Company&#146;s strategic business objectives. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Align Named Executive Officers&#146; Goals with MacroGenics&#146; Stockholders&#146; Goals </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee believes that MacroGenics&#146; long-term success depends upon aligning executives&#146; and stockholders&#146;
interests. To support this objective, MacroGenics provides the named executive officers with equity accumulation opportunities by awarding stock options and, in certain cases, restricted stock. Generally, stock option grants vest over four years,
which supports long-term retention of our named executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Align Named Executive Officers&#146; Compensation with Market Benchmarks
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With the assistance of an independent compensation consultant, the Compensation Committee evaluates benchmarks for each named
executive officer&#146;s current compensation against the market data with a philosophy that generally targets the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentiles for
base salary, the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile for annual cash bonus and the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile for
long-term (equity) incentives. The Company believes these are common reference points among biotechnology companies similar in size to MacroGenics and that the Company remains competitive by setting specific targets for competitive positioning
relative to the market data, while allowing for individual differentiation based on performance and other internal factors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Independent
Compensation Consultant </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee retained Radford, an Aon Hewitt Company&#151;a division of Aon Corporation, a
national executive compensation consulting firm, to conduct market research and analysis to assist the committee in developing executive compensation levels for 2015, including appropriate salaries and target bonus
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
percentages as well as equity awards for our executives. After review and consultation with Radford, the Compensation Committee determined that Radford was independent and that there was no
conflict of interest resulting from retaining Radford for such engagement. In reaching these conclusions, our Compensation Committee considered the factors set forth in the SEC rules and NASDAQ listing standards. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Oversight and Operation of the Executive Compensation Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee is appointed by the Board to assist the Board with its responsibilities related to the compensation of the
Company&#146;s directors, officers, and employees and the development and administration of the Company&#146;s compensation plans. For details on the Compensation Committee&#146;s oversight of the executive compensation program, see the section
titled &#147;Information Regarding the Board of Directors, Certain Committees and Corporate Governance Matters&#151;Compensation Committee&#148; beginning on page &nbsp;&nbsp;&nbsp;&nbsp; of this Proxy Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Chief Executive Officer evaluates and provides to the Compensation Committee performance assessments and compensation recommendations for
each named executive officer other than himself. The Compensation Committee reviews the performance for each named executive officer and determines the appropriate executive compensation. The Compensation Committee then recommends that the Board,
other than Dr.&nbsp;Koenig, approve the executive compensation determinations made by the Compensation Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Process for Setting Executive
Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We review compensation annually for all employees, including our executives. In setting executive base salaries and
bonuses and granting equity incentive awards, we consider compensation for comparable positions in the market, the historical compensation levels of our executives, individual performance as compared to our expectations and objectives, our desire to
motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders and to promote a long-term commitment to our Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee has determined our executives&#146; compensation based on reviews and discussions with the Chief
Executive&nbsp;Officer for all executives other than the Chief Executive Officer. Based on those discussions and its discretion, the Compensation Committee then determines the compensation for each executive officer. Members of management are not
present for these Compensation Committee discussions except for Dr.&nbsp;Koenig, who participates in these discussions. Dr.&nbsp;Koenig is not present for the Board or Compensation Committee discussions regarding his compensation and is not a member
of the Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compensation packages for each named executive officer are analyzed and discussed separately by
Compensation Committee at least annually. Prior to that review, Radford performs an analysis, considering the goals of market competitiveness, the executive&#146;s performance and contribution to the Company, and internal equity. The results of this
analysis are presented to the Compensation Committee, although at any time, the Compensation Committee may request additional information from the human resources team. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Peer Group and Market Data </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
conducting its analysis, the Compensation Committee directed Radford to assess the compensation practices of publicly traded peer companies with a median profile that was substantially similar to that of the Company at the time of review. The peer
group was constructed from U.S.-based biopharmaceutical companies of a similar size to the Company, by market capitalization and number of employees, with at least one product candidate in Phase 2 or Phase 3 of clinical development. As secondary
considerations in selecting this peer group, the Compensation Committee also prioritized selecting companies that were focused on oncology therapeutics, those that had been public companies for a relatively shorter period of time and those that had
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
similar levels of research and development expenses. This analysis was conducted in 2014 and in 2015 and resulted in the selection of the following companies: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>2014</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>2015</B></P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Acceleron Pharma Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Acceleron Pharma Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Array BioPharma Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Agenus Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">bluebird bio, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alder Biopharmaceuticals Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Celldex Therapeutics, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Array BioPharma Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Clovis Oncology, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Celldex Therapeutics, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Endocyte, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Epizyme, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Epizyme, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Five Prime Therapeutics, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Five Prime Therapeutics, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">ImmunoGen, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Immunomedics, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Infinity Pharmaceuticals, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Infinity Pharmaceuticals, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Kite Pharma, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Merrimack Pharmaceuticals, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Merrimack Pharmaceuticals, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">NewLink Genetics Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">NewLink Genetics Corporation</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">OncoMed Pharmaceuticals, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Novavax, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Prothena Corporation plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">OncoMed Pharmaceuticals, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sangamo BioSciences, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Prothena Corporation plc</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Tetraphase Pharmaceuticals, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Puma Biotechnology, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">XOMA Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Sangamo Biosciences Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Trevena, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Xencor, Inc.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Compensation Committee reviewed broader market compensation survey data from Radford&#146;s
Global Life Sciences survey reflecting companies of similar size, both in terms of market capitalization and number of employees, operating in the biopharmaceutical industry. The analysis conducted in 2014 was used in determining salary, non-equity
compensation targets and equity grants in the first three quarters of 2015, and the analysis conducted in 2015 was used in determining equity grants in the fourth quarter of 2015 as well as salary and non-equity compensation targets for 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Market data is used to determine whether or not a named executive officer&#146;s salary, bonus opportunity and equity incentives are
competitive both in terms of each element of compensation and total compensation. When setting the compensation for the named executive officers for 2015, Radford prepared an extensive analysis of compensation-related data specific to the life
science industry and recommendations to review prior to making any compensation decisions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Internal Equity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee considers internal equity for all employees including, but not limited to, its named executive officers when
determining compensation to ensure that the Company is fair in its compensation practices across all levels and to ensure that there is no discrimination in compensation practices among the protected classes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Individual Performance </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent
with past practice, towards the end of 2015, the Chief Executive Officer reviewed and evaluated the performance of the other named executive officers based on the Company&#146;s performance and each individual&#146;s achievements against their
established objectives and made recommendations to the Compensation Committee regarding bonus and equity grants as well as salary adjustments for the upcoming year. The Compensation Committee discussed recommendations with the Chief Executive
Officer and evaluated them in light of each individual&#146;s performance as well as benchmark data provided by the committee&#146;s compensation consultant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent with past practice, toward the end of 2015, the Compensation Committee also reviewed
and evaluated the performance of the Chief Executive Officer, primarily based on the Company&#146;s performance in 2015 against its objectives and the overall value of the Chief Executive Officer&#146;s contributions to that effort. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the performance evaluations, each named executive officer was given a performance rating. The performance rating determines the
amount of any merit salary increase and adjustments to the incentive cash bonus awards and equity awards. Each named executive officer received a performance rating that met or exceeded expectations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Elements of Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Compensation Committee believes that the most effective compensation program is one that provides a competitive base salary, rewards the achievement of established annual and long-term goals and objectives, and provides an incentive for retention.
For this reason, the compensation program is comprised of three primary elements: base salary, a cash incentive bonus program and equity awards. The Compensation Committee believes that these three elements are the most effective combination to
motivate and retain the named executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee has not adopted any formal guidelines for allocating total
compensation between equity compensation and cash compensation, but generally seeks to provide an overall executive compensation package designed to attract, motivate, and retain highly qualified executive officers, to reward them for performance
over time, and to align the interests of the named executive officers with the interests of the stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Base Salary </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee&#146;s philosophy is to maintain base salaries at a competitive level sufficient to recruit and retain individuals
possessing the skills and capabilities necessary to achieve the Company&#146;s goals over the long-term. The Company provides an annual salary to each named executive officer designed to reflect that person&#146;s level of responsibility, expertise,
skills, knowledge, and experience. The Compensation Committee conducts an assessment, typically on an annual basis, comparing MacroGenics salaries to those at other comparable companies within the biotechnology and pharmaceutical industry and makes
adjustments, as appropriate, to assist the Company in retaining this expertise, skill, and knowledge at MacroGenics. The increases for 2015 were effective as of January&nbsp;1, 2015, and were determined by an annual performance review in light of
the individual&#146;s 2014 performance goals and achievement of Company objectives, as well as by reference to the Radford survey. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
2015, the base salaries for the named executive officers were: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Increase</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>in Base</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Salary from</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Base</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:33.30pt; font-size:8pt; font-family:Times New Roman"><B>Executive</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014 (%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">520,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">379,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atul Saran</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">357,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Annual Incentive Cash Bonus </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our bonus plan motivates and rewards our executives for achievements relative to our goals and expectations for each fiscal year. Each named
executive officer has a target bonus opportunity, defined as a percentage of his or her earned base salary. Following the end of each year, our Compensation Committee determines bonuses. Material considerations in determining bonuses include the
level of achievement of the corporate objectives for the year; an executive&#146;s performance against his or her individual objectives for the year; and the executive&#146;s handling of unplanned events and opportunities. The Compensation Committee
considers the Chief Executive Officer&#146;s input with respect to the Company&#146;s performance against our established corporate objectives. Based on these factors and the judgment of our Compensation Committee, we approved the bonuses in the
table below for our named executive officers for the fiscal year ended December&nbsp;31, 2015. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The target bonus is set at a percentage of
the named executive officer&#146;s earned base salary, with such percentages being evaluated in the context of market data as described above. The Compensation Committee believes that the higher the individual&#146;s position within MacroGenics, the
more closely his or her bonus award should be tied to the Company&#146;s success. The Chief Executive Officer&#146;s bonus is based solely on the achievements of the 2015 Objectives and the discretion of the Board. For named executive officers other
than the Chief Executive Officer, 60% of the bonus is based on corporate achievement and 40% of the bonus is based on individual performance. To be eligible for a bonus, a named executive officer must achieve at least a &#147;Meets
Expectations&#148; on his or her annual performance review. The Board retains the discretion to make adjustments to the calculated bonus based on unexpected or unplanned events, the overall financial condition of the Company, extraordinary
performance or underperformance or other factors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With regard to evaluating Company performance, early in 2015, the Board, with
management&#146;s input and recommendation, reviewed and approved a set of Company objectives for 2015 and then evaluated the Company&#146;s performance against those objectives towards the end of the year. In setting the 2015 objectives, the Board
sought to create targets for management that the Board believed were consistent with the Company&#146;s long-term strategic plan and in the best interests of shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2015 objectives were divided into three categories labeled as Pipeline, Discovery and Infrastructure. The Pipeline objectives related to
advancing clinical-stage programs with expected enrollment timing for each ongoing clinical trial, expected initiation timing for each new clinical trial to be started in 2015 and the expected filing date of an investigational new drug, or IND,
application for new molecular entities entering clinical testing for the first time. The Discovery objectives related to the identification and testing of potential new molecules expected to enter clinical testing in 2016 through 2018, consistent
with the Company&#146;s long-term strategic objective to advance at least one IND for a new molecular entity per year. The Infrastructure objectives related to compliance, the development of skills, capabilities and talents required for the
long-term success of the organization and the management of the Company&#146;s cash and other resources against budget and the Company&#146;s strategic plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In making its assessments of performance at the end of the year, the Board determined that 91% of the Pipeline objectives had been met, 100%
of the Discovery objectives had been met and 90% of the Infrastructure objectives had been met, and weighted these categories at 55%, 25% and 20%, respectively. Accordingly, in the aggregate, the Board determined that the Company had achieved 93%
against its objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the foregoing, while the Board always retains the discretion to recognize extraordinary
performance, the 2015 objectives also included criteria for a transaction that would significantly accelerate the Company&#146;s long-term strategic plan by providing significant additional funding or meaningfully expanding the Company&#146;s
pipeline. A transaction meeting the specified criteria, had one been executed, could have resulted in up to a 20% bonus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The individual objectives for each of the named executive officers, other than the Chief
Executive Officer, were established between each such named executive officer and the Chief Executive Officer during 2015. These objectives were determined, in the Chief Executive Officer&#146;s judgment, to provide the greatest opportunity for the
Company to meet its annual and long-term objectives. At the end of the year, the Chief Executive Officer evaluated the performance of each such named executive officer and assigned an achievement percentage against the individual objectives for each
such named executive officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For 2015, the bonus targets for each named executive officers, each individual&#146;s achievement against
those targets and the amount paid to those individuals were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="18%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="18%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:33.30pt; font-size:8pt; font-family:Times New Roman"><B>Executive</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B><br><B>Bonus&nbsp;Percentage&nbsp;(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Performance</B><br><B>Achievement&nbsp;for&nbsp;2015&nbsp;(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus</B><br><B>Amount&nbsp;Paid&nbsp;($)&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott&nbsp;Koenig,&nbsp;M.D.,&nbsp;Ph.D.&nbsp;(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">266,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">107,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">127,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">117,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atul Saran</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Amount paid in the first quarter of 2016 reflecting 2015 Company and individual performance. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The Chief Executive Officer&#146;s bonus is based solely on the achievements of the 2015 Company objectives and the discretion of the Board. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Awards </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our previous 2000
Stock Option and Incentive Plan, or 2000 Plan, and 2003 Equity Incentive Plan, or 2003 Plan, and our current 2013 Equity Incentive Plan, or 2013 Plan, each authorized us to make grants to eligible recipients of non-qualified stock options, incentive
stock options, stock awards, restricted stock units and other forms of award, such as stock appreciation rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We typically grant stock
option awards at the start of employment to each employee, including our named executive officers. In addition, employees, including named executive officers, have typically been granted stock option awards on an annual basis. We believe these
equity awards encourage retention and align compensation for our named executive officers with the long-term objectives of the Company. The Compensation Committee also retains discretion to make additional targeted equity awards in certain
circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The annual stock option grants to our named executive officers are evaluated by the Compensation Committee in the context
of each named executive officer&#146;s total compensation and takes into account the market data provided by Radford in addition to the individual employment situation of each named executive officer. In the case of named executive officers other
than the Chief Executive Officer, the Compensation Committee also takes into account the recommendations of the Chief Executive Officer with regards to appropriate grants and any particular individual circumstances. We award our stock option grants
to named executive officers on the date our Compensation Committee approves the grant. We set the option exercise price and grant date fair value based on our per-share closing-price valuation on the date of grant. Time vested stock option grants to
our executives typically vest 12.5% six months after the date of grant with the remainder vesting in equal installments over the following 14&nbsp;quarters. The Compensation Committee retains discretion to make adjustments to the vesting schedule
and types of awards as may be necessary to meet the Company&#146;s long-term objectives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides certain information as of December&nbsp;31, 2015, with respect to
all of our equity compensation plans in effect on that date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Number&nbsp;of&nbsp;Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Number of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Remaining Available</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Securities&nbsp;to&nbsp;be</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>for Future Issuance&nbsp;Under</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Issued Upon</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Equity&nbsp;Compensation&nbsp;Plans</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Exercise of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Exercise Price of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(Excluding Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Outstanding&nbsp;Options,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Outstanding&nbsp;Options,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Reflected</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:49.10pt; font-size:8pt; font-family:Times New Roman"><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrants and Rights<BR>(a)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrants and Rights<BR>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>in Column (a))</B><br><B>(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Compensation Plans Approved by Stockholders&nbsp;(1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,146,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,575,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Compensation Plans Not Approved by Stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,146,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,575,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Includes the MacroGenics, Inc. 2013 Equity Incentive Award Plan, 2003 Equity Incentive Plan and 2000 Stock Option and Incentive Plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Includes 4,146,064, of equity available for issuance under our 2013 Plan. In addition to being available for future issuance upon exercise of stock options and vesting of restricted stock unit awards that have been or
may be granted after December&nbsp;31, 2015, our 2013 Plan provides for the issuance of restricted stock awards and other stock-based awards. The 2013 Plan contains an &#147;evergreen&#148; provision, pursuant to which the number of shares of common
stock reserved for issuance or transfer pursuant to awards under the 2013 Plan shall be increased on the first day of each year beginning in 2014 and ending in 2023, equal to the lesser of (a)&nbsp;1,960,168 shares, (b)&nbsp;4.0% of the shares of
stock outstanding (on an as converted basis) on the last day of the immediately preceding fiscal year and (c)&nbsp;such smaller number of shares of stock as determined by our Board. As of December&nbsp;31, 2015, 1,575,235 shares were available for
future issuance, which number increased to 2,863,201 on January&nbsp;1, 2016, due to the effect of this evergreen provision. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning the compensation earned during the fiscal years ended December&nbsp;31, 2015, 2014, and
2013 by the named executive officers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:61.75pt; font-size:8pt; font-family:Times New Roman"><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards<BR>($)&nbsp;(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)&nbsp;(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nonequity<BR>Incentive Plan<BR>Compensation<BR>($)&nbsp;(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)&nbsp;(5)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">523,048</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,112,995</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">266,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,906,018</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">466,548</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,592,296</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">280,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,342,744</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2013</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">456,065</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,520,820</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">275,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,825</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,255,720</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">336,518</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">933,899</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">107,600</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,381,991</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="4"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Chief Financial Officer and Corporate Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">313,818</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">740,656</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">115,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,173,374</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2013</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">306,748</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">800,763</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">123,296</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,825</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,234,632</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">380,758</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,141,432</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">127,100</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,653,265</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Clinical&nbsp;Development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">369,699</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">740,656</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">131,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,245,255</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2013</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">148,649</TD>
<TD NOWRAP VALIGN="top">&nbsp;(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">237,464</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">801,106</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">106,215</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,293,433</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">353,048</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,141,432</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">117,400</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,615,854</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Research</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">328,048</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">925,820</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">130,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,387,768</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2013</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">310,426</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">430,534</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">108,063</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,825</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">852,848</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atul Saran</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">357,727</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">933,899</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">119,700</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">94,047</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,505,373</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President and General Counsel</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">228,867</TD>
<TD NOWRAP VALIGN="top">&nbsp;(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">469,575</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,732,494</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">88,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,572,836</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2013</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect a $50,000 new hire bonus paid to Mr.&nbsp;Saran in 2014; and a $237,464 new hire bonus paid to Dr.&nbsp;Wigginton in 2013. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect the grant value for restricted stock units (RSUs) using the Company&#146;s closing stock price on the date of grant. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect the grant date fair value for awards granted during the year indicated. The grant date fair value was computed in accordance with Financial Accounting Standards Board Accounting Standards
Codification Topic 718, <I>Compensation&#151;Stock Compensation</I>. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect the performance bonuses paid in 2016 for performance during 2015 and the performance bonuses paid in 2015 for 2014. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect $3,975 in 401(k) matching in 2015 and an RSU lapse for Mr.&nbsp;Saran of $90,072 in 2015; and $3,900 in 401(k) matching in 2014; and $3,825 in 401(k) matching in 2013. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">Dr.&nbsp;Wigginton joined us in 2013. This represents the prorated portion of his $365,000 base salary that was paid for the portion of 2013 he was employed by us. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Saran joined us in 2014. This represents the prorated portion of his $350,000 base salary that was paid for the portion of 2014 he was employed by us. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables provides certain information as of December&nbsp;31, 2015, with respect to
equity grants made to our named executive officers </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Grants of Plan-Based Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information with respect to equity awards granted during the fiscal year ended December&nbsp;31, 2015 to the
Company&#146;s named executive officers: </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All&nbsp;Other&nbsp;Stock&nbsp;and<BR>Option Awards:<BR>Number&nbsp;of&nbsp;Securities<BR>Underlying<BR>Options&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;or<BR>Base&nbsp;Price&nbsp;of<BR>Option&nbsp;Awards<BR>(per share)&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date<BR>Fair&nbsp;Value&nbsp;of<BR>Stock&nbsp;and&nbsp;Option<BR>Awards&nbsp;(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atul Saran</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Exercise or base price represents the market closing stock price on the date of award. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect the grant date fair value for awards granted during the year indicated. The grant date fair value was computed in accordance with Financial Accounting Standards Board Accounting Standards
Codification Topic 718, <I>Compensation&#151;Stock Compensation</I>. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal Year End </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information with respect to the value of all unexercised options previously awarded to the
Company&#146;s named executive officers as of December&nbsp;31, 2015: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>securities<BR>underlying<BR>unexercised<BR>options<BR>exercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Underlying<BR>unexercised<BR>options<BR>unexercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>exercise<BR>price&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>expiration<BR>date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>shares or<BR>units of<BR>stock that<BR>have not<BR>vested&nbsp;(#)&nbsp;(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market&nbsp;value<BR>of shares of<BR>units of stock<BR>that have not<BR>vested&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/16/2007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">159,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/15/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/11/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/9/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/14/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/13/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/6/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/5/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/10/2008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/15/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/11/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/9/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/9/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/8/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/14/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,987</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/13/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/6/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/5/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,395</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/19/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/18/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/11/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,316</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/9/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/9/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/8/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/14/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/13/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/6/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/5/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atul Saran</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/28/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/28/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">522,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/28/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/28/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Options vest and become exercisable with respect to (a)&nbsp;12.5 percent of the underlying shares six months after the grant date and (b)&nbsp;the remainder of the underlying shares in 14 equal quarterly installments.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Reflects restricted stock units granted to Mr.&nbsp;Saran, 12.5% of which vested six months after the date of grant, 12.5% of which vested 12 months after the date of grant and 25% of which will vest on an annual basis
beginning on the second anniversary of the date of grant until all restricted stock units have vested. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Options Exercised and Stock Vested Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information concerning the exercise of stock options and the vesting of restricted stock awards held by
the named executive officers during the fiscal year ended December&nbsp;31, 2015: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="53%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Acquired&nbsp;on<BR>Exercise</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value<BR>Realized on<BR>Exercise&nbsp;(1)<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Acquired&nbsp;on<BR>Vesting</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value<BR>Realized<BR>Vesting&nbsp;(2)<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">831,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,039,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atul Saran</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,072</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">This amount represents the difference between the sales price and the exercise price. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Based on the closing price of the Company&#146;s Common Stock, as reported on the NASDAQ on the date on which the stock vested, or, if the stock vested on a weekend or holiday, the closing price of the stock on the next
day the Company&#146;s Common Stock was traded. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Perquisites and Other Personal Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of the named executive officers are eligible to participate in the Company&#146;s employee benefit plans, including health, dental, and
vision insurance, a prescription drug plan, flexible spending accounts, short and long-term disability, life insurance, and a 401(k) plan. These plans are offered to all employees and do not discriminate in favor of named executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employment Agreements and Severance Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2015, the Company had employment agreements in place with Dr.&nbsp;Koenig, Mr.&nbsp;Karrels and Mr.&nbsp;Saran. The
employment agreements provide for certain payments if the named executive officer is terminated by the Company without cause or leaves for good reason. The terms of these agreements are described in greater detail in the section titled
&#147;Overview of Employment and Change in Control Agreements.&#148; All of the named executive officers are &#147;at-will&#148; employees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tax and
Accounting Implications </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;162(m) of the Internal Revenue Code (&#147;Section 162(m)&#148;) limits to $1 million the amount
a company may deduct for compensation paid to its chief executive officer and any of its other three named executive officers (excluding the chief financial officer). This limitation, however, does not apply to compensation meeting the requirements
for qualifying performance-based compensation within the meaning of Section&nbsp;162(m). The Compensation Committee reviews and considers the deductibility of executive compensation under Section&nbsp;162(m) in designing our executive compensation
program. The Compensation Committee, however, believes that a compensation program that attracts and retains highly qualified executives and rewards them for their achievements is necessary for our success and, therefore, is in the best interests of
the Company and our stockholders. Accordingly, the Compensation Committee believes that in establishing the cash and equity incentive compensation program for the Company&#146;s executive officers, the potential deductibility of the compensation
payable under that program should only be one of a number of relevant factors taken into consideration. Consequently, the Compensation Committee may pay or provide compensation in excess of $1&nbsp;million that is not exempt from the deduction
limitations under Section&nbsp;162(m). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Hedging and Anti-Pledging Policies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our insider trading policy prohibits all directors and officers from pledging or engaging in hedging or similar transactions in our stock, such
as prepaid variable forwards, equity swaps, collars, puts, calls and short sales. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Risk Assessment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not believe that our compensation policies and practices create risks that are reasonably likely to have a material adverse effect on our
business and operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Risk Analysis of Our Compensation Plans </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation policies and programs are designed to encourage our employees to remain focused&nbsp;on both our short- and long-term goals.
Our management assesses and discusses with our Compensation Committee our compensation policies and practices for our employees as they relate to our risk management and, based upon this assessment, we believe that any risks arising from such
policies and practices are not reasonably likely to have a material adverse effect on the Company in the future. The Compensation Committee believes that the mix of long-term equity incentive, short-term cash incentive bonus and base salary
appropriately balances both the short-and long-term performance goals of us without encouraging excessive risk-related behavior. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview of
Employment and Change in Control Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Dr.&nbsp;Koenig </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2013, we entered into an employment agreement with Dr.&nbsp;Koenig. Dr.&nbsp;Koenig is employed &#147;at-will,&#148; which means
that he has no definitive term of employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Koenig&#146;s employment agreement includes non-competition and non-solicitation
provisions that will prohibit him from competing with us, soliciting our customers or employees, or hiring our employees for a period of two years following the end of his employment with us for any reason and, with respect to the <FONT
STYLE="white-space:nowrap">non-competition</FONT> provisions, for the period during which he is receiving severance benefits. Under his employment, Dr.&nbsp;Koenig is also subject to confidentiality and invention disclosure and assignment
obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Koenig is eligible to receive severance benefits in specified circumstances, as set forth in the employment
agreement. Under the terms of the agreement, upon execution and delivery of an irrevocable release of claims against the Company and subject to his continued compliance with the non-competition and non-solicitation, confidentiality and invention
assignment provisions, Dr.&nbsp;Koenig will be entitled to severance benefits if we terminate his employment without cause or if he terminates employment with us for good reason. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, Dr.&nbsp;Koenig is entitled to specified accelerated vesting of options related to a change of control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following definitions are used in the employment agreement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;Cause&#148; means: (a)&nbsp;a failure to substantially perform the duties with us (if the failure to substantially perform is not cured, if curable, within thirty (30)&nbsp;days after receipt of written notice
from the Board of Directors that specifies the conduct constituting Cause under this clause (a); (b)&nbsp;willful misconduct, or gross negligence in the performance of duties to us; (c)&nbsp;the conviction or entry of a guilty plea or plea of no
contest with respect to, any crime that constitutes a felony or involves fraud, dishonesty or moral turpitude; (d)&nbsp;commission of an act of fraud, embezzlement or misappropriation against us; (e)&nbsp;a material breach of the fiduciary duty owed
to us; (f)&nbsp;engaging in any improper conduct that has or is likely to have an adverse economic or reputational impact on us; or (g)&nbsp;a material breach of the employment agreement. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Good Reason&#148; means the occurrence of any of the following events (without the executive&#146;s consent): (i)&nbsp;material adverse change
in functions, duties, or responsibilities that would cause executive&#146;s </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-family:Times New Roman; font-size:10pt">
position to become one of materially lesser responsibility, importance, or scope or (ii)&nbsp;a material breach of the agreement by us. No resignation will be treated as &#147;good reason&#148;
unless (a)&nbsp;the executive has given written notice of such event to us within ninety (90)&nbsp;days after the initial occurrence thereof, (b)&nbsp;we have failed to cure the condition constituting &#147;good reason&#148; within 30 days following
the delivery of the notice, and (c)&nbsp;the executive terminates employment within thirty (30)&nbsp;days after expiration of such cure period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;Change of Control&#148; means: (a)&nbsp;any person (excluding our employee benefit plans) is or becomes the &#147;beneficial owner&#148; (as defined in Rules 13d-3 and 13d-5 under the Exchange Act directly or
indirectly, of securities representing more than fifty percent (50%)&nbsp;of the combined voting power of our then outstanding securities; (b)&nbsp;we consummate a merger, consolidation, share exchange, division or other reorganization or
transaction with any other corporation unless our outstanding securities immediately prior to the transaction continue to represent at least 50% of the combined voting power immediately after the transaction; or (c)&nbsp;stockholder approval of the
liquidation or winding-up of our company or the consummation of the sale or disposition of all or substantially all of our assets; or (d)&nbsp;during any period of 24 consecutive months, individuals who at the beginning of such period constituted
our Board (including for this purpose any new director whose election or nomination for election by the stockholders was approved by a vote of at least two-thirds of the directors then still in office who were directors at the beginning of such
period or whose appointment, election or nomination was previously so approved or recommended) cease for any reason to constitute at least a majority of the Board of Directors. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the schedule of severance benefits Dr.&nbsp;Koenig would receive in the event of a qualifying termination. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:27.95pt; font-size:8pt; font-family:Times New Roman">Scenario</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.10pt; font-size:8pt; font-family:Times New Roman">Salary Continuation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.60pt; font-size:8pt; font-family:Times New Roman">Continuation&nbsp;of Health<BR>Benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:104.95pt; font-size:8pt; font-family:Times New Roman">Acceleration of Unvested&nbsp;Equity</P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absent a Change in Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">24 months of base salary and target bonus (55% of base salary)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12&nbsp;months (or&nbsp;until&nbsp;Dr.&nbsp;Koenig obtains&nbsp;other employment&nbsp;which provides the same type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">50%&nbsp;of&nbsp;the&nbsp;shares&nbsp;with respect&nbsp;to&nbsp;which&nbsp;the&nbsp;stock option is not vested</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination occurs within Two Years Following a Change in Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">24 months of base salary and target bonus (55% of base salary)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months (or&nbsp;until&nbsp;Dr.&nbsp;Koenig obtains&nbsp;other employment&nbsp;which provides the same type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">100% of the shares with respect to which the stock option is not vested</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, upon the occurrence of a change of control (irrespective of whether Dr.&nbsp;Koenig&#146;s
employment terminates), each outstanding stock option held by Dr.&nbsp;Koenig that was granted by us to him prior to the IPO will become fully vested. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Mr.&nbsp;Karrels </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
October 2013, we entered into an employment agreement with Mr.&nbsp;Karrels. Mr.&nbsp;Karrels is employed <FONT STYLE="white-space:nowrap">&#147;at-will,&#148;</FONT> which means that he has no definitive term of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Karrels&#146; employment agreement includes a non-competition provision that will prohibit him from competing with us for a period of
18 months following the end of his employment with us for any reason or for the period during which he is receiving severance benefits, as well as a non-solicitation provision that will prohibit him from soliciting our customers or employees, or
hiring our employees for a period of two years following the end of his employment with us for any reason. Under his employment agreement, Mr.&nbsp;Karrels is also subject to confidentiality and invention disclosure and assignment obligations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Karrels is eligible to receive severance benefits in specified circumstances, as set
forth in the employment agreement. Under the terms of the agreement, upon execution and delivery of an irrevocable release of claims against the Company and subject to his continued compliance with the non-competition and non-solicitation,
confidentiality and invention assignment provisions, Mr.&nbsp;Karrels will be entitled to severance benefits if we terminate his employment without cause or if he terminates employment with us for good reason. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Karrels is also entitled to specified accelerated vesting of options related to a change of control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Karrels&#146; employment agreement contains substantially similar definitions of the terms &#147;Cause,&#148; &#147;Good reason&#148;
and &#147;Change of Control&#148; as those defined in Dr.&nbsp;Koenig&#146;s agreement, discussed above. The following table summarizes the schedule of severance benefits Mr.&nbsp;Karrels would receive in the event of a qualifying termination. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:27.95pt; font-size:8pt; font-family:Times New Roman">Scenario</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.10pt; font-size:8pt; font-family:Times New Roman">Salary Continuation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.60pt; font-size:8pt; font-family:Times New Roman">Continuation&nbsp;of Health<BR>Benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:53.50pt; font-size:8pt; font-family:Times New Roman">Acceleration of<BR>Unvested&nbsp;Equity</P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absent a Change in Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months of base salary </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12&nbsp;months<BR>(or&nbsp;until&nbsp;Mr.&nbsp;Karrels<BR>obtains&nbsp;other<BR>employment&nbsp;which<BR>provides the same<BR>type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">50%&nbsp;of&nbsp;the&nbsp;shares&nbsp;with respect to which the stock option is not vested</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination occurs within Two Years Following a Change in Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months of base salary and target bonus (35% of base salary)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months<BR>(or&nbsp;until&nbsp;Mr.&nbsp;Karrels<BR>obtains&nbsp;other<BR>employment&nbsp;which<BR>provides the same<BR>type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">100% of the shares with respect to which the stock option is not vested</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, upon the occurrence of a change of control (irrespective of whether Mr. Karrels&#146; employment
terminates), each outstanding stock option held by Mr.&nbsp;Karrels that was granted by us to him prior to the IPO will become fully vested. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Mr.&nbsp;Saran </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July
2014, we entered into an employment agreement with Mr.&nbsp;Saran. Mr.&nbsp;Saran is employed &#147;at-will,&#148; which means that he has no definitive term of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Saran&#146;s employment agreement includes non-competition and non-solicitation provisions that will prohibit him from competing with
us, soliciting our customers or employees, or hiring our employees for a period of 12 months following the end of his employment with us for any reason. Under his employment, Mr.&nbsp;Saran is also subject to confidentiality and invention disclosure
and assignment obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Saran is eligible to receive severance benefits in specified circumstances, as set forth in the
employment agreement. Under the terms of the agreement, upon execution and delivery of an irrevocable release of claims against the Company and subject to his continued compliance with the non-competition and non-solicitation, confidentiality and
invention assignment provisions, Mr.&nbsp;Saran will be entitled to severance benefits if we terminate his employment without cause or if he terminates employment with us for good reason. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Saran is also entitled to specified accelerated vesting of options and restricted stock units related to a change of control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Saran&#146;s employment agreement contains substantially similar definitions of the
terms &#147;Cause,&#148; &#147;Good reason&#148; and &#147;Change of Control&#148; as those defined in Dr.&nbsp;Koenig&#146;s agreement, discussed above, except that the definition of &#147;Good Reason&#148; in Mr. Saran&#146;s employment agreement
includes a material change in geographic location of his employment of at least 50 miles from our Rockville, Maryland, headquarters. The following table summarizes the schedule of severance benefits Mr.&nbsp;Saran would receive in the event of a
qualifying termination. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:27.95pt; font-size:8pt; font-family:Times New Roman">Scenario</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.10pt; font-size:8pt; font-family:Times New Roman">Salary Continuation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.60pt; font-size:8pt; font-family:Times New Roman">Continuation&nbsp;of Health<BR>Benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:53.50pt; font-size:8pt; font-family:Times New Roman">Acceleration&nbsp;of<BR>Unvested&nbsp;Equity</P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absent a Change in Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months of base salary, and a portion of target bonus (35% of base salary), which portion starts at 25% on the first anniversary of the date of the employment agreement and increases 25% on each anniversary thereafter until it
equals 100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12&nbsp;months<BR>(or&nbsp;until&nbsp;Mr.&nbsp;Saran<BR>obtains&nbsp;other<BR>employment&nbsp;which<BR>provides the same<BR>type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination occurs within One Year Following a Change in Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months of base salary, and a portion of target bonus (35% of base salary), which portion starts at 25% on the first anniversary of the date of the employment agreement and increases 25% on each anniversary thereafter until it
equals 100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months<BR>(or&nbsp;until&nbsp;Mr.&nbsp;Saran<BR>obtains&nbsp;other<BR>employment&nbsp;which<BR>provides the same<BR>type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">50% of the shares with respect to which the stock option and restricted stock units are not vested</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC, and is not to be incorporated by
reference into any filing by MacroGenics under the Securities Act of 1933, as amended, or the Exchange Act, as amended. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis contained in this Proxy Statement with management. Based on our Committee&#146;s review of and the discussions with management with respect to the
Compensation Discussion and Analysis, our Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement and incorporated by reference in the Company&#146;s 2015 Annual Report on
Form 10-K. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Edward Hurwitz, Chair </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Paulo Costa </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">David Stump, M.D. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION ABOUT STOCK OWNERSHIP </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc172766_12"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information as to the beneficial ownership of our common stock as of March&nbsp;29, 2016 for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each of our named executive officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each of our directors; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all executive officers and directors as a group. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares beneficially owned and
the percentage of shares beneficially owned are based on 34,536,521 shares of common stock outstanding as of March&nbsp;29, 2016, except as otherwise noted. Unless otherwise indicated in the footnotes to the table, and subject to community property
laws where applicable, the following persons have sole voting and investment control with respect to the shares beneficially owned by them. In accordance with SEC rules, if a person has a right to acquire beneficial ownership of any shares of common
stock, on or within 60 days of March&nbsp;29, 2016, upon exercise of outstanding options, vesting of restricted stock units or otherwise, the shares are deemed beneficially owned by that person and are deemed to be outstanding solely for the purpose
of determining the percentage of our shares that person beneficially owns. These shares are not included in the computations of percentage ownership for any other person. Except as otherwise indicated, the address of each of the named executive
officers and directors in this table is 9704 Medical Center Drive, Rockville, Maryland 20850. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:86.80pt; font-size:8pt; font-family:Times New Roman"><B>Name of beneficial owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Common<BR>Stock (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Common<BR>Stock<BR>Issuable<BR>within 60<BR>days (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Number of<BR>Shares of<BR>Common<BR>Stock<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Beneficial<BR>Ownership<BR>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5% or Greater Stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FMR LLC and affiliated persons (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,605,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,605,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Oppenheimer Funds, Inc. and affiliated persons (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,888,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,888,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Point 72 Asset Management, L.P. and affiliated persons (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,111,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,111,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BlackRock, Inc. and affiliated persons (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,087,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,087,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Johnson&nbsp;&amp; Johnson and Johnson&nbsp;&amp; Johnson Innovation-JJDC, Inc.&nbsp;(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,923,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,923,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Named executive officers and Directors:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D. (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">809,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">589,830</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,399,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels (9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">202,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,683</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,683</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,573</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atul Saran</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,834</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,834</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paulo Costa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Fust</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,541</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kenneth Galbraith</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward Hurwitz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,053</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Stump, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All directors and executive officers as a group (12 persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,120,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,208,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,329,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Represents beneficial ownership of less than one percent of the outstanding shares of common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE="font-family:Times New Roman; font-size:10pt">Beneficial ownership is determined in accordance with the rules and regulations of the SEC and includes voting or investment power with respect to
shares of our common stock. The information set forth in the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
table above is not necessarily indicative of beneficial ownership for any other purpose, and the inclusion of any shares deemed beneficially owned in this table does not constitute an admission
of beneficial ownership of those shares. Except as otherwise noted, to our knowledge, the persons and entities named in the table above have sole voting and investment power with respect to all of the shares of common stock beneficially owned by
them, subject to community property laws, where applicable. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Consists of shares of common stock subject to stock options exercisable as of, or within 60&nbsp;days of March&nbsp;29, 2016, and shares of common stock issuable under restricted stock unit awards that vest within 60
days of March&nbsp;29, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">FMR LLC and affiliated persons reported sole dispositive power with respect to 3,605,231 shares of our common stock as of December&nbsp;31, 2015, in a Schedule 13G/A filed with the SEC on February&nbsp;13, 2016. The
address of FMR LLC and its affiliated persons is 245 Summer Street, Boston, Massachusetts 02210. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Oppenheimer Funds, Inc. and affiliated persons reported shared dispositive power with respect to 2,888,944 shares of our common stock as of December&nbsp;31, 2015, in a Schedule 13G filed with the SEC on
February&nbsp;4, 2016. The address of Oppenheimer Funds Inc. is 2 World Financial Center, 225 Liberty Street, New York, NY 10281. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Of the reported shares, Point 72 Asset Management, L.P. and Point 72 Capital Advisors, Inc. may be deemed to beneficially own 2,111,876 shares of our common stock and reported shared voting and dispositive power with
respect to those shares, and EverPoint Asset Management, LLC may be deemed to beneficially own 558,647 shares of our common stock and reported shared voting and dispositive power with respect to those shares. Mr.&nbsp;Steven&nbsp;A. Cohen controls
Point 72 Asset Management, L.P., Point 72 Capital Advisors, Inc. and EverPoint Asset Management, LLC and reported shared voting and dispositive power with respect to 2,670,523 shares of our common stock. Each of Point 72 Asset Management, L.P.,
Point 72 Capital Advisors, Inc., EverPoint Asset Management, LLC and Mr.&nbsp;Cohen disclaims beneficial ownership of any of the shares reported. The foregoing information is reported as of December&nbsp;31, 2015, in a Schedule 13G/A filed with the
SEC on February&nbsp;16, 2016. The address of Point 72 Asset Management, L.P., Point 72 Capital Advisors, Inc. and Mr.&nbsp;Cohen is 72 Cummings Point Road, Stamford, CT 06902. The address of EverPoint Asset Management, LLC is 510 Madison Avenue,
New York, NY&nbsp;10022. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">BlackRock, Inc. and affiliated persons reported sole dispositive power with respect to 2,087,529 shares of our common stock as of December&nbsp;31, 2015, in a Schedule 13G filed with the SEC on January&nbsp;28, 2016.
The address of BlackRock, Inc. is 55 East 52<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Street, New York, NY 10055. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">Johnson&nbsp;&amp; Johnson, a New Jersey corporation (&#147;J&amp;J&#148;), and its wholly owned subsidiary, Johnson and Johnson Innovation&#151;JJDC, Inc., a New Jersey corporation (&#147;JJDC&#148;), each reported
shared voting and dispositive power with respect to 1,923,077 shares of our common stock as reported in a Schedule 13G filed with the SEC on February&nbsp;5, 2015. The securities reported herein as being held by J&amp;J and JJDC are directly
beneficially owned by JJDC. J&amp;J may be deemed to indirectly beneficially own the securities that are directly beneficially owned by JJDC. The address of J&amp;J and JJDC is One Johnson&nbsp;&amp; Johnson Plaza, New Brunswick, NJ 08933.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i)&nbsp;53,265 shares of common stock, (ii)&nbsp;703,413 shares of common stock owned jointly by Dr.&nbsp;Koenig and his spouse, of which Dr.&nbsp;Koenig has shared voting and dispositive power and
(iii)&nbsp;53,265 shares of common stock held by the Scott Koenig Family Trust, an irrevocable trust, of which Dr.&nbsp;Koenig&#146;s spouse and brother-in-law are co-trustees, and of which Dr.&nbsp;Koenig may be deemed to have shared voting and
dispositive power. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">Consists of 100,331 shares of common stock jointly owned by Mr.&nbsp;Karrels and his spouse. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Exchange Act requires the Company&#146;s directors and executive officers, and persons who own more than 10% of a
registered class of the Company&#146;s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than 10%
stockholders are required by SEC regulations to furnish the Company with copies of all Section&nbsp;16(a) forms they file. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the
Company&#146;s knowledge, based solely on a review of the copies of such reports furnished to the Company and written representations that no other reports were required, during the year ended December&nbsp;31, 2015, all of our officers, directors
and greater than 10% beneficial owners were in material compliance with applicable Section&nbsp;16(a) filing requirements. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER
MATTERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this proxy statement, our Board of Directors does not intend to present any matters other than those
described in this proxy statement at the Annual Meeting and is unaware of any matters to be presented by other parties. If other matters are properly brought before the meeting for action by the stockholders, proxies will be voted in accordance with
the recommendation of the Board or, in the absence of such a recommendation, in accordance with the judgment of the proxy holder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HOUSEHOLDING OF PROXY MATERIALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to reduce printing costs and postage fees, we mail only one copy of the Annual Report and Proxy Statement to any one address, unless
we receive contrary instructions from any stockholder at that address (known as &#147;householding&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will deliver upon written
or oral request a separate copy of the Annual Report and Proxy Statement to any stockholder at a shared address to which a single copy of these materials was delivered. If you are a stockholder of record, you may contact us by writing c/o the
Corporate Secretary at our corporate headquarters located at 9704 Medical Center Drive, Rockville, Maryland 20850, or by calling us at (301)&nbsp;251-5172. If you are a beneficial but not record owner, you can request additional copies, or you can
request householding, by notifying your broker, bank or nominee. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are required to file annual, quarterly and current reports, proxy statements and other information with the SEC. You may read and copy
these proxy materials and any other documents we have filed at the SEC&#146;s Public Reference Room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Please call the SEC at <FONT STYLE="white-space:nowrap">1-800-SEC-0330</FONT> for further
information on the Public Reference Room. Our SEC filings are also available to the public at the SEC&#146;s website at www.sec.gov. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It
is important that your shares are represented at the Annual Meeting. Whether or not you plan to attend the Annual Meeting, please vote your shares as described in this proxy statement, so your shares will be represented at the Annual Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The form of proxy and this proxy statement have been approved by the Board and are being mailed
or delivered to stockholders by its authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">James Karrels </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><I>Corporate Secretary</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rockville, Maryland </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 7, 2016</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" ROWSPAN="6"> <P ALIGN="justify">


<IMG SRC="g172766compcpg01a.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P ALIGN="justify">


<IMG SRC="g172766compcpg01bv1.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Electronic Voting Instructions</B></P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="justify"><B>Available 24 hours a day, 7 days a
week!</B></P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Instead of mailing your proxy, you may choose one of
the voting methods outlined below to vote your proxy.</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">VALIDATION DETAILS ARE LOCATED BELOW IN THE TITLE
BAR.</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="justify"><B>Proxies submitted by the Internet or telephone must
be received by 1:00 a.m., Central Time, on May 18, 2016.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="4"> <P ALIGN="justify">


<IMG SRC="g172766compcpg01c.jpg" ALT="LOGO">
&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:9pt"><B>Vote by Internet</B></P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:ARIAL" ALIGN="justify">&#149;&nbsp;&nbsp;&nbsp;Go to <B>www.investorvote.com/MGNX </B></P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:ARIAL" ALIGN="justify">&#149;&nbsp;&nbsp;&nbsp;Or scan the QR code with your smartphone</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:ARIAL" ALIGN="justify">&#149;&nbsp;&nbsp;&nbsp;Follow the steps outlined on the secure website</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt"><B>Vote by telephone</B></P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:ARIAL" ALIGN="justify">&#149;&nbsp;&nbsp;Call toll free 1-800-652-VOTE (8683) within the USA, US territories &amp; Canada on a touch
tone telephone</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:20pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">Using a <B><U>black ink</U> </B>pen, mark your votes with an <B>X </B>as shown in this example. Please do not write outside the designated areas.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:20pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:ARIAL" ALIGN="justify">&#149;&nbsp;&nbsp;Follow the instructions provided by the recorded message</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g172766compcpg01d.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><B></B><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT></FONT><B></B><B>&nbsp;&nbsp;IF YOU
HAVE NOT VOTED VIA THE INTERNET <U>OR</U> TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.
&nbsp;&nbsp;</B><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT></FONT><B></B><B></B></P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px dashed #000000" align="left">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" BGCOLOR="#000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#ffffff"><B>&nbsp;A</B>&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Proposals&nbsp;&#151;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:9pt"><B>The Board of Directors recommends a vote <U>FOR</U> all the nominees listed and <U>FOR</U> the Proposals 2 and 3. Our Board of Directors is not making a
recommendation with respect to Proposal 4.</B></P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="35"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">To elect two Class III directors listed in these proxy materials to hold office until the 2019 Annual Meeting of Stockholders or until their successors are
elected;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="font-size:25pt">&#043;</FONT></B></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>&nbsp;Withhold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Withhold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD ROWSPAN="2" VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">01&nbsp;-</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Paulo Costa</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL" ALIGN="center">&nbsp;<FONT STYLE="font-family:Times New Roman"><FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">02&nbsp;-</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Edward Hurwitz</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Against</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Abstain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>&nbsp;&nbsp;Against</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>&nbsp;Abstain</B></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst &amp; Young LLP as the independent registered public accounting firm of the
Company for its fiscal year ending December 31, 2016.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">3.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="11"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">To approve, on an advisory basis, the compensation of our named executive officers as disclosed in these proxy materials.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;<FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="12"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="7" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>1&nbsp;Year</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>2&nbsp;Years</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>3 Years</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>Abstain</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="11" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="12"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">4.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">To approve, on an advisory basis, the frequency of future advisory votes on executive compensation.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="11" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:0pt;margin-bottom:0pt;page-break-before:always"></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" BGCOLOR="#000000"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt"><FONT COLOR="#ffffff">&nbsp;<B>B</B>&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:9pt"><B>Non-Voting Items</B></P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:7pt"><B>Change of Address</B> &#151; Please print your new address below.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:7pt"><B>Comments</B> &#151; Please print your comments below.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:7pt"><B>Meeting&nbsp;Attendance</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:20pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:7pt">Mark the box to the<BR>right if you plan to<BR>attend the Annual<BR>Meeting.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><B>&nbsp;&nbsp;</B><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT><B></B><B></B></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" BGCOLOR="#000000"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt"><FONT COLOR="#ffffff"><B>&nbsp;C</B>&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">
<P ALIGN="justify" STYLE="font-family:ARIAL; font-size:9pt"><B>Authorized&nbsp;Signatures&nbsp;&#151;&nbsp;This&nbsp;section&nbsp;must&nbsp;be&nbsp;completed&nbsp;for&nbsp;your&nbsp;vote&nbsp;to&nbsp;be&nbsp;counted.&nbsp;&#151;&nbsp;Date&nbsp;
and&nbsp;Sign&nbsp;Below</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor,
administrator, corporate officer, trustee, guardian, or custodian, please give full title. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:7pt">Date (mm/dd/yyyy) &#151; Please print date below.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:7pt">Signature 1 &#151; Please keep signature within the box.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:7pt">Signature&nbsp;2&nbsp;&#151; Please&nbsp;keep&nbsp;signature&nbsp;within&nbsp;the box.</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt">
<P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:24pt; font-family:ARIAL" ALIGN="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g172766compcpg01e.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:8pt; font-family:ARIAL" ALIGN="justify">02BR3C </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:48pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><B></B><FONT STYLE="font-family:Times New Roman"><FONT
STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT></FONT><FONT STYLE="font-family:ARIAL"><B></B></FONT><B> IF YOU HAVE NOT VOTED VIA THE INTERNET <U>OR</U> TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED
ENVELOPE. </B><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT></FONT><FONT STYLE="font-family:ARIAL"><B></B></FONT><B> </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; " ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px dashed #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g172766compcpg02.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="justify"><B>Proxy &#151; MacroGenics, Inc. </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="justify"><B>Notice of 2016 Annual Meeting of
Stockholders </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Proxy Solicited by Board of Directors for Annual Meeting &#151; May 18, 2016 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">Paulo Costa, James Karrels and Atul Saran, or any of them, each with the power of substitution, are hereby authorized to represent and vote the shares of
the undersigned, with all the powers which the undersigned would possess if personally present, at the Annual Meeting of Stockholders of MacroGenics, Inc. to be held on May 18, 2016, at 9:00 a.m. local time, at the Hilton Garden Inn
Rockville-Gaithersburg, 14975 Shady Grove Road, Rockville, Maryland, 20850 or at any postponement or adjournment thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Shares represented by
this proxy will be voted by the stockholder. If no such directions are indicated, the Proxies will have authority to vote FOR all the nominees listed in proposal 1 and FOR the Proposals 2 and 3. Our Board of Directors is not making a recommendation
with respect to Proposal 4. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the
meeting. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">(Items to be voted appear on reverse side.) </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g172766brkpcpg01a.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="54%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Using&nbsp;a&nbsp;<B><U>black&nbsp;ink</U>&nbsp;</B>pen,&nbsp;mark&nbsp;your&nbsp;votes&nbsp;with&nbsp;an&nbsp;<B>X&nbsp;</B>as&nbsp;shown&nbsp;in</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">this example. Please do not write outside the designated areas.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:10pt"><FONT STYLE="font-size:16pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g172766brkpcpg01b.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><B></B><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT></FONT><FONT
STYLE="font-family:ARIAL"><B></B></FONT><B>&nbsp;&nbsp;PLEASE FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED
ENVELOPE.&nbsp;&nbsp;</B><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT></FONT><FONT STYLE="font-family:ARIAL"><B></B></FONT><B> </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt dashed #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" BGCOLOR="#000000"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:9pt"><FONT COLOR="#ffffff"><B>&nbsp;A&nbsp;</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:9pt"><B>Proposals&nbsp;&nbsp;&#151;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:9pt"><B>The Board of Directors recommends a vote <U>FOR</U> all the nominees listed and <U>FOR</U> the Proposals 2 and 3. Our Board of Directors is not making a
recommendation with respect to Proposal 4.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD ROWSPAN="2" VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:ARIAL" ALIGN="justify">1. To elect two Class III directors listed in these proxy materials to hold office until the 2019 Annual Meeting of
Stockholders or until their successors are elected;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:10pt"><B><FONT STYLE="font-size:20pt">+</FONT>&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt"><B>For</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt"><B>Withhold</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt"><B>For</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt"><B>Withhold</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">&nbsp;&nbsp;&nbsp;&nbsp;01 - Paulo Costa</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt">&nbsp;02 - Edward Hurwitz</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Against</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Abstain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Against</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Abstain</B></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:ARIAL" ALIGN="justify">2. To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst &amp; Young LLP as the
independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><B></B><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT><B></B><B></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><B></B><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT><B></B><B></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B></B><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT><B></B><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:ARIAL" ALIGN="justify">3. To approve, on an advisory basis, the compensation of our named executive officers as disclosed in these proxy
materials.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></FONT></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>1&nbsp;Year</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>2&nbsp;Years</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>3&nbsp;Years</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>Abstain</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:ARIAL" ALIGN="justify">4. To approve, on an advisory basis, the frequency of future advisory votes on executive compensation.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:12pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" BGCOLOR="#000000"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:8pt"><FONT COLOR="#ffffff"><B>&nbsp;B&nbsp;</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:9pt"><B>Authorized Signatures &#151; This section must be completed for your vote to be counted. &#151; Date and Sign Below</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor,
administrator, corporate officer, trustee, guardian, or custodian, please give full title. </P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:7pt">Date (mm/dd/yyyy) &#151; Please print date below.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:7pt">Signature&nbsp;1&nbsp;&#151;&nbsp;Please&nbsp;keep&nbsp;signature&nbsp;within&nbsp;the&nbsp;box.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:7pt">Signature&nbsp;2&nbsp;&#151;&nbsp;Please&nbsp;keep&nbsp;signature&nbsp;within&nbsp;the&nbsp;box.</P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:20pt" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER:1.50pt solid #000000; padding-left:8pt"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:20pt"><FONT STYLE="font-size:24pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/</FONT>
<FONT STYLE="font-size:24pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.50pt solid #000000; BORDER-TOP:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.50pt solid #000000; BORDER-RIGHT:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.50pt solid #000000; BORDER-TOP:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.50pt solid #000000; BORDER-RIGHT:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000; padding-right:8pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g172766brkpcpg01c.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:17%; font-size:8pt; font-family:ARIAL" ALIGN="justify">02BR4C </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><B></B><FONT
STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT></FONT><FONT STYLE="font-family:ARIAL"><B></B></FONT><B>&nbsp;&nbsp;PLEASE FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED
ENVELOPE.&nbsp;&nbsp;</B><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT></FONT><FONT STYLE="font-family:ARIAL"><B></B></FONT><B> </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt dashed #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g172766brkpcpg02.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="justify"><B>Proxy &#151; MacroGenics, Inc. </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="justify"><B>Notice of 2016 Annual Meeting of
Stockholders </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify"><B>Proxy Solicited by Board of Directors for Annual Meeting &#151; May 18, 2016 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">Paulo Costa, James Karrels and Atul Saran, or any of them, each with the power of substitution, are hereby authorized to represent and vote the shares
of the undersigned, with all the powers which the undersigned would possess if personally present, at the Annual Meeting of Stockholders of MacroGenics, Inc. to be held on May 18, 2016, at 9:00 a.m. local time, at the Hilton Garden Inn
Rockville-Gaithersburg, 14975 Shady Grove Road, Rockville, Maryland, 20850 or at any postponement or adjournment thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Shares represented by
this proxy will be voted by the stockholder. If no such directions are indicated, the Proxies will have authority to vote FOR all the nominees listed in proposal 1 and FOR the Proposals 2 and 3. Our Board of Directors is not making a recommendation
with respect to Proposal 4. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the
meeting. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">(Items to be voted appear on reverse side.) </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g172766noticepg01a.jpg" ALT="LOGO">
 </P><DIV STYLE="position:relative;float:left; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">&nbsp;&nbsp;&nbsp;&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:2%; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="98%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="55%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="4">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;


<IMG SRC="g172766noticepg01b.jpg" ALT="LOGO">
&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Vote by Internet</B></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">&#149;&nbsp;Go to
<B>www.investorvote.com/MGNX </B></P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">&#149;&nbsp;Or scan the QR code with your
smartphone</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">&#149;&nbsp;Follow the steps outlined on
the secure website</P></TD></TR>
</TABLE></DIV> </DIV><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g172766noticepg01c.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><B>Important Notice Regarding the Availability of Proxy Materials for the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><B>MacroGenics, Inc. Stockholder Meeting to be Held on May 18, 2016 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">Under Securities and Exchange Commission rules, you are receiving this notice that the proxy materials for the annual stockholders&#146; meeting are
available on the Internet. Follow the instructions below to view the materials and vote online or request a copy. The items to be voted on and location of the annual meeting are on the reverse side. Your vote is important! </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to
access and review all of the important information contained in the proxy materials before voting. The proxy statement and annual report to shareholders are available at: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g172766noticepg01d.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:12pt">
<TD VALIGN="top" ROWSPAN="6">


<IMG SRC="g172766noticepg01e.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Easy Online Access &#151; A Convenient Way to View Proxy Materials and Vote</B></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>When you go online to view materials, you can also vote your shares.</B></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Step </B><B>1: </B>Go to <B>www.investorvote.com/MGNX</B>.</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Step </B><B>2: </B>Click on the icon on the right to view current meeting materials.</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Step </B><B>3: </B>Return to the investorvote.com window and follow the instructions on the screen to log in.</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Step </B><B>4: </B>Make your selection as instructed on each screen to select delivery preferences and vote.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>When you go online, you can also help the environment by consenting to receive electronic delivery of future materials. </B></P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;page-break-before:always"></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g172766noticepg01f.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:10pt"><B>Obtaining a Copy of the Proxy Materials &#150; If you want to receive a copy of these documents, you must request one. There is no charge to you for requesting a copy.
Please make your request for a copy as instructed on the reverse side on or before May 8, 2016 to facilitate timely delivery.</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g172766noticepg01g.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:8pt; font-family:ARIAL">02BR5B </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g172766noticepg02a.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>Annual Meeting of Stockholders of MacroGenics, Inc. to be held on May 18, 2016, at 9:00 a.m. local time, at the Hilton Garden Inn
Rockville-Gaithersburg, 14975 Shady Grove Road, Rockville, Maryland, 20850. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>Proposals to be voted on at the meeting are listed below along with the Board of
Directors&#146; recommendations. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>The Board of Directors recommends a vote <U>FOR</U> all the nominees listed and <U>FOR</U> the Proposals 2 and 3. Our Board
of Directors is not making a recommendation with respect to Proposal 4: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">To elect two Class III directors listed in these proxy materials to hold office until the 2019 Annual Meeting of Stockholders or until their successors are elected: Paulo Costa and Edward Hurwitz </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst &amp; Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">To approve, on an advisory basis, the compensation of our named executive officers as disclosed in these proxy materials. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>PLEASE NOTE
&#150; YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your shares you must vote online or request a paper copy of the proxy materials to receive a proxy card. If you wish to attend and vote at the meeting, please bring this notice with you.
</B></P> <P STYLE="font-size:150pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:11pt">
<TD VALIGN="top" ROWSPAN="4">


<IMG SRC="g172766noticepg02b.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Here&#146;s how to order a copy of the proxy materials and select a future delivery preference:</B></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL"><B>Paper copies: </B>Current and future paper delivery requests can be
submitted via the telephone, Internet or email options below.</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL"><B>Email copies: </B>Current and future email delivery requests must
be submitted via the Internet following the instructions below. If you request an email copy of current materials you will receive an email with a link to the materials.</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>PLEASE NOTE: </B>You must use the number in the shaded bar on the
reverse side when requesting a set of proxy materials.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#103;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>Internet </B>&#150; Go to <B>www.investorvote.com/MGNX. </B>Follow the instructions to log in and order a copy of the current meeting materials and
submit your preference for email or paper delivery of future meeting materials.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#103;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>Telephone </B>&#150; Call us free of charge at 1-866-641-4276 and follow the instructions to log in and order a paper copy of the materials by mail
for the current meeting. You can also submit a preference to receive a paper copy for future meetings.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#103;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>Email </B>&#150; Send email to investorvote@computershare.com with &#147;Proxy Materials MacroGenics, Inc.&#148; in the subject line. Include in the
message your full name and address, plus the number located in the shaded bar on the reverse, and state in the email that you want a paper copy of current meeting materials. You can also state your preference to receive a paper copy for future
meetings.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">To facilitate timely delivery, all requests for a paper copy of the proxy materials must be received by May 8, 2016.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:8pt; font-family:ARIAL">02BR5B </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:17pt; font-family:ARIAL" ALIGN="center"><B>*** Exercise Your </B><B><I>Right</I></B><B> to Vote ***</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><B>Important Notice Regarding the Availability of Proxy Materials for the</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><B>Shareholder Meeting to Be Held on May 18, 2016</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="13"> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g172766noticepg03c.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><I>MACROGENICS, INC.</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B><U>Meeting
Information</U></B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL"><B>Meeting Type: </B>Annual Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" ROWSPAN="9"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g172766page6.jpg" ALT="LOGO">
&nbsp;</P> <P STYLE="font-size:32pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"><B>For holders as of:</B> March 29, 2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="8">


<IMG SRC="g172766noticepg03b.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"><B>Date: </B>May 18, 2016 <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Time: </B>9:00 AM EDT</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"><B>Location:</B>&nbsp;&nbsp; <FONT STYLE="font-size:7pt">Hilton Garden Rockville-Gaithersburg</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="text-indent:4.00em; font-size:7pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14975 Shady Grove Road</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4.00em; font-size:7pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rockville, MD
20850</P> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify">You are receiving this communication because you hold shares in the
above named company.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify">This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete
proxy materials that are available to you on the Internet. You may view the proxy materials online at <I>www.proxyvote.com </I>or easily request a paper copy (see reverse side).</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify">We encourage you to access and review all of the important information contained in the proxy materials before voting.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#4c4c4c" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000" BGCOLOR="#4c4c4c"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.50em; font-size:11pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B>See the reverse side of this notice to obtain proxy materials and voting instructions.</B></FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:8pt" BGCOLOR="#eaeaea">&nbsp;Broadridge&nbsp;Internal&nbsp;Use&nbsp;Only</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8pt" BGCOLOR="#eaeaea"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="right">Job #</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8pt" BGCOLOR="#eaeaea">Envelope #</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8pt" BGCOLOR="#eaeaea">Sequence #</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt" BGCOLOR="#eaeaea"># of # Sequence #</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>&#151; Before You Vote &#151;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center">How to Access the Proxy Materials</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>Proxy Materials Available to VIEW or RECEIVE:</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL">1. Annual Report&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Notice &amp; Proxy Statement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"><B>How to View Online:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:10pt">Have the information that is printed in the box marked by the arrow


<IMG SRC="g172766noticexxxx.jpg" ALT="LOGO">
 (located on the following page) and visit: <I>www.proxyvote.com. </I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"><B>How to Request and Receive a PAPER or E-MAIL Copy:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:10pt">If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following
methods to make your request:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="text-indent:8.00em; font-size:10pt; font-family:ARIAL">1) <I>BY INTERNET</I>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;www.proxyvote.com</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="text-indent:8.00em; font-size:10pt; font-family:ARIAL">2) <I>BY TELEPHONE</I>:&nbsp;&nbsp;&nbsp;&nbsp;1-800-579-1639</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="text-indent:8.00em; font-size:10pt; font-family:ARIAL">3) <I>BY E-MAIL*</I>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sendmaterial@proxyvote.com</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL" ALIGN="justify">*&nbsp;&nbsp;&nbsp;If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box
marked by the arrow


<IMG SRC="g172766noticexxxx.jpg" ALT="LOGO">
 (located on the following page) in the subject line.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to
your investment advisor. Please make the request as instructed above on or before May 04, 2016 to facilitate timely delivery.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:6pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>&#151; How To Vote &#151;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center">Please Choose One of the Following Voting Methods</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">


<IMG SRC="g172766page8.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Vote In Person: </B>If you choose to vote these shares in person at the meeting, you must request a &#147;<I>legal proxy.</I>&#148;
To do so, please follow the instructions at <I>www.proxyvote.com </I>or request a paper copy of the materials, which will contain the appropriate instructions. Many shareholder meetings have attendance requirements including, but not limited to, the
possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.</P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:ARIAL; font-size:10pt"><B>Vote By Internet: </B>To vote now by Internet, go to <I>www.proxyvote.com. </I>Have the information that is printed in the box marked by the arrow


<IMG SRC="g172766noticexxxx.jpg" ALT="LOGO">
 available and follow the instructions.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Vote By Mail: </B>You
can vote by mail by requesting a paper copy of the materials, which will include a voting instruction form.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt" BGCOLOR="#eaeaea">Internal&nbsp;Use Only</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:6pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom" BGCOLOR="#b2b2b2">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#b2b2b2"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="98%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center" STYLE="BORDER:2.00pt solid #000000; padding-left:8pt"><FONT STYLE="font-size:8pt"><B>Voting items</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="16" ALIGN="center">


<IMG SRC="g172766noticepg05c.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><FONT STYLE="font-size:7pt"><B>The Board of Directors recommends that you</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL"><B>vote FOR the following:</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:7pt">1.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:7pt">Election of Directors</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL"><B>Nominees</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:7pt">01</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:7pt">Paulo Costa&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;02&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Edward
Hurwitz</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL"><B>The Board of Directors recommends you vote FOR the following
proposal(s):</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:7pt">2.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL">To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst &amp; Young LLP as the independent registered public
accounting firm of the Company for its fiscal year ending December 31, 2016.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:7pt">3.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:7pt">To approve, on an advisory basis, the compensation of our named executive officers as disclosed in these proxy materials.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL"><B>The Board of Directors does not have a recommendation for voting on
the following proposal(s):</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:7pt">4.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:7pt">To recommend, by non-binding vote, the frequency of executive compensation votes.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL"><B>NOTE: </B>Such other business as may properly come before the meeting or any adjournment thereof.</P>
<P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
</TABLE></DIV>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">


<IMG SRC="g172766page9.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000" BGCOLOR="#eaeaea"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000" BGCOLOR="#eaeaea"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000" BGCOLOR="#eaeaea"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" BGCOLOR="#eaeaea"><FONT STYLE="font-size:10pt"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#103;</FONT></FONT>&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000" BGCOLOR="#eaeaea">0000 0000 0000 0000</TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000" BGCOLOR="#eaeaea"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" BGCOLOR="#eaeaea"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" BGCOLOR="#eaeaea"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000" BGCOLOR="#eaeaea"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000" BGCOLOR="#eaeaea">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">Broadridge&nbsp;Internal&nbsp;Use&nbsp;Only</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">xxxxxxxxxx</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">xxxxxxxxxx</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">Cusip</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">Job&nbsp;#</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">Envelope&nbsp;#</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">Sequence&nbsp;#</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right"># of # Sequence&nbsp;#</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000" BGCOLOR="#eaeaea"><B>Reserved for Broadridge Internal Control Information</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:96pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000; BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-RIGHT:2.00pt solid #000000; BORDER-BOTTOM:2.00pt solid #000000"><B>Voting Instructions</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:14pt">
<TD VALIGN="bottom" ROWSPAN="3">


<IMG SRC="g172766page10.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000" BGCOLOR="#eaeaea"> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL" ALIGN="center">THIS SPACE RESERVED FOR LANGUAGE PERTAINING TO</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL" ALIGN="center">BANKS
AND BROKERS</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL" ALIGN="center">AS REQUIRED BY THE NEW YORK STOCK EXCHANGE</P> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" ALIGN="right" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:8pt" BGCOLOR="#eaeaea">Broadridge&nbsp;Internal&nbsp;Use&nbsp;Only</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000" BGCOLOR="#eaeaea"><FONT STYLE="font-size:14pt">THIS SPACE RESERVED FOR SIGNATURES IF APPLICABLE</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#eaeaea" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt" BGCOLOR="#eaeaea"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">Job #</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">Envelope #</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">Sequence #</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right"># of # Sequence #</P></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g172766brkpcpg01a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766brkpcpg01a.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!$@*N P$1  (1 0,1 ?_$ .@  0 " @,! 0$
M       '" D* P0&!0(! 0$  00# 0$              0(&!PD#!0@$"A
M  8#  $" @8#"@<,"P    (#! 4& 0<("1$2$Q0B%187V)DA60HR(R0U&#A8
M>+BY,4%#5W>WUW)S='6UU9:VUADY>5%"TU34)54V=I@Z$0$  0($ P0$! H4
M"@H# 0   0(#$00%!B$2!S$B$PA!43(4D>$C,V&!H4)2<B2T%95Q8D-3LS1T
MU#55=;46-G:V%U>7.+'1<U0EU5:6UC?PP?&2TM/CE'>W@I/%Q__:  P# 0 "
M$0,1 #\ W^
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M-<QBY[KR>)[Y1%/-X>'@8T<O/\HV.QB!J6
M                                                      45\EW\
MR#>W_%M,_P!9--%U;)_C1E/MJ_T.MZ5\G_\ >.VS_ELW]X9M@]WK_$/C1_\
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MLC]ML_\ >O?2QV^/_M_QN?\ FX=+?VRK0.ETOY_6/W!R_P!Y,3=-/V5ZN?\
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MNX2.FI@IRYQ@/5
M                  J5W3KJZ;:Y3VWKW7D&K9+C8V-82A81%W'L5'RC"\5B
M6=E*[E7;%@C\&/8+*9^(J3&<$],>ILXQFX-JYS+:?K^7SF<JY,M1-7-5A,X8
MT51'"(F>V8CA#.?EKW9M[8W6W0MU;JS,930,I<S$WKTTUUQ1%>3S%JGNVZ:Z
MYQKKII[M,X8XSA$3+%+MKC7I>QQ'"S:%U<^?+ZF\B>^-U;"(6P5!'-;UC;NG
M9Z^5VU+9<6!(KY"2J3Q-X5NURN\3*;V*(D5QDF+ZR.X]%M7=3JN7XB+^D6+-
MONU]ZY1E(MU4^SPPK[N,X1Z8G#B]M['\P'2#2L_U)O:AK5NW;USI1HVDY&?
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MDGM?E&<JWCK+5Y-S"V. ?J,U5<,YF"EFBK=VV4]JR"Q,E.7&0,,.UZ@
M
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M=67RB#^JZ#JOL6=)0T'462#3$@V:G*VPZ;(,R?$;QC-3)5<JB9PI]F&; '&
M #%%W#JW>7/EDD/('Q/"O+5L6GQJ#CJ7E1@J1G6NR-0PB39.1D(UJF@<D5U)
MK&N-#*U"?(7*\FT0S!OL.6JC0C<KIF)[M7_8OCSET/J7J_2.N>A=&VEO<-7[
M2KC2R5B823,V=)I+9.@_AIN.5S\S"V6O2:"S&28+X*NR?-U45,8.3. 4S$TS
MA/:FP$
M                                              .-5))=)1!=--9%
M9,Z2R*I"J)*I*%R11-1,^,D.F<F<XSC.,XSC/ID!JG;6HM[_ &>GIR;Z?TG
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M
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MCA)"5AG3UBJJ@?\ 0<I5,Y+G]&?0###M>F
M
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MEE8\=MRWYQ_X1.1=S^,?D34'3=^V$[V19^P'5DNL+19J(7KC^]YFIJ8DW$Q
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M4&I5&2./:91"+L5\)JXPVB!+A
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MBF;"I%=?-$1$84PS,@XP
M                                                  :\_77_ /1;
MXC?ZKO;/_4B9!R1\W/Y,-A@'&      #H2DI&0<9(S4U(,HF'AV#R4EI62=(
M,8Z,C(]NH[?R#]ZY.DV9LF35$ZBJJABD33+DQLXQC.0&EAQ)*ROFU\\-X[O,
MC(..//'^UCX+12KUH9-A.SD>>=9ZM.A[\>PDE9+*^F;ZX]/<LT;(12"GM]Z>
M1'I?15\G;Y?KI;KPE\X
M
MUY^NO_Z+?$;_ %7>V?\ J1,@Y(^;G\F&PP#C     '&LLBV15<.%4D&Z"2BR
MZZRA4D444BY.JJJJ?)2)I)D+G)C9SC&,8]<@-,[RJ^2K;?E&W)CQ!>*+*U[A
M;G)-X+I_I>LKR+F@IU'#]%E9H)E:H CENSTG"X5R6TSY3')/GQ]3Q97!5E,N
MX<]%,41XE?TH;+7CTX6U3XZ^6M?\T:J+F02KZ"DW?KN[:HM)G9FS)I)NI;[W
M,)I9/\ TF[0*BR:^]7$?%MVS0ISE0P<TN*JJ:IQE=L%(
M
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MJBUC(Y)0Q&S=+!CY-+BJJFJ<97L!2
M
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MI(I)I+E>F]I\Y]29],8R3RQA,Q/8RB@H
M                                              !C"\,7_AA<A_\
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MY-'S_&<C%NFE<C4*_P"M1VI,DD48@C7_ .;51PFY,;!OAF(KIIB,87NZH_\
M$M\4W_!.[O\ 4=3Q'I4T^Q5])E!$J
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ME190QF)A]&'%&],14-]E?JGPJ]KQOV%NUJV73/D=0<:MOLKL:]?:#[:7VO\
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M]^?7/H3PBF8QC&<&:@2H
M
M
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M/;IJHIFFJJ*HSR#%C6:
M
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M3\;+QM'7-*FN8SEBJU/OV=T?*9>URW8HJPKOT3<P\.B*JJHIG9,&&VHP
M
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M&S\QI//S9NS35]WUV:*;/)3,UX35'B\OA1C-<-B@8A:HP
M
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MFU->>BB/"Y+L45TTX_*54Q;^N;'HPXU*@
M
M                     # CY"-_;[UYT=*5K7VM;)9JVE4JJ[1EHOOY#GAJ
MHZ=M%SNT<:V/<80S51!0OH9W\#'S?[KW9]!E+:6EZ;F])B[F;E%-WFJX3D?'
MGMG\TY*O@QX=C9QY6>E_3+=726SJ^Z-7RF3U:K/9FF;=S94ZY5%--413/O\
M&5O<T3'&+7/\EV81BI!_*WZQ_P RMU_-P:_[2!='X"T7\^M?BO\ ])Z,_H+Z
M(_[0Z?\ V95?K!<'@[H;H.^]/4*K7K6%FKM7D&-R/(S$EY#6^^V;0S*FSKUE
MA35I+I,FL&7#YNFD53#<_P D8^'/J7X7KBWMTZ5IF5T6[>R]VW5>CDPB,AX$
MSC73$_*<E/+PF9[>.'+Z6!?,QTJZ6[8Z-ZGK.V]9R>;UFU<RD6[5O8U6BU5<
M^;LT5X:C.4M>!RT5553'/'BQ'@\>?!L&#$S5J
M
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MVN2[%%=-/YI53%OZYL=##K4L
M
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ML^!RT5553'B1XV'@X3SX3L'#$S5F
M
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MJIIM_7-CD8=:F
M
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M)'C8>#A//A.PB,2M6(
M
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M^4JIIMS[38V&'FIH
M
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M/C8>#A5SX3L)C$C5@
M
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MY33$3XE=--N>%6+8S&'FIL
M
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M**JJL/&I\;#P<*N?EG86&)&JX
M
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MO=F;<UYVU?KKM^'=Y+E,13/B5TTVYPBK%L6C#[4^
M
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MZ:YHG9*&&FHT
M
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MXL_FHFW7RW*/#RMR)KHIBN:*.:NG8+&)FK4
M
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M-<T3LBC#;4@
M
M,"'D)><_(='RA-B<F<Y[?LN:E5#+7394MTRSM+AIEJOAI'KHZLYGVC4_DV!,
M9*CDDL=?)<_OB2>?3&<J;1LZI<TF*LIGLW8M<]7=MTY::>V?SW,6JN/;[.'J
MELY\J^7ZHW>DMFK:F^-V:#I'OV9PRFGVMOUY>FKFCFKB=1W!IV9YJYXUQ.6B
MC'V*ZXQE1_ZRY%_5^<:_](.X/P1BZ/=M>_;34/\ NY']>/1WN777^M+J!_\
MHVA_Q<N%P<\YV7Z?H1*#R#S5JFTX87,T=>M>2_43NVQ!,4V<P]3C$-F<O:UI
MQB2;'*C5?+F8:GPW6/\ "PJK[$CV[NJSJUO1;M6:S^<OV>YC173E8IGOTX8S
M:S-ROA.$QA1/&(QPC&8P)YF<OU6M=&]3JW/OS=^MZ+XN5\3)YZUMVG+79][L
M\DW)T_<6?S6-NOEN4>'E;D<]-//-%'-73L&C$K5F
M
M
M
4                        _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g172766brkpcpg01b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766brkpcpg01b.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (@+& P$1  (1 0,1 ?_$ ),  0 !! (# 0
M       ( P0'"08* 0(%"P$! 0$! 0$               $" P0%$   ! 4"
M!@(#  $#! ,    " P0(  $%!@?66!&2E9<8&A()(1,4%D$B%3%1%PIQ(S,1
M  (" @(" @$$ 0,%       ! A(149$4(3%! R)A<8$RP;'1X5(3(S-3_]H
M# ,!  (1 Q$ /P"1'JZLXW%N@YL3Z#C=$;[,](>KJSC<6Z#FQ/H.%$.S/2'J
MZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ/H.%$.S/2'
MJZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ/H.%$.S/2
M'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ/H.%$.S/
M2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ/H.%$.S
M/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ/H.%$.
MS/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ/H.%$
M.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ/H.%
M$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ/H.
M%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ/H
M.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ/
MH.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#FQ
M/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#F
MQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z#
MFQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6Z
M#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<6
MZ#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC<
M6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJSC
M<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJS
MC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>KJ
MSC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>K
MJSC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](>
MKJSC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,](
M>KJSC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,]
M(>KJSC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[,
M](>KJSC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40[
M,](>KJSC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X40
M[,](>KJSC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X4
M0[,](>KJSC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@X
M40[,](>KJSC<6Z#FQ/H.%$.S/2'JZLXW%N@YL3Z#A1#LSTAZNK.-Q;H.;$^@
MX40[,](>KJSC<6Z#FQ/H.%$.S/2-B_VPOYO5@N"[&NO$-AV_E/->3<B&VO9-
M@7&56U5/76S:5IUV_,GW$:DMRHTNL&!MJV:."<A@.D64-2$9DA!#,,[)X7ZF
M/J@IRP_$4B85LNEP76,.X+S97LF618EFN$MFT:YCA?>=STFW4E>J5U6:*]96
MW35M54I4JNL4VDI5@SRI"^0"T1PQ< @%.5R8<7EKY1;6B\)J-_8I6YULMQF'
M;DPS3+F2694\G4V^*.*S:7=M1JB"B4VW*G5SCB2J=5ZK5:JE(2$G2+$J$I*F
M5\P& %-E"LD\8>3UMEXK3;TH^8+AM)R.%[CH#?3U:?.-;I-_4)52<530&'DK
M%-Z5 *F26E4Q.>D-+FLF(2.9I)A<C9C ,,F4'"2PFGY]&14N:,0+;HL2R$F4
M+#4WCE&R%62\;6N5<U+%7+\QTA3$K5M]6I3OZ)**U::-&H+--7$R$G 6.0IB
ME*<"8>,X\(P;;CYFL9809JI;?7#88S'DC#-B7[=E>LFT;R0URHH#[-HU25",
M6H49Q*BHT,JKI"TZE4A&<2#]DI?M#,8)SF5\&G"2Q9-)G'&2N@O-SC \/NTO
M&WK7M^^<B8;NG(]6MJV U8-I(:M0E=W)TR&G JM0J%9E33@6^5,S]JD9O$8^
M I?CA4\K(G&LW%>DS4FW/[P<J95^N-WKL+YQ9C"AYTP!<N-;>Q]CR@E7B59=
M\BS4.WZ3C$]:EJ%PU"YU/_)7";52Q_RJR0G%) !!, OF*>5+QDZR^E*:BF\,
MV5-Y^Q+%U58BW!X+P<C8<;B;G"AJ#%0*O<!]NVD*Z"KHN"B!H=J$5]?5*_4!
M%(J26<>'YJ!)Y#$,P0"^$Y5/QEG.7UO_ +CA#+P2HRBZ=M.$\:V_F3+>>L48
M_P 47<.F M'(=PWG1RK5NX583A64S_%*FD/5EW*%6B%^^0D,CPA(XFBF$N4Q
M2N4C*C)O"3R1[S]]C+>L"9,9E8E7OO'51MYW]S565/R4+)%N)+1L_&5+MQ94
MD&2)*RS51%PTJ];JDDM^CFE&EI3*DH$$1@AA"29&TC4?KE)-Z+MNCOR:]CFX
M;L=#D=K>/:H:YC+N#\?*L=Y=H=8LVN([%&8MH- JU>7W)5$B/+R>WT"U57J/
M,\HRGR3"$,DD,IRD3V1P\_CGUDS=9;MVMY&Q#<C@+$<+B&Z<'V:;4B+ORM2K
MVHX[(M8^D3(DO(N"M'GD$T@XO^LF98#Y $I">5,F1DC2YBN5[(XR3JT\E_AQ
MT;;7#_$.!\[8LR\=.UT5[&)+ O"E7#4$MI5*K+: AN"H4Q(=.HTNGJ:Y35"0
M,U)1(Y*"1%S#(4N$$T_0<91_LL&NUS[O7]HWWC9:R7$C9+_J2!L%"<55%^>K
MBOFUE0R5]]5>R5]*IE4MRLIJ48*2P"#^<HX@N?\ ]IHC#Y!#+A&WG"-QC]=+
MS;]X,E,^^S;%^:FXE98<M5,<-6R+;>5\OX)R-9=V7VA2VZ1DW!R$=?ODFRJU
M6SR%%;IJ6T)2J8RN)IZ<LLX/R-" )@R?CR)?6U+$<M8R2.N1^+*;.!B0V['5
M8+MHO/-%IER8<'7+_H]-#D"W*U, :/<-&FJ-+DFH-4,'("=8L_E3FCD((1S$
M$4I7*,J$WZ3\&6:UGG"%N7C<F/;AR]CBA7W9V.U67KKL^KW=1J=<5O8I0@$8
MMR35:6K5%*4MD(P G,VI3E-*7*4_D.7"<,HE98SAXR?+L%RC><JF5PK&F;L7
MWX;;-ET;)%Q%VO>-(JHZ'CRXT1U2MZ^JK).HG-%:-<IR8Q0DJ ^"502"8P#F
M&7&&4'&2]HY)3,PXLKN*#<[6]?=NW1APNS:WD(K(MK5!/7K9J5EVX@J-2K%P
M4:I(3!I:JA3I*2HF$90YA,$7.4IP)AYQ\FD:Q?LQ^QV]+6Q8[E PFS;B8CF'
M)-&MFU*'8-SWE=SPB<:W3<2FUK=RXLLBFE*:(?2S5"6:XU.6AD'^<00S,+)&
M!;/.7[QX.S^OZ\UM^:X-M^1GD-+Q%E>W<%Y/<CAVP<P7<"G&VSCNZ[TIE%N>
MJE5D^::B#$B5F +I8JT=+XI +1IQJ9SE^N0OE+CK*]')1DU9)X/LUUTS:[8R
M53L,W#GC%='RY5KTHV.*?C);>%+!?"B_+CH,[IH-J"MP)HZDFJ]8MS@L3@-
M6$P@8)R%Q,+D)E>B5>,X\$.[Z^RO$E4<.T;";:<I8+SH3E]R=W8*SQ.V;ME<
M]?Q<GH.)[GOVEJZ4&WZL2D*75&L6_--_4>6MIQQ830%"_:"<PS/G"-KZW5N6
M5A91L]BG,0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! "
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M #I< .EP Z7 #I< .EP Z7 #I< .EP Z7 #I< .EP Z7 #I< .EP Z7 #I<
M.EP Z7 #I< .EP Z7 #I< .EP Z7 #I< .EP Z7 #I< .EP Z7 #I< .EP Z
M7 #I< .EP Z7 #I< .EP Z7 #I< .EP Z7 #I< .EP Z7 #I< .EP Z7 #I<
M .EP Z7 #I< .EP Z7 #I< .EP Z7 #I< .EP Z7 #I< .EP Z7 #I< .EP
8Z7 #I< .EP Z7 #I< .EP Z7 #I< ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g172766brkpcpg01c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766brkpcpg01c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ %0+& P$1  (1 0,1 ?_$ *8  0 ! P4! 0
M       ( 0D* @,$!@<%"P$!  $$ P$               $" P8'! 4("1
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MVZ::>FE0<Y\^JA_/F?<SSR<Y]<_7.?K]UKHJ5QDGM/;E^P]M[3YN+VG%[?\
M;%OX^'\/_$UUT_>U^-2[EG\V>7XJ]/[_ +I_4\_?\9Y9Y>GC.?/IC'X+D7TT
MONTV_'7333[]?2H5H9SX]5H#PZ_)Q[O[NW73^SUJ3GZJIWN8_-RQ^.5N5"H2
MB)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HBQ9
M>UK3UX._4T]%G61Y S>W9]3X*1EQ"",6(,?O.&79H_*G9^P%<GRPXYP8IW'G
B.Z8UP%=.DA;H38Q.F#SWLH-$FA71GVC]L_Y+*:J5:7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g172766brkpcpg02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766brkpcpg02.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2P"& P$1  (1 0,1 ?_$ )(  0 " P$! 0$
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M"5U97MF=$I2UL=FET0FGHG%M<$9X#2#R1C*-+'@0<YQG&>5DK(;Z3R9]Q^Z
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#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g172766compcpg01a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766compcpg01a.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ W@%4 P$1  (1 0,1 ?_$ .8  0 !! ,! 0$
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MW4RZBZAW*4%"@#:TX_(JAM>X>3^F[3L7;+?E?ROO=)A?(#O2@UG7=Q;:[EH
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M")A%&LEIG3\U:B7J8U1K66NZ;ID]3N,E1:N^M2;V-*D2.=DL+J+5ER.F!$"
MBH"W>D!"@40Z!EZS)9&.#RL=Q,VUH1H#W!M#S&D&G'T\.*V^S[@[]Q^$.VK#
M-Y>#;A8]AM8[RX9;%DE2]I@;((BUY<XO;IHZIJ#4K[:-,Z?O$TC9+KJG6UPL
M39%NW;SUHHM7L$T@@S4,LT01E):+=ODD6JIS&3*50"D,(B4 $<09+(VL9AMI
MYHX3S:U[FCCSX @*&%[@;\VYCW8C;V;R]ABGN<YT-M>7$$3G. #B8XI&L)<
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MB@(= L9IKVWG=!,=,T;BTBC>!!H1P%.!"TG+Y7=N"S%QALLX0Y>PGEMY6&.
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MO- WW??]?T?W2YE<_A>WC:V$V0?D,88H.W=MO @&>IL+J5D3+8?4T\XUSP7
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M>ZK'=GEXXS)U8OA>-R5G-UPYC6#J2'5%TWOJSW]+N"M6Y5?[IY!?]8=X^_\
MHGQMS*X;W,1_W7>?]+,NU=E?<[6?^56]O^M9Y9-9GR ZPA9BPPSBG7U5Q7.9
M-!X4NU4$*\**VP=A1T5)1=I;BI/$.-,9(RR8.#F KX#%-V-SAT$=/AVG>SL#
MVR1 ''/O..K[./FWW??/H^CZRO'F/_"[O+(V%KD(LAC&Q7>P+W=K073U%C8O
MDCDMG4A(\V\QDL )AH1JE;Q4#\BMW5W==FXR)UZ*FXH=/^62L:0G1FB,2!)V
M*D:LV8ZD96(]Q>O>^$=DG$P0,MZ*XB0W<F7V=<QAL7-C(+XS.:[S.WW3MTUX
M-?+$ #4#Q#2:TJ/:NF=J.W.5[=X?>+LK/;SC/]CKC+P](O/3@O,CCVQQ2ZV,
MI,TPNUAFIE"-+SQIEISGR\-IA$PB81,(F$3")A$PB81:N^T:!6E]F;$75YA^
M0^(56O5N55B:]JJN.H"+44L$@<\=!NCSB1W,.R,(I-E!*43H%*(@'7IG;K&>
MZ\E#IL<2X=)O%TE''PCB?JSQ/IXGCZ5]FMF;GS,>S\3&S87:J=C<;:@23Y*=
MLT@$# 'S-$)#97^](VIH\D5*H7[.ZM_IJ>2?[HJS_P#D&777N_YAA_X7_P"&
MME^]>;_V>]H_ZTG_ (A;&O$9BWC.-VI6+6UWR\MVU;.1*V;.C&T-?9L@RDB<
M'5EC&BJ[=F_+W>F!2G-^Z(41$1$<X]G7.=EIW.9%&[4/#&:L'A'NF@K7F> X
MU7R9[ZW,MYW;SES-8XS&RONQ6VQ\CI;*$].,:;>1P:YS#354@>(N%*!7&YB%
MR9,(F$3")A%#JW'W2SARY>+:XK*KIWMZ-WZY7.T.)UMRP\>QBHO8IQ]7_*1E
M'1J"*:O[ (D7Z.9$9?)M:&MF>&BW,'/]Y)),?Z)))HM^C[I=PXH66\>7O!#'
M@9,*T!PH,5*]\DEB.'ZN]\CW%O.KCQ700XTZ&:NV[YOJVJ(NVNYI3D.W739'
M*HENV:;*LY7911!;I\SOFJYR*+#]$0-_5R9V9RCQI?.\CRPM^?[R.4?Z(]2N
MI>[_ '-G@=;2YJ^= _;\>#<TO%#B(7!T6/Y?J[' %K>?#FO3C=!::B'D _C-
M=UQD\JVQ+CMFO.46JA58G9&P$9MO=+@T$51[)FQHV1\5R<>H&!R?H =0Z4WY
M3(2-<Q\KBU\38W>V-E-#?D;04^16=WW/[@7\%U:WF5NY+>]Q5KC)VEPI+861
MA=:6KN'&* P0F,<QTV\2NE"<<M&UQ?6[J"UE5HMQJ"6O\[K)5JS.0]+F-J*2
MBNQ)"$$5A]W<6Y2:=&>"/<"@KFZ &5)<SE)A,V6=[A<-C;)4^^(J=,']"@I\
MBN,CW9[D9:++PY+,7LT6>@LH<@'.!%W%C1&+%DW#Q-M1%&(N5- YK\53C=HF
MC-=;,JCJ^J0#33T7=X76*$>R.DG2HK9*R3B]L(,!5-[LWM"R!#.P'N[Q*'[,
MC/FLK=.F=<3R/=<N8Z6I]\Q_9EWKT^A39ONYW+W)-E[C.YF]NI\_-9S9%SW@
MF[EL 6V3YN'B=; D1<J5]*_43QQT9!,JY'0^L:O'L:CK2?TW6FS=HH5*'U?:
M%8Y:PTEF45C=D'+*Q#8RR8]3&%$OT@]N2OR^3D<Y[YGE[YFRD^N1ONO^45X*
M6^[M=R,G<7=U?YB]EN+[,0Y6X<YPK+D;</$%V[A]M$)9 UPH!J/!=-AQAX_Q
MA61&&J*DU+':7=<=F0),E ]WT@]7*Y=ZT3$5A'Y877(!S(CU,(A_6R8YK*D:
M3/)3S GY_OP%!)^D!PJKBY[R=T;PR.N<W?/,NX6YU]7CQ9=@TMR!X?K#6F@=
MRIZ%V77&S1#YC(QKO5U5782VG8SC[(M3LC^D[TM#"^-%ZX5 %@$:TQ-)+BFD
M @8/5-]+(#,Y0$'KOJ+@SCC^_.IJD_2-!54H>[O<NWN8KN#-7K;F#/R9N-P>
M*MRTNCJ7XX?K#^FS4[D=(X+BLW&70=R"Z%M&JZG-AL2E5K7-W!\S44"RT>G.
MSOJQ69/M7+ZL9"/%#*(%#M$IA_:.0AS&3@+##,]IC>Y[:>AS@0XCVD$U^4J;
M#]X>YV ./.&S5];G%9"XOK30\#R]Y=-T7%Q'P-))FC2\FH(]"Y)OC7H>R&V6
M>=U;4Y0VXT*"UV@+MB<XW=OJT$0UXE.]%@]Y)40;D]SZ=OI]H?MR:+-9:'H=
M*>1OEC(8J'W.K]II]6NO%2X[N]W,Q P[<;FKZ$8!UZ[':7@>3=D:^>,/#PFZ
MU'J\]53R7/9..NC[A\]_,^LZQ-?:=9:5<;_[ZT44^:[/KE"&;4>:ENBQ?7>U
ME"OLB-3!V@4&Q.H#T'K)%E\E!TA%,]H@:YL=/HM>27 ?I$DGY52Q'=?N-@?A
MGP?,7EO\&M+NULM#@/+6]^977D47#@RX=/*9!QJ7NH0N"0XUZ'E7DO(2.KJJ
M[>SVTZWNV8<K,U#*R&V*>@T;5F]N!!8.Z>A4&*1$5 Z% "!U*/MR+,ODHVAK
M)GAHA=$/_=N]YGR%5;7N[W+LK>"UM,S>QV]MA;C$1-#A1F-NBYUQ9MX?8RE[
MB]O,D\PN\;C[I4S@[HVMZR+E3<27((ZPLS=YMTH1B4,EL@1]7_*9.+0(@"W[
M/3* =N/C&3IIZ[]/EO+\_P!YK7I_HUXT5L.Z?<,1" 9>\Z0P!P@&L4^$F0RF
MPY?JYD)?IYZC6JZ#/C5H:/=Q[]EJVJ-GD5MR>WU'.$F:@*--Q6=!RUL&PDA]
M8>EBE6[Q0BJH]2B!QZ%#V8?F,G(-+YGEI@$/_--]UGZ(5S<=WNYEW!+;7.:O
M7V\V"APSVEXH[%6[FN@L3P^PC<UI:WF*<UVJ]QWTC5!I@US6E8AQUY;[C?J3
M[DT43^6[EL!O--+I88SJL;TI&QMK$](Y,/4#%<GZ 'LZ2RY7(S=02S/=UF-8
M^OTFL(+0?D(!"HY7NMW%S?Q 9;+WD_Q6PM;*[UN!\Q:V3HG6D$G#BR!T$1C'
M @QMXE<,'QOT56U-:+06KZK%JZ<6V"XU<=HR.0U(6VM[]]HRD$(JC[L:X?$E
M_?>O=ZGJFZ=.N5)<UE9A.)9Y'"YZ?5J??Z5.GJ]>B@I\BJ9'NWW*R[,Q'D\S
M>S,W VQ;D0YX/G!C='D!-P\7E>FSI<M.D<UP5;C+H.D!0RU/5=3@0UA5;72-
M?@P9*)_*E3O#LKZW0,3W+']%A/O" HX*/<)C?TAD)\SE+DR.GF>XS/:Y]?I.
M90-)^2@I\@57-=X>YVXSDSG,W?7)S-[;7E[K>#YFYLVZ+::7@*OA;X6$4 'H
M7/'\;]%Q+*%CH[6%6:,:[J>8T7"-DF:@)1NH9\\>K,T!N45AZ5Z14B6PJ)CU
M,(HE^E^WK YC)N)<9GU=.V8^V5M=+_TA4T5*Z[M]R;VXN+J[S-Z^XN\Y%F)G
M%PK)E( \17KN'V\8DD#7<AJ/!>;^5?CQ[G\/^R.G^YCI .-GH>XJ=GV$%7%R
M&K^OK]WRJ#@>_P!'KW=WM[LG^.9;EUY*>9\QS_?J4ZG+WJ<%=_VU=UNOYGX[
M?]?[Q_'ZZQ_VSIT_$?=_6=/#5RIZ%Z4CQOT7+LIN.DM859XRLFJ8;1LZV6:*
M"E)ZCKQY!6%H+DH+!W5^-4EG(I)AT, K&^E^S)&YC)M+7-F?5L[IA[)74U/^
M4T%5:6G=ON38W%O=6F9O8[BTS<N8A<'"L>3G#!->MX?;R".,.=R.D<%P6KC+
MH.\!?BVW5=3G@VC5ZG2]@A(,E%/FRJT5V9_4(.6[5B>LQK[PXJ-RAVB0W](Y
M&#,Y2U=$ZWG>UT+G.93Z+GU#B/TJFORE5,)WA[G;<.,."S=]:G"WES=V.AX'
MEKF\;HNIHN!H^=OAD)J"/0NQ.<<-%V579:\]K"JRBNXW.O7>T5';(YS7=SJ@
M6 ZY6G1!4/>3T\8MO[D(=OI^B7KUZ8BS65@$ BGD:+82"*A]P2UZFGU:ZG5\
MJIXWNWW*Q#,/'C,S>PQ[?9?-QP:\#R;<EK\^(>'A%UU).KSU:CR7+8..^D;4
M-Q&Q:UK,N.P+E3]@W07C10_S'=: WA6E,L<ET6+ZLE76U=8D;&#H!2MB=0'V
M]9(LKD8>F(I7M$3',93Z+7DEP'L)))5/%]UNXN%%@,5E[R 8NPNK&TT. Z%I
M>NE==P1\.$<[IYC(.))D=0A=5YQIT,_=OG[W5M4<O)/;T'OQ^X59J&4=;DK3
M=NU@=B*CZP -CBV[1,B2H="@! ZE')V9G*1C2R=X'ES!_P T[FS]$JO;]WNY
MEK!';6^:O66\."FPK&AXHW%7#G.FL1P^PD<YQ<WF:\UWB\?-*D<)NRZWK)7*
M6XE^02:P,S=Y-TNHU>'<;( ?5_RF5BW*B K?L],XAVY#XQDR-/7?I\MY?G^\
M@UZ?Z-16BMCW3[ANB,#LO>&%V ;A"-0H<2V02ML.7ZN)&M>&\]0YJ8\QJT!,
M(F$3")A$PB81,(F$3"+4BVYN=RRVOLYF'%C6DJ#385T;!)NN2OC,C',B"%DD
MD@?N(VS<:I.R1Z[SL]0Z$@Y</DC&$JZJBH'./H#'8\.L('>=G;6%G 6V1('A
M' %MT&D#UM :?0 %]T-B]OH;C9.&G.]<Q"7XJT=TVX#N#(V.MO&=#9+?<$=N
M]K:Z0^"..%P&J)C6%K1'OVX.O]$G5OZH_%C_ -ES+SX:/Y_<?T7)_P"-K:O[
M.8?].<U_J[W'_P#$:V@.%\N:=XN:9ESUJ/IYGU5,L-:BK!KRU1T1TEI(GNS2
MPZGK]5UU*I"!._U(J/:MNIA#L[P.(\-W$SIYJX9K,E'CQ%LC2?".;97.D'_"
M<3[:47QI_$'8C&]Y]P6+;R6_$=Z!YB2"^MGR_51G4Z#)3W-]&>---S/))PKJ
MTEH%S^85<;3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PBUCMG:WICC96PEU?'9HBQ*KWBV
M+*6!]H3D8_>SJBD_('/,/'T:H$<]=29C"NHJW_<*'.)B?1$,[793/\E#_P#5
MKAGU3?")K8 >$< "*BG*AX^M?8O9VZ\_'M'%1L[K;EM6-QML! S-8%C(0(6
M1-9(.HQL?N-:_P ;0 '>(%4/]F5(_EJ<?OT\\F?_ &F7/6=_EBY_AK7\BV3[
MW[B_VO;H_KS;WY%L0\38YG$\=-41T?0X36#-K7#D0H-<A)ZMPE9 TG(*&81\
M'9^L_'(F.<51(Z_>"901_8(9R'..+LM,3*Z8ZAXW%KB[PCF6^$TY</4OE-WP
MNKB][L9NZNLG<9F=]V*WL\T,\UQ2-@UOFM_J)"  VL?AHT#F"KB,Q*Y2F$3"
M)A$PBQZ[8YSN=8R7*6$'7",K,:#M&D("G-368&?VE-=LP-8FIN1$#1:BD*&O
MT91\L\(F#OO:-$U.I#+ 4-PL-K-OF6$O6+8[N.=SSIKTS$YS6CGXNI1H'+B2
M.-%ZIV/^&V'>-ILO(C+.@L-SV67GNG>7U_#W8R:XBACX2 2^>,<+8B[I4EE<
MWQ",D^QH;EY8]N[AD=<.JYKE6.3<[=(J6C7J9L=WUZUUGL1_1(5WMNM/ZE$Q
ME<;[#&-74CC(2"YS+H'33373*LLA1RNWH<?CA>-?-KI#[[ UDG5C#W")P>2[
MIU =5HX&I(- <?W-[$8G8FPHMVPW>6;=EF+(\Y9Q06=\[(6++R9N,N&74LD[
MK'J,;.'P, 8]KW/C<61R3)JSD&TV7L/=M$2@TF9M7RY$JRY:S321>WB :/)N
MH3\J$<!$"PSJ)V;3)N*] ZJO<@@V<&,3WD$R8^_Q#K*SM;HOKUV^*H(#'$->
MT5](,;V.K0<2X<=-5H&]>UD^T-J[<W*^Y=(,S 3<-=$Z-EG,YD-U!'KJ[JME
MQ]W:7.L-;1[YH@UW1U.@.K\TK7-ZDVC>W6OJ.2[5(:7&UW6#39+MG9V%^V',
MKUN"U/MR)M=/K-BUW;(><!$CUZ#!Y%.T%%56*JX-E0S*3;:MX\A!:MFE\M(7
METIC!:8XVASI8BU[FR-<VNENH.!H' :@NGYG\/6$QV^L-MJ'*Y([=OO-R3Y%
MU@U]N^RL8A/-D\9+;75Q!?6TL.LPP]:*YB>UC+ED1F85XUT\A4;78[><M"4
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MT, ]_M#)3;SM)!8\$/TG@?>_-Y>][.:M9,)F89'12VETV5ESY9P,3P6W'$=
M@MJ)J@CI'Q\#X>"_!K;5"-6;T]FKQ&4C*KP4>[--1I6KZ<;+/&SF&9N!<@DZ
ME6[B/<)G;D$RQ#H*%$H"0P \O<%Q:&/U-;J(TFH::$$\. H1QY<1ZU,,%FW3
M26[;.Z-Q# )GMZ4FID+@US97MTU;&YKV.#R TA[2#1PK4.45BDPB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+7QV&CRJ&_P!Y&)VWO9G%
MC<+,,:T827+4K%K'_&GON;=D6(U&\BBM$&_:5,&JJK<" 'IG,3M,/7K,X'RD
M74M[0R=-M21:5)H*DUE!K\H!]?%?4[:LG9+[KXWSV"VS)>^0M^HY\>V=;G])
MFMS^KE&RZBZI=U&M?6NMH=4*CO0Y=?YY.0/_ #IS&_!O+G5M[^;6?[5G_'+/
M=3L3_D#:W\'M7_.JSF\:@LI=%:V"X2DU-68( ?C$I8E+.K-/77O[W][(J7.+
MA;09?TNT/\=:HJ]H!]'MZ"/*\ST?B<WEVM;#JX!NF@X#EH);^T2OFWW>.(/<
MK+G 0V]OA_-?51P"W$+&Z&<&"TDEMP*U/U4CVUKQK4"<LQBYNF$3")A$PBQF
M6_6=JGMX;7BF.E[$:;F^2>G]P5;=BT57F59B*)3-0Z;@;:@RN!9I*T'EYL*K
M,UP8I%L/KDD#^J'N:BYPW>WOK>'%V[W7+.DRRFA=#5Q<7OFF<RK*::-ULDU$
M\-/#Q !>P\#O#"8SMSA+VYW#:#'6VT,IB[G$"2=]Q+>W>4RLUJ7VO2-N(H?,
MVE_YETG@,#='\H;$TP%K+5E]:<>-=5*RZYY'C8=<?8T]6,33_'R"D=>V&N:\
MMU0<2%4K"$,K![^KS-_,FC))G.'7>(,'A9-FJ#I 5,RM_?VCLO//!-9=&;K
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MTAL@N19H-6S1JV8H(M63=L@@S:MD2-V[9JDD5-N@W02*1-!%%(H%(0H 4I0
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7B81,(F$3")A$PB81,(F$3")A$PB__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g172766compcpg01bv1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766compcpg01bv1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ H@%  P$1  (1 0,1 ?_$ 0<  0 " @,! 0$
M       &!P4( P0) 0(* 0$  04! 0$             !0(#! 8'" $)$
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M/S]9+?;F_P K-?=HK8=L>INNWZQ,5^=(-8#;9Z"&#?M:VK\H[MHU?R/SE?\
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M M?<5W$$:@I7#@"+D$\+<>RK+'2KJ9)<R#+& RZWL3#3+FA,1XF+%6T7D2)
MT? LJ9274N+LE2 5 V%=",W.;=9J!=6J'SEBB3K3)Q96CR>8WNN.HALZID6W
MF[:W7D$9 [5-:M0[M)T^*)@%JW4*HIRE, ZK5A<PAT,+BOAXZ>[H5?ODI3PM
M?O*! ]TBPXUE3.CG5C'Y-&%G[;S;.7<3'4AE<-]+JDRW%,QE!!0%$2'4J;9-
MK.+24IN017<GMQF!*M6UKE9,RXR@:FWMH4)>R2UT@&$(C=NS*O/DFI).7R;0
MEB[(@=7L@FZX)E$W+P 1U2UB,J^_X9F,^I\MZ](0HJT7MJM:]K\+VM?A5C&=
M)^I^:RZ=OXC;^8DYU<'QJ8[<1];QB:@CQ(;2@J+&LA/- T:B!>]?A#<C@!TM
M:D&V:<7N%J/9'-.N2*-VKZBE6M;-O-NW5;GR%?B:*FV[6M2"AVRP$5*1DN(E
MX)'X?3A\L A1C/!+B-:>XKO(.FRAPXCOIXCAWA[HJIWI)U181"<>V]F4MY*(
MF5%)B/@28RU,I3(8[GPC*E2& '$722\V+]]-_DKN1V_P-7F;M-YJQ?%5"NS,
M=7)ZSO[M7FL%#3\O&M9F*A9*36?D:,Y.1B7R+E%!0X**(*E.4!*(#KXC#Y9;
MJ6$1GB\M!6E(0JY2#I*@+7(!X7[ 12#TDZHY/,Q]O8_;V9?SLN.Y(9CHB/J>
M=8:<4TX\VV$%2FVW4+;6L I2M*DDW!KNQN?\'S,S.5Z)RYCF2G:Q-PU:L4.R
MM\&YDH.PV(RA("$E6B3TR[&4F3)&!LBH4JBPE$" /#5*L5DT-AU<=T-J25 Z
M38A/:>SL'NUCR^E_4B! C96=@LLSC9D=Z0PZN*\EMYABQ>>;44@+;:!!<6DE
M*+BY%ZZ9-R. %*U8;D3-.+SU.I0]=L%HLA+O7C0E>@K<8I:K+S,D#\6D='6(
MQR@R65,4CD1#IB/'5:L-ETO(CF*^'G%*2E)0JZBCSP!:Y*?KAY/+60KI)U11
MEXN 5M[,C-SGWV(['@W^<^]%XR6FF]&I:V "74I!+8!*K6KAC-S&WF:?.XR)
MS=BN2D&%<K5P?,6-XKKETTJES"&-4;&X02D#*)0ME+8F LG)@!)R#U#IB;JD
MX_5X7,-@%R,^ 5*2"4*%U)U:DCAVITJN.T:3[AM7,Z0=5<='1+G[<S3,9V7(
MBH6N&^E*I,3F^)822@ NL>'?YJ!WF^4YJ T*MEVV>L)O6]A=-,LX[<MZE7IZ
MVVA="W0:J-=J]6E9>#LMAFE"/1+&PT!,U]\U>.%1*DW<-%B',!DS %"L5DTJ
M0A4=[4XM*$C2>\I8"DI'NE04" .)!%JP7NF742,Y%9D8/*H=G2F(T=*HKP+\
MB2TT]'8:&B[CK[+[+C3:;J6AUM200H$QR-W4[:9A:-;Q6>\12*\S3Y3(,2DR
MO]:<J25%A'4NQF;>R*E(F%S7(MY /DG#PG%!)1FL4Q@%,W"XK!YE%]45\6<"
M#W%<%J"2E)X=I"DD#RZA[M2TOHIU?@(=<F[8SK2&)[<%PKA2$AN8\EI;45=V
MQI?<2^RI#1LM0=;(!"TWF$9FC$DU-K5J(R71I.PMQL8.(1C9XAS*H_(]*(7M
M8*L471W*8UQ&P,3O>)?J8KM(5.4%"\;#F-R#38><9=2T=/>*"!WKA/'[:QM[
MMC4#,Z>[ZQ^.3F)^'R3.*7R-+RX[J6U>*+HC664Z3SRP\&K'X0M.!-])M"X;
M==MGL0U8(#/V'YGY<+3S:F^+<@UE[\J'-71;N+&W@NA(G"47@F[I,[LB/,9
MIRB<  =7W,)F&=8=BOI4V 5 H4-(5P23PX7/8?+6P9#HEUAQ7C?2>U\['&.2
MRJ5S(4A'ATR"I+"GM38Y:7BE0;*K!9!";D5+XW-^'9F9AZ[$Y1H,E/V%PQ9P
M4*RM4,YDYAW)U-2^1S:-9)/#.'B[ZDHGEDBIE,92/**X *8";5E>,R+3:W7&
M'@VCSB4JLFRM!N;6'>[O'R\.VH*7TYW_ (_'2,M.PN39QD1"U/NKC.I;:2W)
M$):G%%(" B61&45$6?(;/?X5%6NZC;6^59(,\]8C=K2-V/C9@DWOU:5.\R"G
MPYZ6V*21,*UG+Q\+(.+CPA[GPZN+PN81?5&>%D:N*%>;VZNSLMY?)_B-3;_1
M7J]&0X[(VSG4-M8[QZRJ%( 3"/9+42CA'^_'N=O&I"3/>$U'D7'DRSCLS^<=
M5UC#,PMT(+F4>V^8FJ]56C!'MO4=.+%/5N09LB$ 3.7+)=-,#'3. 4'%9/2I
M7AWK(2HGN*X!("E$\. 2% J]P$$V!%1)Z9=14L/2C@\J(T9M];JO"O:6T16F
MGY*UG19*6&9##KJCP;;>;4H@+23'I7=/ML@W-F9S.><21;NF6AA2;8V?WVMM
M5ZU<)55VA&5B<25D2GC)U\LP7*DU5 BQQ1. %]R;A6G#99:4+3&>*%HU)[BN
M\GAWAPXCB./OBI2%T7ZNY%F'(@;9SCS&0AKEQE(A2%"1%;""N0R0@\QE 6@J
M<3=("TW/$7D#O/>$V,DK"O<M8Z:3"+MK'JQCBWP:3U-\]MZ6/FC0[8ST%BN'
M-Z7)#D)PYC21@;@'5$"ZI]$Y/EA[P[W*()OH5;@CF=MK>9WOWO'LJ,9Z8]1I
M,,9&/@\JN"IM2PX(KQ04(BF:I84$6TIA@RB?(P"Z>YQK!V3=#MRI[ZZ1=JSI
MB>N2..%XEM?V,U>ZY&NZ8XGU6J$(C9D'<@DI"J2JSU(B +@053*E O'F#53.
M&RSZ6ULQGU(=\PA"K*MVZ3:Q^H*D<3T:ZLYZ-CYF$VUFY<3+)<5"6U#?<3*#
M(473'*4$.AL(45Z+Z0DD]E6K7K?5K:224JUBA;"2&D31$L:&DFLD6-E"-F[P
M\<^%HHKV5Z5H[24%,_*?D4*/#@(:PWH\B.4B0A2-2;C4"+B]KB_:.!XUI65P
M6:P193FHDB(J0R'6@ZVIOF-E2DA:-0&I&I*DZA<721VBI'JS4532E-*4TI32
ME-*4TI32E>#L&'#O4+7^%%<Q_P#YM5']774WR3L5F_\ H21_^HKK],LG^Q7
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M8BC\/E)WF'T>\%R+[?YN/]W_ .A^9J_*^(PWY(;^ZAUG;C'_ '1T?M__ )9
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M^)?S/^^-F \'@_>GZNMCG6Y;@MP]"J_<<KUYO+AA\Y^H1O\ <76_3$ #+VW
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MNJWJ3=7Z\<%^(;<KU=V]>F;:OSN\#_JYM3UH^8^;S7[V#]W)KQ)U5_9]@_\
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MEB%@51;2,>V8.>TMEG/(=,MQ6U8;CR3#E+5#0Z\V\I3>E2#':+KBDI"E:TE
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M*<;)FOEXQ<PB<'W5MGMSAJV5^VJS-LFB8 ;6-_(DOE:?0,3'UA3(4349%Y"
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M311K,)KF<( W.EK$7E\7*2,PX\$26H4ACDV45K4Z'6VR"!H"$H="EJ)!N@@
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M@LT5*LG"7(FHV03D6?752,[;@ICM;=R#D'QHY87H6L-%7PJD-DA:PFW%*2%
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MUJH90HT_8<;&7#(,9%S\:X=U8&9G"3Q:: JH @W8+-%4UU1$4T%$S$.)3%$
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MMRNWFTT6X9)K>8,=RV/Z(J[2NUM96.,-!5P[4A#KFF'@JE2:IJD5**1S>X<
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M!O #51]R<6PAQZ:S?7'OJ]&>@%7[;6^$YE_)?GA0'OZ;]ZOT1PZW1*PFHO\
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MWW^.^]>)J4(^LY7]!;S5#])Z;GP,T_9?B7_.^)>CJRKYECUG\=_Z'YQ[/?\
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%32E?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g172766compcpg01c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766compcpg01c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ .@ Z P$1  (1 0,1 ?_$ ,X   (# 0$
M      <)!0@*!@0!  $% 0$! 0            8#! 4'" D""@ 0   ' 0 !
M P$"! P7 0    $" P0%!@<($0 2"1,A%#$B%5@RLY6U%M87&#B8&7EA@9%R
MTB,S4W.3TS1TU#755G:7MW@Y60H1  $# @4" P(%"1,-      $" P01!0 A
M$@8',0A!(A-1%&%QD3(5L=%"LB,S4Y,6\(&AP5)RDK,T5'34-5:6%Q@X>.&B
MTD.#TR1$M'655W?_V@ , P$  A$#$0 _ #!B6(\"4;@3.>K.J\YW.^V"^[E=
MLD10R6[MH4&XPC>8E(MTXBY27A(])LG'0BB:ATU3JG5.4?;X$1"QY$BZ/7-<
M*$MM*4-A7F!\33PK[<?21R+R-W0;E[G[MPCPE=MM6NUVO;<2YDW.&I[5ZRFF
MW$I<;:>65%QY*D@I"0D$5K0&;MN)?''L_#/7G0?,67]!T.Z\[%R]D@IJU]:2
MC%V[T.Y1D0*C>+AYN<:O448<'13@N9(2**)F+[O ^$_>+M%GLQIBVU-NA?S0
M?L4D^-/'$=8^1>[7CWN1V)Q9S'>MJW/;VZ_I%9%MA*;6E,&(X[13CK+*D$N^
MF1H"JI2H&E174!H4[M]EQK(LNY#VG!*'T0SI><W&?KNL*%L+XV4#4E8Q]((4
MV')(V-LFYLB[ J3\[0&GA-1+Z@',4/0>A#"7W'IK;BHVI0!2,M5:]:@=*Y5K
MXXXT[5MO'-HY OV].=]O;GN?%#EQGQ6'[8"PCZ3]Z#B$&4Z6V%%,=+Y4P'?5
M\R%Z2E)PJ?H;#*1S)KO/VR:G;:Y"_)7T%)W>2B.BWUD_(7(5+OE%@8N(>SMX
MJ]B/%.(VN/L^ED6#<$F:QC2@_4,!0$HC+Q7WYD9R.P";8T!5%"5FH/2A/V0K
M2O3QKGC;7%7)&X^8MB;IV!LJ#+D=H6UF8;;MB1'];=$N',><=0S#D,>JEQ]$
MYI;R]3J (WE25$&D1\<_5FH\H5O4,MT_D3JW4;+J'4M^T0=7R'&I-YD,RRO;
MFM0P6N$E9-2).>JR#V*7DV[A%-1L:+714(80\@"UV@LS"AYA]E"4,A.E2QK!
M!)H1GF*].M</^[/A+9?-]WLN]-F;[V19;19=EPH/T9=+JVBZ-+AID.^[/--A
MT"2A#B([B%J2X)"'$J2,L#WH/ >8]3[F^5S6NH:UH5KJ7-M%P"^,8G-[0-;G
M7*4KF4<VFFZ0*.&3)^X63BF_T0772(G[3?;^-Z5CRIC%LA,PRE*W5+&8KT4:
M8*^+.4.8]E=MG"&QN&9EJ@WS=URO<);L^/[PRDMW!Q32C1*UH2"XO44(455&
M66 )RMDOQ!]@:JIC.=X=UI5K2M2KC;VDM<M.B4X,B%2C ?N$%30MHFGOWA?Z
MA03 $#$$?T0@'IS.?OMO:#[KC*D:@,DFN9^$#%F\U[Y[\N!=DCD'=>Y-C3;*
MFXQ8JFHEO=+Q,IS0DCU8[*-(H=7G!]E<9]OJ&_H?U/1;CJ9H&':8E;N&=G^.
M/+^8N@^NPYVNM"Z"OFKG199?<=#=.V,JTFX>+;*&B(W\D(HO&LX9?W%='5(*
M0%,0/=Y 7D>_QKLN9&9#K:FPG-:4^-?$U_0QSHY%L7<EQ[W:7GF3BS8GY5[>
MN>UH5M!7<8L%*5MJ9=<4/5<]4E*F0BA;"3JJ%&E#.V.Q_'_SC\?_ &IAV'=I
MCT'H/08Y$^@X1]D5WH"Z#B@7B+?NVS=V_C%HE;ZT0NX7,9=PW\?=P*4#F. >
MDB;C,N+,B2R&FF@NIUI5\Y)'@:]?CZ^S$9:K3W1<M=T7'G(_(_'@VMM;:PNB
M'GD72'-!3-AN(2I24.!T4="$ (0NNLJ44I3AO-IQK.[)U[G>LU?M^V8+M6><
M5Y/;]'RZK9P_F?RYSK1)1C8;&\E;:9=&/5A9]^"2#ADW*N])]$BA4E $ ]0@
M?=$)<<L!QE4@@*U)^>:@"A!/MSR\:$8PC9>0-V6C@BZ[&O/'$'<_'EUY$N46
M!<9,]#7HWV8VMB.AN+I*PZRC6M#RRAHZE)*TFIP$.ONP"=#Z=AU;1^.;+^O<
MSU^0N[;B_1[GJ:%76U)C%P]>?:,\B:Y.5]K(4H6CYFD@L28%D*_W1,Z?N Q?
M*\*"AF*XM4HLN #U$A-0*@E-3F#45.5:"N+&X'X&5Q5LW<EW<Y9O.P]X6%J&
MK=D");C)%N6XZ^B AV0R^I$O6A2EH,7U0CU%)50@X]^E;S=\PX.@;'C'4]TL
MU@;=ZYUEEG(UBUJX;"FB\;'-K3RG#NY!H8ECJ.;$(DV2D$?>B](<#D/[/L])
MMQVG9Y2^VD(+1(-0=?W2@6:="<TTZ^W//#7:/&6W-Y=S,FT\@[*M\.UKXRGW
M*.5."1],J#CBHVY'4H55B5/)4M3"Z+:(*5)U9X&6VZMS-6>V_EXQKI+;T<-B
M>A\ZY[H=?M(5*R71RDNQS-BYEUT(BN1SWW*,$))N;V.%&Q5 5_%,(@/AVTU*
M7;8+T5&M32EDC4E/51I\[_+@RX[V3S#>.W/@CD#B/;BMR3MJ7:^37XWO4>(D
MA=P6EH%U]Q&2RVX*H2X4Z<TYBH(XW;?%IQELBNW0OR/KZ5)M:#>:@VJLAS]H
ME:;N3VV)!B#C\JMXJ2,D=N=(H@44O:81^TQ0\^G%P<NUQ9$=49*$Z@:^H@]#
M7VXLOGY_O1[@M@#CFX\2HM$-=TARE247N#(4D1G=>GTU.-U"@34ZJCV$XSH_
M70_OZ'^.2_L_1CJ3[1CK)Z;GZE7R'ZV->37KO>N2=UO5$[YY9H&DY_!YFRLT
M7<N/N9)&>@&4X^=-GYUIRU7%>#BT8F(KC5X+W["B@L*8B/L P@ F'%G,)7;'
MUH>*Z4=73+,9 5S)I^8C'!][@CC+G3C6V[E[8=ZW2T;IDWA<=R+NG<*&7ELH
M2I #,:(EYPNNOJ:]',A:-0 U%(Q:'0]'M_0>3Y?N_!)^#J9FSZK+3>LH]30,
M(VL%,=3[N-1I3"93I)YF)JKM<A'A%T7SHIE%3) F)A]WAFTTB*\N/<_>2Y7R
M^G6AIU/FH3\F*9VKM*P\6;XO/&?<X.3;AN]J:&;8=N//*8EI82X9:VC,#3LE
M*26BA;+9 2%E=,JUC'L_HRZ\HP+R_P!+RYKOE\Z=#FO5HJM9S)Q4_&\?ST8]
MB+%I$1%.I-2T0E*2.<ZC2S.0- HB)!,03>/3DPHK<LEE3GNR&]::FH+H733[
M":>'6F?3%QCM\XFV]S=)8VO<+TOC&V;-^G[:Y(GMN,.;I8<0ZQ =<2V([TL@
M!+MO;I,7YJ*I@$-L6ZA^/'=(2*X\MV"W?G'HV86+D6I[<_LNJU7%X/,ZY]60
MDK=I$0PAJGF#6TSMJ?-DU8]1=*24212-X.CZ=B1!N<6LY+J930\R49%15TH"
M254"?&E*_#BRW>0^&.ZOC61-Y\@;GMW+6THX^E+=:$1[;)NSUP?HVW%@.K=D
MW%49F,RM27TH5'2IQ::I<QP<GI?7$-W] 2EJUGX]Y2QQW/+RV3:E5EUEN>7]
M,8:&Z?SB:;!RX3:..D'CA-86*ZH%7.R%(#*@GX$%?=X*K80VW* ]6@J//6@_
MS/J&OPU)X>S^"KAVO2H5DL?*C%I=W6B,R)+0%\1+7!2ADE:4E2;"E)3ZR$U0
MET+(05Y%@'4_RR<H1?+58WK-*#"6;6MWBKJVS6(N='S>SSM0LM+?%A6[C;8-
MG<%)J$AY$K?W,A26<J+MP*( 4/ >HN#99RY9CN*4EEO34@J (4*^7+J/'IGE
MC+G"O8[SA,YIF\8[PNDF'L;;+\15P=B3)\=F5'EH+JDVAY44-/.ME5'M2&TH
M<U DG/%3N2?F,S)7-[%/]?<RI3$D30FD!"W7#.=ZLAF,1$R4;")L8JU3]EMB
M;9C9S2[APJ*7U?(M#I"4HB/VR$^PO!\(@/4&BM%K5JK7PH.G3%X\Z=@F\6]W
M1+7P-O$QXAM2GWHEXOLDW%UUMQXK<C,QXQ4N/Z24)U:<G0X"0!A_?[->'_\
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M[';HRSO)6&8X@-3E73A>=1;D>%F$2>!  ,'IO$8?@J<<82E<XI)(();],G,
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M;J@H5J<OV"/D$VF;:N2B*]!4TI850E:C\U)/2OQ?+B.V5QUVZ7CF#;G$?('
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MT<_1\#\ S^P3];':C^S_ ,#_ ,RMI_\ B+?_ !?%<E/T7](/3O%M(Z8\Z_\
M<%_\ M^E']?E?-/Q85;^^)_7#ZHQL%FOX>6P_P R,M^FI>@)/\FM_P#<1^GC
M@G;O[LU@_P 1@^H< [GG_-O_ ,\7]=U%^'_0A_!Z]._>[C\37VN+'Y4^^]U?
MQ;<^VP%Y_P#@'[+_ #W[W]=8_P!./^?;_@(^WQ85M_O,;?\ \.*/VMS#@^1/
M_;)\IW_+_*?_ &X7]0\_^1(7^T^VQ@OG?^XYPK_"MR?]>,<_\67^S/D__P#/
FKI'];HKU[O?SH7\%;_3Q)]Z?[LX:_P#F%@_;',8=?5DX^D''_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g172766compcpg01d.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766compcpg01d.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (@+& P$1  (1 0,1 ?_$ +$  0 !! ,! 0$
M       ( P8'"0$$!0(*"P$!  (" P$!              $" P8%!P@$"1
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MSJ/W50OME]IL-1&.US^[A%VL@HY0X2&3X,W';(^T)$Y0SCEKNX%8_+!HD10
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M;)J6 ^@!*0GE5)H90TNHIJ.:@M<#E(-5W[.91XVY#[H;#WVM9=XZL7138Q)
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M"!500X'/^BLX481Q_D.?K^5OK[2P1![+V,(1 &$=,6KB4J 8!!'2OXC<OX5
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M ?BBV%06RZ"\V<G>YE#+#F25WY:<9\=DE@INN;$SE)(K/)SBB[43.T >#B%
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M*DJA,K<EHJ !O"J#;41 2SN9V5MG4H=%=NC3[=MQJ[\S+9KG,:V,>YKIG9W
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MA!JE:8Y*#2+VVC)-4.1Q0"#G)087(@C.<3B"@EC4"K4X0 T#45:4I32H3(_
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@1$X7HB<+T1.%Z(G"]$3A>B)PO1$X7HB<+T1.%Z(O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g172766compcpg01e.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766compcpg01e.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ + +& P$1  (1 0,1 ?_$ -<   (" @,! 0$
M       )!P@%!@,$"@(!"P$  00# 0$               4&!P@" P0!"1
M 0,# @(' @D)!@4"!P  !0,$!@$"!P ($A,1%!46%Q@)M3DA(B1V.'@9>0I!
MLB.T)2:V=[<Q44)S-[@R0S0U-H+6)UB8J"EI&A$  0," P0$!@T* P8& P$
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M+U2:C<F1@14T-..FZ29):BRY$E8]>JJ+VN;[5Z^3+G9';LW<S27-S&JOC(0
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MICZ3=]7UG<D_K'B>4C8V_P!*OZ&GK ?5:'?PGF[6&O/G'IW]_7W3&$'OK_>
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M1?Y\7%9^^YRG^JL_(S,.%]8'W1HK_)VY?K #3!Y?>L%?UG_;7%"NX9]^E_\
M6OOM/81FU]PV2^\#3_IDPU*1^M0?-7_67'TB?_$R9^JY?YB>)HC7N2=NWWA8
M#VI+-(\GUDS/-:^[#$>7G\135?U5O>3C88%)?>F^K+]W,3_I?AW37C_,BP>=
MQ\L_BKUH^Y;R.^MAO^8W7$P^G=[C0A_)'=Q[>R[I-U7ZS6_WB'[AG#"[UGXD
M37]1:8\A:\(N]*S_ $$]53ZCTP]ERO4HZX^5[!YQ:]M,?2;OJ^L[DG]8\3RD
M;&W^E7]#3U@/JM#OX3S=K#7GSCT[^_K[IC"#WU_O <AOZT<_B;1BY03_ %%_
M#O?RZ)>SX9II'_H]5_&I[3F*_7'YJ=ZOSLW[N7B\/I$?2.]63ZX1;^+,LZ;O
M,'Y(L7F\?)L8KEW[?5+R/_H)K^%MF$N[/O?VD/K4;L?9>9M2;J+U4)^X1?;8
MQ]">??X9#7]%::\I:<<_I9^^?)?/?=1[*R!K3KCU;#\4Q[MO&GOI?A\M>;M.
M>5@XS63?=*[NOO3I;[/":YH/S\M_F4?*EA.T=]^30GU+1O*/8;%$O?KQ_P"H
M6&_.9Z8<CU:'YR+VUQ2"^_AKROK-=_SX4'ZX?O.@7S(PC[4(:D7EA\RG/C7,
M7P_MQ?<YD^<;OY,,'JC>^D'?/S:I['QWHT1ZM2^*D>[<P=S'\/9[S9J/RL[#
M-<L_3I]:#[N9'^C$?TR+;\W=.>=A\NYBG>A_NV]WOZV%_FS^*;"?HW?A]?K.
MR/\ W Q[3C+Y7U5^XA_"GBP$WUN=Z3^C8_\ (W\>P#5?,?!K!HP8-&#%#O4#
M]0;#WIYX4/Y2R(+E4]E]L0G<IQYAK'P@@9G&1;<>"&QF5NDKV;!\PB4+B+!\
M@Z/R(G5$8%8J<Q2Y16Y%NL8R$5):)BY4(DE)G"XC,+6=1ULKC "24'W.*.ZL
M:'130I1G5U:DWHYJUHZX.91.RE_#T\-.GHT8QQ7K:MN@;;G?,=U:%.87Y>MU
MF8-K[CK)U$[WL<XEK'J*S5OR18SL=L=[>IP,+^L7M^57I74XO@,>JE*?E3!L
MDW0-MYNV/&^Y)G"G./&V1%YVBG#WAU&2N1/<C)$OQY?<H:;C R+SM)2)U=VT
MHV3Y5J]$Z\5;*WW& DRK3%/A6_\ W:9)R#N= ;?=@H;+\'VO[@9/M[D,C<[M
MXECV;3"1Q"-0J6F'T5@$DQ2H'3L4#SEKU5-](FJ2Z]EZ=5[.CBT8RRHE*KTI
MB]FU7<?!=W>WC%&Y+&S0\-AV68NE(AP>4LD1TFC[Q%X\#GXS(6;9R]9HFXS(
M1CM@ZY"Z[>Y=M=<DHHG6V^XQBJ**T7%+%_50@D0Q_N1\7L6R>";EMN&5A.&5
M=JH<RUF,^S/-,HO%$]L"F"2=!8"V>1W<DQ52O%/NI-K!+AL42(6HV"':U#&6
M3HIT+AEL*(RDO#XL5G$:8PR9$X^(?RJ(#)#;+1\7D#Q@@X+1YI*+!81.1(!G
MRE[>U[8S;6.J)\RU.RVZE*&,,;/HP8-&#!HP87K9OHD"#P!-C>W:81_;3*LO
M,L+ <U%)8%:R=:0&)ZKB^.RXCAAT/;2,5C20SFU-JU(7OKB5S9PD[N'6MKZ*
M:=RZ79RG&;F-G>FXZO$R@*HY4!'"!'D515P0VJ.7+5%'/7%J"[MEK<8E:=MV
MJX$KF_"L)W9ZTMQGBCHPU"2XOQ6[L)DPY<&(>9QQE&4CHX!L)+5T5'#"M-'%
M5\+[W#;P\U[>^W3)7: =DT$;3$+"H?)1&;\6H&\C&I2<:1Z(#(G EU5)2\/R
M8H^3L;C;4KW5*<5UU*667W6NRTZ>MMV$0;N A+W1&0*RY0$$5(E)S8""*)M)
M50>C;M3%I.57(3EYS3X:WPM>1H>IC@.RY4=VT7%68+49DGY3DF:B)&!B.V!*
M;ZDC=:(BJ1"BWR#.B#X0*>EA=0A5V-8NB86YXW(W""#AJDJ]%U(-/DK^K!S?
M<ESDOT:O!Q6_!6FFLX("X0MEF;0E1"I2J5V+1=J53;1>C%9K@S%C3WX\%[B8
M3;QBV[D)O>@)*@.9"ZP9Q1"R%UAK1=J8JIO4WA0O9?B!WDN1A'TUD#IQ5G#\
M=!'J;$W*EVO*<G7O7+VA"P/'8J&NO?$R*J%Z#5*VRRO2LN@FHO::T[)U)<4A
M,DC;*;3<5*H%=@I2J5(BV"*+5=J]"*J3;W>>0FH>\)KP-(6F0U;K6 YI4]X%
M-F,A5%D,B$"NOR7:,QV!-#<)2+8VVX0VY14YJ22O1P\U.Q3AZ>GHX[:7='3T
M4Z>CITWU2BTQ!3@Y#(.FBJG^S%7-VN[?&VT'&A2=S9N;DAVH*5%X=CJ)C7Q6
M532^("K2Y^]M8S9O$@L=CH]6QT8,/*6,13*M55;KKJII*+=AL$V_RTC1<HM(
M0H9DJ((YEH*;53,1*E !-I%L2B55)FY&\B]7<]]7LZ:TX4>);4DQFI4Z2X#<
M:(DIQ6F$)3,%=??-%;BQ6JO27: "(F8PGZ#R:V:0J'S&UG4=;+(M'Y-:/N<4
M=W,+3PEH4HSJZM20M<U:T=<',I992_AZ>&G3T:2I3'#27(U<V[<(:]%<JJE:
M>"M,1AJ2SKI[44^P*YO5@S7X^?+ES[ETF\^6I9<V6N6JTK2J].(=W!Y_OPK;
MCF.QJ"D\IY8S),%X1BW' LR+C5ILF, %)9)#)^3F*+,XU$8G%PKEZ0>4;O%[
M+;;$T6RRJEMFE&TVGM+?//.HQ C-H;KBBI944D 4$4VD1$2(*51/95*8?W*S
ME>/,-;M=KO<F;+H?3\ 9=QGN-.2-RVX\W&CM,QVJ%(E29#K;3#2FT"JI$XZV
M $6.[@;.GC$A/09^'OL;92Q)+4X1E+';\PPD=L?,O@0J5@"(63"TV[*31:41
M4ZT?,'M$&JMUJEZ*Z""Z*J5N-UM?9RM.M.(]!D-YVG$11S(A*)(HKM$A(5$D
MJJ>%%5%1<<_,SEMZ N6RY6N>W=]%WV"LNW3@:-C?M \Y&>;>CN*1QY,>2RZR
M\TIN"BB)MNN-. :Y7/F:Q&!L?UF;\$8EQ@K)(K X+!H]>Q2/SS(4Z.,XY#XD
M)<E'#,6Q5*%GUM5G3I9-LS:IJKJ7<"=>G7:;8Y=9?# 0MMB!.&95R@V J1FJ
M(BJM$38B(JJM$3IQP\L>7<_F;JCT?BR6($!B))FS)CZ&K,*##9)^5*=%L2<-
M&VP7*VV)..N$#8)F-,8?">6<ESTE,XOEK!$BPI+H;V ZL4I(&T_QS,!$C0?J
M-7D(R.P#Q]L8("%QJJ!4>LQ:.QZEZ-UUEZ+A%6_9<X$*(#;\"4$F.YF3Q=VX
M"C2J&VJDHHM:@2$J%1>A45,*',30^D-,1+?>M#:EB:BL5PWPJFX*%/BNL*"$
M$R ;KY- ZC@G&?!YUI\4<1"%QIP!FXV:$QL,7D1\BT$ @ Q^:-%GZUC9B+$B
MVJKXB1>N%*T30:,F:%ZJE]U:4MLMK6OP4TF--./.BRT*DZ9((HFU555HB)^5
M5V)B.;=;YUWN#%JMC1OW*4\#330(I&XZX2 VV IM(C,D$43:JJB8JKMBWB0O
M=5*LY!X%&9.+CF'#\,",)1*6#\ O/VLQB])2QDP>,%QH\R+C+QBHFJ.<.:<1
M)FLFYLL33OLXEV]:>DV*/&<EF"O2!-5$50D#(2"HJ2*J*2+5"1/%)%';3$V<
MX^0>H>2EDTW/U/,AO7:_Q9;QQXY@\D(HLCACCNR&G#:<D":$+X-[([H&R1$8
ME2WNF_B!\&C!@T8,4ND.RB#2B3.#IR2&20QY(1AUU%WC-DL&O00/1V1G!"5M
M*IJ-V<I+1ZQ=Y=;7F7+*W7TNZ:6]#E:U-*881EH!$T!1S(JUVB0BOYQ0J)^1
M*8L+:N\1J2RV<;;;8D=F6W$<9&0)FCJ*3+[#+JKM0CC-/J#2+U4 4&E%6N2)
M[1 Q.)0.)5R',AK;%(4L+QL[!+6@E0KR^8 Y5%3!]N*7:-)F[BR<5&-:IO[+
MD2-4%EW%M5G-]U, U"X$AV1N6U602*XB];,F0@)!5:J"'G)>KM&J(FP4QQP^
M>]PAWRYWQ+5;WGKW(:<GB\F^1X4BO1I+3).B11!DK)D.(K*H3&=MII4;:%%[
M$BVI-);.I1*SF0CJ8N5%A) H+C(QC##Y-F%- )((#2*;1A<:5D+6-&HRUH&<
MJI6$AX^]=G5RLDK3@Q9OY1XH1VF0S@*HBDJF**J$)$(%5!4A)<Z(N4BH65%3
M&JT\[I%CTU"LEMM499D)AUMMR0X<MELW67X[KK$20CC;!2&I#G%-B2QWWT;?
M1ELP7-J+W8]''X<&'<9&EZR0",CHJU6<(,7*KMG&5@C*$$BMRUUUY,]%8@/>
M![':MURCA$HX5OZ%.C72&J'@<-Q&6T4S4EHJI12S*:)[ F:H=$Z%%$39A=C]
MX^[1I\F>U:8 G*F.2202,4$I"/',;;I\&S)E&U*5H400..T U"N-I<[3A@X;
M,8O I*PA4+R+B7PMG(3NC:>)F5;&,^:)2Y.1O9 @\M-JW3R_K%':;ZBR+)%*
MER=M/@YQOYD;3TH%<D,2-Z"Y\J#M;7)E0:9?>]E%2BJJ[<(K//"9+F6^\ZGA
MNW'4-IOO:,-[BE9;:13A$L56 8(-RG!)N]T3.0G7#5"5=OT=VGC9;!0$'/R]
MP%:1=O-U@=,5BWN,AC.12INU;"I+>*'R4LH\=1A.KVMK9=RHR>7OKKEDJ\%E
M->,WXX\HI++:$1J&;>JCBJ(JJJ-5%*(75VHE4R[%VX\MO/"98M2RM26N $A^
M:<-'NTG N#AL1B(G8Z.'':0!D+ND5P&Q=:1E$;/K$N.Y7;(X$34IDJ$Y#7CD
MW- Q \FX>Q0<<C3D\P('EB$RK&[" BZR0&Q)A!BO6CNB541;.ZMMUR=_,\[<
M1R*,&2RAQ1-52A*A(*H- S47JHJ*2;*U,O92G.G.)J=IUG2&HK4,O3D>2Z;8
MA)<9D"R8,H$3?J#OO#+K1O F[S9Y$A$5$,<O',=I47ET4A42OETF8M8;$NYM
M7U+6#E](Q2@4TS>=X;J(MD'/:$C>L#2R:=B2%SX4A2EE$JULI[&U _'D.R$;
M!2=<STVT%<PJF7V*"A E:KE-=M=N,[!SSO-BOEQO@P(;CUPG<7DZX@PXCS)!
MN-I*.1@'H@D2D:,R7%4E-$+&.CNSJ*Q01D()'Y47$LLLQA]&\B+L!S!H5-U(
MS(_(7QAB61NL?!"KZ/RL@(7O0NX;K*MW5M+'"%;E<WM1OR'&77FQ(X[B$W55
M5$H BB*G02(0":5_*.T5V==UY^WN]SK5<;I"8?D6.8$B"AN&3;.2(PP#1M+4
M'FP?C,2@0TJBHZRJDTXB!S$MIZ*T:CL0%Y'-H@HQ/)A,@_>(,/F!\1;,CR,G
M74 3 NYI+0<QCAI1]40<2>U5;MB*R"Z#I.B?!B%_5'SD.,BKIM "Y54!7(.5
M,P(F0@),N<%2BJ**BBM:ZXG.]QN[R[[,M$8KE,MD6([N'3BL.\(RL<4?BM#P
MST5]I&4E0R:RFXPVZTZR2GFQM=F81- ^FTR;D!)S*$ Q0R_=$5"KNS( HY+#
MCB= *DG+A.,*EEIJ017'LK4F=$+[+;*6\-:W;/21U2!289RMJJ(B)1-VH@.[
M*GC4R"J$M5K6O3CL3O!7$G8I/V>UDS")UMH!;1L5A.LQF1AO;L160C21&"!]
MY2=4T)24JT3C&;*X=&ACE:*&[1TY;32*RZ*S4M'TCM8LVBKF(K-XVQ!7%6#.
M@I^C$DT7*J"C5VLDKPWJW6IV6T'-2R7G$WX5BJT0$"%ES*2'UE*BK5,ZJB*B
MHE.C;C*9WAK_ '>8#=[C*[IL[=)BR8C3ZL\24D92%(-[=F>\!91&V)BXT)#4
M00B)<;$.VS/FAW+YYQ. _:>9@! 7(CXG'R B9#WY>)1>*D'0>2UD[ZB(JRV-
M]::LE&JES=96WI7OHE3BTG>P)J.TC19(QHHBKE05$,C1%'*FWK45:[4\"5PD
MR^<,9^VV&V-6V1P>GI0.,,.SB=BF#4J3) 78_#A5Q>(W;CHN"AB*^]#G6F+5
MV:0NHQ,*VETP2'!LD13(L)6>OU3AV(U#2(-(Y+%D)$=7(E"T;G;EF^2?).;[
MKDT2=]$JTN0;W)[!U))0]XK;:F3!MGLH)YA(1+*-$0FZBHJGA%*[%5%[6^\#
MJ%)BW!Z# *5(M$F#+0 1EF5O6'6(\E6&4;;:D0Q-DF2;1$(XXYT47'1+=Q.W
M^]4)+Q,[FSF9*2P#"87QMX^QCHX3!8$]?/Q 1J,3=E+G!-ZZ,/;WC]5>ZY6J
MUE$TD;4;;:\IW>CC;D5I&]V9GXRDJFXB(JJM$V(B#043P+55KAN3N:(A<8$[
M35N"WC!E2Y="?-]QV9-  =>)Q1;06P%IE&F1!$%!+.;BN*J1.VV,Q%*@@@]F
MAHU*XZX1/@96:$"2+]I.N;BA\4E[UNXXFQ1:1E\7\\BV5IRG%A5PG;5.MB-]
MB@6J9"YA%H1CFF4@%51%#WU$!/8RB[053:F5%VU5,/A[O)7T]_%CVZ/'LDL5
M9>C,NNM@4.ER!N*!#0FT8:N.1AP>L"QFB5"S."4HL]M[,=.9AD,=D*;M)+/
M^20LD6N>VD1U&\W< KHZZ! #-24;!D<>L(VT;,U+&:ECVRV^KNQ6JE=<!7DC
MBMQ#9:5EHFU'91>HA9D(DH2HXI*I;=FS*J4PS'^;<B7IN!I67:K<=HMC]O=C
MID5MS-#%[?B\^UNWW@G'(=<=1715I5%&"!!3$:@]EC 9<P)+Y+D"!X 4#$H@
MC$1O<J Q%-H86?R(6'QH+,+QRHB9,E[T7C9;F(H++*KM+4+E."G:[J4SJ",
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MVH(BMHJXF$;6E(,E$H\PR<?(0&,R5.6.0!,./<2(^4$SV8SV*-"<RZQ:M0,
M?R5JG>G8SZT]H*2N5<?IE[;]DJ_<6KCQL DLV\F9%7***V#9*@>R2"7AHF=:
M)L3'=J/G2&I7)UUDV:*UJ>9#6,+S;IBPPVY"BPI)-Q<M-Z\$=PD)7=VUQ)H#
M7O;2C;73?Q!F#1@P:,&/*1D#+^8&WXKO"N'F^5<G-\0$-LKHP]Q0A/)8CC)\
M2MP5F9_0J[@29:V*.G]I(>BOS[VERE%T++^+CLMK3SPXW(B;E5\-?_+'JWU[
MC3C^/UZI?O+=_GUO<]_U#-Z\QVAXB?F3%#M&,L>Z[\'!_IKOZ_F1@?\ @^?Z
M$QSO]*8]I&O<:,)3]?CW>QW^;.,?UXCJ1N5GSK'X@_\ +CZ&_P!L+[T\;S'<
M/<-XC**^_,QU]0,+^8XUVO\ JU>\Z%[:8>5[_#>NWUGO>V.%&^NM[RJ/?RUP
MW[</:D3E9\S7/CG/]V+T_P!M;[H<KSO=/(LX^/5;]\D.^=6U[V;"-&A/5R7Z
MC_NW,9=R3[@+W[EJ'RDS#!]SOTRO6;^[<'_P%"]-"Q?(&G?.Z>4>Q5GDWZ@>
M[[];9_QLS$'!_P#QS\.C\^Y1_43&NE-?'U;\2'D7L21.^5N]AYMC_P !<,;A
M^)=_ZC9W_DYT_/Q-K#DIXMQ_.Q[3V$'^T!\%K[]:S>U<\+[]4/Z,WI._4T&?
MJ$'TZM$?+M__ '\_;+%I.YIZX>>']?N>[EX<0+^FWZ&GU,I'_M[OU';OS>U/
MYP_[D<4(F_=V[R/U@,?SQ,+%=^ZA]1G[PIC[>@VGBOSWM/FHO\^+BL_?<Y3_
M %5GY&9APOK ^Z-%?Y.W+]8 :8/+[U@K^L_[:XH5W#/OTO\ ZU]]I[",VON&
MR7W@:?\ 3)AJ4C]:@^:O^LN/I$_^)DS]5R_S$\31&O<D[=OO"P'M26:1Y/K)
MF>:U]V&(\O/XBFJ_JK>\G&PP*2^]-]67[N8G_2_#NFO'^9%@\[CY9_%7K1]R
MWD=];#?\QNN)A].[W&A#^2.[CV]EW2;JOUFM_O$/W#.&%WK/Q(FOZBTQY"UX
M1=Z5G^@GJJ?4>F'LN5ZE'7'RO8/.+7MICZ3=]7UG<D_K'B>4C8V_TJ_H:>L!
M]5H=_">;M8:\^<>G?W]?=,80>^O]X#D-_6CG\3:,7*"?ZB_AWOY=$O9\,TTC
M_P!'JOXU/:<Q7ZX_-3O5^=F_=R\7A](CZ1WJR?7"+?Q9EG3=Y@_)%B\WCY-C
M%<N_;ZI>1_\ 037\+;,)=V?>_M(?6HW8^R\S:DW47JH3]PB^VQCZ$\^_PR&O
MZ*TUY2TXY_2S]\^2^>^ZCV5D#6G7'JV'XICW;>-/?2_#Y:\W:<\K!QFLF^Z5
MW=?>G2WV>$US0?GY;_,H^5+"=H[[\FA/J6C>4>PV*)>_7C_U"PWYS/3#D>K0
M_.1>VN*07W\->5]9KO\ GPH/UP_>= OF1A'VH0U(O+#YE.?&N8OA_;B^YS)\
MXW?R88/5&]](.^?FU3V/CO1HCU:E\5(]VY@[F/X>SWFS4?E9V&:Y9^G3ZT'W
M<R/]&(_ID6WYNZ<\[#Y=S%.]#_=M[O?UL+_-G\4V$_1N_#Z_6=D?^X&/:<9?
M*^JOW$/X4\6 F^MSO2?T;'_D;^/8!JOF/@U@T8,&C!A?WJLQ@_,/34WYQN(Q
MPS*Y>?VD9Z QR/1D.^/28X3+8\-MV@0$(%-G94H0)NN6FDV;IJ*+J<-MMMUW
M130N,V_'3\^+;X8:NF.'L4,GS9PR>L\:P5J\9NT%6SMHZ;Q<6BX;.FRUMBS=
MP@K96V^R^VEUEU*TK2E::,8KTKA,F"=Q(;T\LD[^,7;A,2[FESF4][.9MS6#
MR^)MM.9,TQ+-\&S1%XE(00*!2K%L3E@)K.P)0"\$%!AMP(O;O$[%>*K57G6>
M8S5,R(J4Z,71])K#.1\ ^GEMIQEER-N89D9C&Y7+)3#7ZK=8K#WF3LD3/)[>
M)F[VBJ[7O!&1\Q18D+4K[T[7J"MMM:VTI77N,35%)53HQ0G;)L,/9GRSZFDA
MG>;=\NWX-*_4)RY0)$L0Y;DF$(-/H2^Q)A%"V<"6B<:M(E;CRW6F%YT8^MM6
ML8VIHJ6*MJW:\QDI4IT+LP[3#^(L7[;,/0C#F)XTSA&*L3Q-I&XK'V5SMVF*
M!!F]UURCATY4=DRQ)W?S'+QVX46=O7:JBRUZBRE]UWN,%556J].//GEK$NZK
M<AFJGK/8PQ*]9R7:(6>Q+:'M5FL"LC>3-RFU:/\ >L3GR5S!O(Q:4QB67<P=
MX2CS$K!RDU4#LV#2JZ%M\A>\!C8BHB9%7IQZ)\89#!9:QU"<G1EI(QX">1D/
M*A0Z81HS#98-:&623U,;)HE(F; [&Y /YM47C%VBFNV<67IWVTK;HQJ79LQO
M>C!@T8,&C!A, 3<)$MR^X6/R#.P7.D/QQC7)K)MM\P(XVV[A^J'LA"#=PJ/Y
M\S5+F6,UHA2K=\I1S&!5Q"HT&C=:1?J==I;1I(SEHDV:T&W:RBN2WF5W[_$Q
MZH"IUF&05W/14V.%ES'XH]5=OT&N/*R^\H.5<JV<M9&FI^K;O9S*^7H;_8\S
M,%UG>/V6TQ3N"2NL"*W<)*,<1,-%BQ1X=55]S^HYQ\^<4:GL8D.3]^&&AQH*
M4OQ3MXPW)\T#GRXM92,FLX9#./,8Q5.]^NG5@N;@4#8'7:*5E:K-KC*2]:6U
MJE=IT1'V8.E9)M&/'RY(LJE>LC+8HX2TZ4$S4!7P+D5/9Q9'3%YM6C>[/J"7
M;I#*:WU7?X]I<!'$20U9X+(7"2J BYQ9FS3AM$2H@.)%-O:B&F+RZ:^*W81I
MZEFW+=4?B.[K+$:(XRR+%Y;B..8YA4(MA.2CV7H9 &1>/EY-&L<H1PW6/WFI
MQ-D>TBSJ\<X7>-F3)!2O*9(VV2CHF\V)F3;[?(1]EYN03AGG;%HS4202<S)F
MH =4$0D05(E1*DJK](^Z#S:Y*6R_:$T/>&KQ:;S!OK\^7,XNWLVN7--I]J/(
MGJ^UOT:AQ%W$9M'VP:<>D.#UY#BDZ6%IRM*(QI.<K1YQ,DP@ZR3KQ)J48QA4
MW:U3H14 ,S;I\8;";G-+JH6.EE5[4^BE]U;NFNHUDJPL@UBH:1LRY<ZHI9:[
M,RBB(JTZ:(B8^>FH2LAWV8>FQECI]9#BQTE$V<A&<R[M'S9$&B=RTSJV(@I5
MRHB8KYOE"%9#LSW7!@ @@<D)?;EF<.%$AV#DF9*/R< .-FPH6P9)+OGKP@YJ
MFFF@E9=>JIPVTMK7HII6TPZVSJ. Z\2"R,QE255HB(C@JJJJ[$1$\*XE/NW7
M&%:N\#HBX71]J-:F-6VEUYUTQ;:;!N:R1..&:H " YB(R5$$:JJHE<2YA5HZ
M88;Q*Q?-7#)ZRQE VCQF\05;.VCIO%12+AJZ;+VV+-W""UE;+[+[:7674K2M
M*5IK@N9"=RD&"HHJ^XJ*FU%127:BX8O,1]B3S OLF,8.1G+Q-(#%4(2$I+BB
M0DBJA"2*BHJ*J*BU1:8K#OH"!>Q<+Y >*9=B9[&V5^U(WFW#,4:3T[A)8Y"9
M8 (26801<%)G,NQ;(FSNT*=:(,%KK$WZ3BZY&Q&JUBUI=UW>28@\.XT\Q0F7
MC5L7LIB2"!YA071IG!55.A42JKB9.[9<;CVCJ'2T=+%.MEWLF[D6BZR2A,W=
M&9<9X(\68CT<8MQ8(5EPW3>!%)DVA0R<1LM']/R"2=J>W29K.D\F'16<<HQ-
MU%)/E^/JPJ<SP5CW'0*(/L@K8_H#C#:#1>1'DW: %AV:T<T",6MZMM:7IW5Z
MM62F%9@VQH61<C,'G%HLX KCBDC:.9BSD(T4US*F<BIX<./O1ZELSULT7R[M
MK-GC3=-V62,F/:WTEPX3LZ<]*""DW?2"F2&&5:.:]OW6^+>>$%11-,9_U'\8
M%LCX:QP29!YC(P6*MQ&(\IY$CV.4C2^0S&+0[\G',B(0M".*HR%P:9Q:5.'=
MR0^ZC]9HW6L:_*+DM:M&SFX5Q? B;!U^&ZTV3E-VCJHA-Y\W5RJ0(G6ZM53-
MLKA,[I.LH.DN8%WB2)%OB7.]Z4N=N@OSU:2"U<70;?@K+5]%8%DI,8&D)]%9
M%PVR>]Z0\:ALGCL4%YLSN2VZQB=0C:,[A6+&D=!RJ/3V(10MG! A.'&0I%BJ
M)Y%9C38F/TB3D"T++H-6S%\72ON3HHJDLI7HU*\^=LBA>#:=U CKJD0DV9(S
M0-V+I-JHJ6?.HHJJJ!2M*HF%WO$W6]S.7>FHG->9;;CST"XW$GWHS\*5):LZ
MA#&"Q<I, G&77^)&:Y& W''F8I"A* &V&&8WV6*67IJ66J)J6W67V7VTNLOL
MNI6VZR^VZE;;K;K:]%:5^"M-,I%5%JG3BGPD0$A@JH2+5%38J*GA3%#-M4=D
M0O>)ZBYPJ!.#0LGG^W-Q&3)$409"I&V%;=HH+(K@"3INDS,MQI%"YLO>VO4M
M07LJG?6V^E;=.R]O,N:;LS39B3K;,A"%%15%5D&J9D3:E4VI6E4VIBS?-ZZV
MJ;R"Y36V%*C/7"':[\,AIMP#<8)R^R7&Q>;$E-HG&U1P$<05,%0QJ*UQ?733
MQ6/!HP8-&#"L)OMQS_*)0+%((7IPP+,I$N*<%CR,@!N >4\OP3*4T<RN(4E
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M@E<9CE+;-QM(Q;I&AHK@3M$H[ED)DK<1/A^,R:,@F0@F7QJ[/AX5:K5VO!8
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-T9:_^6/3EKW&K'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g172766compcpg02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766compcpg02.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2P"& P$1  (1 0,1 ?_$ )(  0 " P$! 0$
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M"5U97MF=$I2UL=FET0FGHG%M<$9X#2#R1C*-+'@0<YQG&>5DK(;Z3R9]Q^Z
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#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g172766noticepg01a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg01a.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ^ +& P$1  (1 0,1 ?_$ 0(  0 " @,! 0$
M       '" 8) @4*! ,! 0$  00# 0              !@$$!0<" P@)$
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M,8[CG SC4?-#D)+.0]CU\]RMI4Q:.<M^7M4-2$N*,"<\F$5+0A,[@K:-:0C
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M<5R'X<-/O82RR1[-T/8]:#K(6O4.YMKMEV+9A++IT]-9[70.AT]GD#M5>/$
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MR7:@:4XZJT/'AZJQ>[O2MRN[.G6X.GLN&M8+;/VN%A?,V>1SH1AIY9V.:PL
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M>1[ORV R6X\':[<Q.W+/./RKVW[[26PR'@!:/BABLGWVN4Y&W:8WVK',.LO
M#:D/G&UM];6M,9)2%LQJ<5%:M;4V_P!-KE=:KIFX32W3:X!7Q#.^LT]<:\.0
M/A=I-@Q'FO!04NO5T=V;!TV&UY'WMO;075N^VN()9FS 2!@9#S.95IC$E1RG
M< PUX41OHWWEUN_"8#$;CP=YMS.X2_RL&58V_9:,M,6+\WQEAELH[X/A..N
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M03P7;^(._?@6YW)\"97\7K.9\4]UX.?P\$L9#9(YIN7RXWQN(:]KW-<UQ <
M2%V0N#O&\$R.KH?-WF\"P$S=MW4087DKY$AEY#4%-I8)R.C>[4T\%H0HQ:.V
M;LG0-%;T/KV[UO.'@KPVXO!%+X0FFO2[16M*:J4K7A2O;P5F-H[N=M]N[&XJ
M_.UGR\IMYX:7PKI-6CEBXT<HOU]W2'UU=VE>"Z"*\2.(\[;9"\PGR <P9>T1
M%#ISE;I&/*%?+ZW1EM$4I/"XR!:UVVJ3,R 1",X>CE BRMA*'ONZ %T[KC%9
M2U>R*ZMIXY)#1H=&]I<?,T$ D\1P''B%E,WTVZC[:N[7'[BV_F;"_OI.7;1W
M%C<PR7$E6MY<#)(FNE?5S1HC#G5<T4JX5Z]SXO\ #)FCT?ESOY$N637%9:-R
M+BLE</*9>2-ADAC,842\%L+NHM\M [F-)QX *0IS#-IQC#HSMWO6LY,P^6EE
M?!':W#IHZ:FB-Y<VO$:A2HJ 2*]M."NK/I1U4R&5NL'8;:SLV:L1&;FW9CKI
MTUN)03$9HFPE\0E#28R]K=8!+:@%9@?P=XWI44H<E/-WF\G;H0E;ETS7G^2S
MD02CB*)W:T[VTK).I,M0)+"E<V964K3F*A% .3&!-!O8!:%OH%C>N=&QL,I?
M*2&#2ZKR#I(:*=XAP(-*T(H>*P,>T=W37%G:0XK(/N\B^1EHP6LI?=/BD=#*
MVW:&5F='*UT3VQAQ9(US' .!"Q\/$CB..3OD)!S_ .80IC&$[NKDD4#Y0+Z%
M(X^ECZ4:U^4O;+JV]N+40R(RQ&JQGEEA3%AV(S80ZWO.SX*R?);<^'G\.\@-
M=H=I<7$!H!I0U) %.VHHLH>FW4=N'MMPNV_F!@+QT3;>Y\#<<B=T[@R%L,W*
MY<CIGD-B#'.,CB RI*[63\*^,4)9OI',N='-6)Q_VS*M^.R3R9<A&-G]G)/?
MZCRSXFY6LF1>U??A2KV9G?V*?;&^GL7ICZ<(,??W,G)MX9I)JD:6L<XU;34*
M $U;45'DJ*]H5EAMD[VW%D/@G;^'R5]E-<K.3;VDTTNN#1SV\N.-S]4/-CYK
M:5CYC-8&IM<ABOC^HV=,#?*X3S"YZR^,.P#QM4CC'D9Y*OS$Y 3*CT2D:!V:
M[-5(%@"%B8PH>RS!:"86(.^FP[UKIGMY[64P7+'QSM[6N!:X5%14&A%00?66
M*S>%S>VLI+A-Q6=Q89F @207$+X9HRYH>T/BD:U[2YCFN&IHJUP(X$+DE\?E
M'+VMD?$/,'GJL99+[7Z..Z7R,\E%#8_^^3F+$7P5>59PTKI[Q(2,TKT!F>H6
M#8@]=:WO#K>=DCHG,>)65U @U;3@=0[10\#7RJD^'S5M>W..N;.XCR%GJY\3
MH7MD@T.#7\UA:'1Z7$-=K TN(!H2NA<>$O&AGCA4P=N<?-ELB1S GE9,H</)
M?R%1QTZ+JU"!(EDA3THM4MM-85*IU2E%K F[3C,4E!"/>S :WVLL+Z28V[(9
M3<!Y:6ACBX.%26TI74 "2.V@/F*R=ILS>=_EC@+'$9&;.MNG6QMV6LSIQ<-:
M]SH#$V,R"9K8Y'.B+=8;&\EH#74[&%\#>/\ 8[&7)J]YG<ZYU'#5*A&4_P /
M\D')"2,QBM(+0%:4#FSV@L1#4)A[UHP&A]P-[Z;UK.%S:75G+R+N.2*8"NE[
M2T_L$ JTW#MS<FTLB</NK'WF-RS6->8+J"2WE#7<6N,<K6/#7#V)I0^199_L
MT:V_G.^1/^T"Y2?QC9T+!ZSYA^P$_P!FC6W\YWR)_P!H%RD_C&PFL^8?L!/]
MFC6W\YWR)_V@7*3^,;":SYA^P$_V:-;?SG?(G_:!<I/XQL)K/F'[ 3_9HUM_
M.=\B?]H%RD_C&PFL^8?L!/\ 9HUM_.=\B?\ :!<I/XQL)K/F'[ 3_9HUM_.=
M\B?]H%RD_C&PFL^8?L!/]FC6W\YWR)_V@7*3^,;":SYA^P%C\I\?M&P=B<)3
M-.87/6(QEJ 6:Z2&3^1GDHPL;<6<<6F)&N=72SDJ%*$Y0< L&QF![AC"'77>
M]:SM@MY[F406S'R3.[&M!<X^7@!4GAQ64PN&S>X\E%A=O6=Q?YB<D1P6\+YI
MI" 7$,CC:Y[J-!<:-- "3P!7S)^!-!*T45<DO,WG6I;IV>4EA"]/Y(>1YR*9
M*3VI<^D)XJJ+M$1$A/.9&M2L !((X0DJ<TW6O3+&+7(VMRUTC'1R!\0J\:35
M@J&U<*=WO$#C3B0.TKNEV]N*"XO;2?'W;+K&-+KQCK>0/M6B1D)=<M+*P-$T
MD<1,H:!)(QA[SF@]>=P@XVIY@=7A_-[FZ3/D[68]J(0;Y+.1!<M(9B4VEAKJ
M='!VIIW*;BT>_5$<(G1>BOG[WV_+G,6-Z;<7@AE-H74UZ7:*UI352E:\*5[>
M"NH]H;OEP#=U18K(.VP^80MNQ:RFV,I=H$8G#.49"[NA@=J+N[2O!8?/N!O"
M9SBQZ>WN8/*&1UV8VPB=/3):'D9NYXKYXC+A)D2J"/,D:Y):!C"ZQ*1R9J*
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MX@Y4R*'-&G/,4(27A,G,,2B-"'1Y8-B!W!UUSI?!-'&V61CFQN)#200"6\'
M'RT)H:=GE6'N\-E["RAR-]:W$./N7RMBD?&]D<KH2&S-C>X!KS$YP;(&DECB
M ZAX+O,ZEC4PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%Y6/[R[^O<.
MO^CO3_G5-F^.BG9D?\!]29?:[^J ^U[^_?8?ZF34K13]WG^[U?5IFO\  !&<
MQUQ^#=W>_6_?#E",Y\VGI4?+"T_GNX5BN27VY7 #]X&UOQ?NK,+AOFRROOIG
MMK=:GZ1?JWNJ/RGQOW?$+2D[_9"\Q?ZRDW\%1/-DQ_.!C?BC^$>OH?8_IW;
M_-$/NMROE</L!6+Z[AWX'><YL^==WQ?_  @7?:?K/[G\W0^[1*6(5]CQPC_K
M*HK^,5AYCKSYP<I\4N]M$H/N+]/;J+^:*X^XV*VN>:3_ !UXZ?KN5W^VV_('
MTZ^U9;XN?]1R\1_U>WX/ZK_FZOO:O5,YM^<%_>"/JW(/X.C,D5I^#-J^_/\
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M)E>;+Q[SN)J>)XGS^OZJJ[)Y)^O5<3GF2B1]9']Z0<1([CWGBIHXU<*\"A+
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MGNO496D?O4!;4L[VY&+W;82$0"6U5W$[]= 4$>]!)'U+#K>^FOERO-EX=YW
MU'$\#Y_7]5&Y/)-T:;B<<N4R,I(_NR'B9&\>Z\T%7"CC3M7(YC9%&E85#.UG
MA7HR6Y=HYO2&Z6MZ;U-IT*O0R1:4(R-G#["A]0![M]-:Z[R@DD%*.=P-1Q/
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M^$)^-DR)CR0>]]XB0N:S0C1C,[]=_8'=>V(HW8. NL\;(=)[TEF)7GB?9/\
M$LU?\$+[ ^CYC+2?HU@99-J[ OGFU?6>^VG%?W<GNTO&>\=G[0SN'8'&WBHT
M-;I.G4:P?25U_G4<_?[0E\__ ,C9G^3%_P!0Q'^CV_\ >UN7X'L?_172_P#U
M'A_^)UO9\7ZY0OHV8G*; N&QAAM)U+T\W5<RN[Y*D#J+1(6FUOE"RN*R,;F0
MK8O4 ATA."6>::;ZXMF[ 7JG?+6LRD8;#;0CD#NPPB!I[[^):)):N\FK4.
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M65?Q:E02(:YVT6WK*<K<BM9ZTL]W@9WE15(0MB(R*76F2O@%BZ/K-@+ ,YR
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M&K']E2%RA<F;(R8I=4) )$Y+$"MU2-[$,T\(7=<J:T!ZDLI/ZA@TY)A@=;
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M7L![X8(7. -!1T,K'%I-*M>0/8A3S?/5;:]QM>48K,L;U!VWM[;&/Q=S;-D
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M4I)&T -TL[6DJK_MKL_3\C/]L7QT_P"KV9W7COVF)_T1/_C%N;G=._-TF_\
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MMKY7$Y3Q[K7C1'I2^*J@M NSG^';DC0%F-N0%G$U*FE\A&[RAC8X\0\KT\)
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M$<'1S PN&RJMM7#^.8+:UU<_;I?MUQ?;PQUW*[]U-96[M- &EH#W5D^AA_\
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M4*_[)#DA_KJX.?V:?'3_ -#YD_Z0<7_U?)?Z0N?[=;#_ /SHZ2?^G>H_^O\
MGO\ &K9WPHXY3CC+6<BA,]E-3RUU>)PME"1?4%%PJ@8\G;U3$P-8$;A$X*G3
M-3J\A4M)HQN!@?7,(&43O?:2#(3N7,V^;O&7-LR=C&Q:2)9GSNKJ<:ATA) H
M1W:TK4^4KQQZ1'5G;?6'>%IN+;%EG+&RM\:RW<S*9B[S<[GMFFD+V7-XYTL<
M1;*T"!IT->'R#C(Y7&R.K0281,(F$3"*JG+6!3RW83&*DA;/'%[;-IFW&V$O
MFR!R<H2AA$32K)68W/Z%C?8^_+/I/)6IM;RRDJ@&]@.-&9OTP""//[?N[7'7
M3\C<N>)(HSRPP@/+WD,JTN:YHTM+G5([0*<5NSH;N?;.Q-Q7F^MPW%W%>8['
MR"Q9:/CCNWWERYML)('S0SPM\/;R7$[G2,/%C&M&IP+:/QVM+Q=%\L@<^IJ7
M.L_E_P#)40D7+I+'?H(UOG'U\3MDOLSZ2*923)VLY>GC.WQI3$)S5IXEQ!&_
MG"-V"3S7V+C;'=6ES&VTC\43#WM9;<-)9%ITZ30NT/)(:*$^9>CLMO#IO96U
MCN;;&X+&':]A^,CSBM4_C9(<Y"Z2UQ_(;;&WD#'7'@[F1[VPL$,D@X!@=+'&
M"NIR5+::&[4]*:S/I-JY L\TELG1QUK(F95D3<EQC$=BAC%(7)QDK*8%+IU4
M'JTY*=,8D(T'[\;O0,?G+VU-O<B.X9.+EUN6,:7'1RV$.<[4T!IXZ0 22''R
M!0?K+NS;3\'N!MCGK+,1;BGPDMI:V[IY'6AL+0QW$]R)H(X[>4:C;,9%(]\C
M9)"?<V5=EO$NM;:KRRIRAFC.[B92FZ<"<Y1(VR':)<91([NF\O8M5Q(69,"5
MO$7=X:\%KW@MW//VG<S2 @[%&UH V^X+W'WEE$ZV<WFZF4:TOX-; QCN8UQT
M!P>-+"P"K0:U&DK!]<MW[&W5M#&W.WKB 9%TUGR[>"2ZK';08BSM9O'P2N-M
M%<17<3H;5UJQFNW;*7:HA;N.P;(BO+*81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$
..3")A$PB81,(F$3"+_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g172766noticepg01b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg01b.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ .@ Z P$1  (1 0,1 ?_$ ,X   (# 0$
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M1+7P-O$QXAM2GWHEXOLDW%UUMQXK<C,QXQ4N/Z24)U:<G0X"0!A_?[->'_\
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M[';HRSO)6&8X@-3E73A>=1;D>%F$2>!  ,'IO$8?@J<<82E<XI)(();],G,
M4!U:@*#IIJ>F>*IXCXMW[P/?;[<-A,6BZ]PZ[3<)DYM9,O:AVXX6W7F(KD=#
M3J[Q[RVTA$-2RT8JE5!)!P-)3I7G.A$[2^/'9H#7= R!A^YS2*SN.$TMII6^
M:%%*-/V<2\OM&H@NZAK%-QLH[;LXE<T:!2,B+H^SW)^[TK[I*4F/<V2E+I"B
M4+*M R"?*FA(KF34YFAP7P^(>6-SJX\[J^/I5AM>_7??Y<BSWF6JWV6"X%>Y
MM-6FW:4NL,N-I6[*0)!)>4VYJHNF*,9-T/P-C7932V??^I-;P9+G6>RH4MVK
M<!H&K5/3GUG03BF=.B9 Z#*#AJU#L2&CU$R%792"JI2$\&]2S\6YR+=IHRW(
M]4+\A(24T\?&I/4>RF-)[YXI[G^0.WY=C]+9=BY-5NQFY5LTA^#;9-O1')<7
M+=0%+>=D.K(?2HE#S"6RI51CT_(3T-1[EA'*F>\V%[,54YGF]3GY'5-\KEDB
M+Z5*Z*L9%C(N-!CE$E5'4>\%= BGAH#9F1(@&$ ])V:*IN0\N5Z-'$H 2FM/
M*".BAXCKUJ:X1[5N*MQ[?Y+WMNKEW^KY*=X1[:PW;;*^P["K$"VUMI@N @)6
MC0LI^Z^HZ5J(%<7SI^'?NE+<V?'O<-*UBY9AUER]4NXKC=KA>'5BU:M:Y%0;
M!2-J]&M,RU?Q<'F8/(I-4[%>.>/0.JH8KLIC>0C'9'HK=N3:$)=9>4T !Y2D
M$9D5KJS\"!\&,RW_ )(_)!&[^Z>PV>QV_>6QMYRMGQ8D6&EBVR+8X\L.2)D9
MI2''KAH=4D/(?:9HE +! SK[_)$?,+^<2S_C4;'_ +D]/OIVP_@3^P3BT_[=
MW81_-1S^CEJ_WV#!@70?<^I<R5KJ#6OE<H?-M1M>@V;.(AC?,!S.5(YGZV9T
M<4$9AM&Q*2R[YDQ6<%2! /8FF/DPCZ;RH]L8F&&S!4ZM*031:AD?@K@"Y0XL
M[;-E\QS.&=C<(7/=U]@VJ//=7"O=P;*69&D5+2G'"$H6M""K7FI0R&)K5=N[
M:K/,^W])8U\O&<]$16%H5$;57J)SWFC%=-S=;+'5R';KR[AC)(1ZA_OJK@@F
M;J@H5J<OV"/D$VF;:N2B*]!4TI850E:C\U)/2OQ?+B.V5QUVZ7CF#;G$?('
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MT<_1\#\ S^P3];':C^S_ ,#_ ,RMI_\ B+?_ !?%<E/T7](/3O%M(Z8\Z_\
M<%_\ M^E']?E?-/Q85;^^)_7#ZHQL%FOX>6P_P R,M^FI>@)/\FM_P#<1^GC
M@G;O[LU@_P 1@^H< [GG_-O_ ,\7]=U%^'_0A_!Z]._>[C\37VN+'Y4^^]U?
MQ;<^VP%Y_P#@'[+_ #W[W]=8_P!./^?;_@(^WQ85M_O,;?\ \.*/VMS#@^1/
M_;)\IW_+_*?_ &X7]0\_^1(7^T^VQ@OG?^XYPK_"MR?]>,<_\67^S/D__P#/
FKI'];HKU[O?SH7\%;_3Q)]Z?[LX:_P#F%@_;',8=?5DX^D''_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g172766noticepg01c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg01c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (@+& P$1  (1 0,1 ?_$ +   0 !! ,! 0$
M       (!08'"0$" P0*"P$!  (" P$!              $" P4$!@@'"1
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M_P!$5^.HHWYJWN2\F=1]4_C*[5?YR[QW["[A?H1I1OS3W)>3.H^J?QE=JO\
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M')BRDS<;%-+T_7?0QRX# XGP!CCA!Q[\]OM2U="0L;.$@052\D9J),93<--
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MX<BF&,=FS:3IO26]OQ%'5R3#V <351JH)51'D[H?-'U_92SBWAQ(<:\:?O\
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M2_Q$AW)G=M[^V1#M-V]_'^1Q5A)E,3:WO999SK>[<ZPN<:6L>^7VIWN%RUH
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M9?<-<K"ZS9X6"5$D* *3W%>&@"QTJ(I+0D%1"J&HJ]0W5<9*[S4EQE83;SN
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MAE[K2&.B-(K$$2M(D<1R.JU*D5"!2II18P@,K2E14KLII4)H?R/0KV#G%@^
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,<+T1.%Z(G"]$7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g172766noticepg01d.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg01d.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ + (F P$1  (1 0,1 ?_$ )4  0 !! ,! 0
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M@,!@,!@,!@,!@,!@,!@,!@>UC)2,8J"\<^=L5@$!\C1PJ@81#[=WC,4#=/\
M/J&%9IIVYGS59%C;.CQD<2IA+))%(\:]1 H'=I) 5-T@7_<8I2J 'UZ'^V9N
MOP6;?%)+YC3XGS_DH?!\'ROE^4GQOC=GD\_F[O'XO']>[KTZ9AM%?<5H5E9\
MT$BI_P#G09@*<A1'M7DSI@*ZJGT#N%J0_B+_ /4>_P#QS>LXRQM>6'\TR8#
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MQC'57D'JJAC@)3B8[E0PB8H@ E-]?J'0.F5+U>#"& P& P& P& P& P& P&
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MEE3;U[:V3KEC&U^W;B_0N'^D^8]WK^X*]6^2#U]':+T_^T(R9WCLATRE',<
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M5]IPS]35;HD"\K]@FX)2(VCR"OCK8\E+L%8I9E\6P,Z;6T42.BJ?)2(82D,
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M[;=.VU4:G='9"$#JX6F:H8B;LA.AQ1L"BAA[2&ZS;B_FWZK-M);UTM_DF#[
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MQ*\QA$I5--0A03<+.6X?5L< UK<QP]NGAMCMV;(<KF8# 8# 8# 8# 8# 8#
M8# 8# JC&,5>,9M^4!\$.R:N%3]!Z>1W*,6"*?4/IW'*X.8 '^!!PJ4.TZ&I
M9V2<M%) >;C4A("!>TII%EW"<6P&,8I070,8QTNOWZF+_N 0QK<<=F[,_FB8
MHFHDHHDJ0Z2J1S)JI*%,11-0@]#$4(8 ,0Y1#H("'4,VYN. P& P& P& P&
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M32T[@OL-.GU1/8#J#2K#J^$KD,2ZN:R@X*[1KCBUE9!/K0"+LA52,C.!;%4
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MXWZ.[K_\=,VP\> P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!5HK\!YT_SGYG
MXWU\GXKX7D^_T[?E?[>W[_QZ_;'/9>$M=>_L/X2G[-\'E["_.\W?^8Z=?T_-
8^1_V?'W?;M_E=?\ 3F+GNW,=F1LRK__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g172766noticepg01e.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg01e.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ .0 ] P$1  (1 0,1 ?_$ )X   $$ P$!
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70!T = '0!T!G8_\ -%_O@_\ ''T!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g172766noticepg01f.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg01f.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1  V P$1  (1 0,1 ?_$ (P   (" P #
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M D"*#G <8"+KD?H/C76SKS>+K8"QSE!NR?+5OM8J54I">?&J57U)J=$#2O\
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0Y]4XN9QS)B]"&>@,] ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g172766noticepg01g.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg01g.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ %0+& P$1  (1 0,1 ?_$ )<  0 # 0 #
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MDC[+6[@_FV_"=%K%:1?_ #7<8@?W.2K')[/0G)>.>>.2$$K4:J:&GX5(@
M
M
M               S=77O;VLB?N1\GZ(Q^J*-^J=DP!Q=)K*_TE2%$WME)CFJ
M6@LE^K5:X>[H<\3M=9K_ $DY(J/\C[/9[#'*:GTDJ-3M*[]VOW&D45(CY&GF
M3_Y6O(!_J3N/\SB!12\C_0A6H![-UWV<']FO?K^\C!_Z'W\$+>?Q0VD"I
M
M                               $*N[&BZ%5:_B&:YA:#4"T=D.P%.P]
M;2&[>+=2] K,I7[==+=/5=O.-W<(K<'->I+AA%_)26*D[>E6*FH=(I><EXU2
MJ6);5VZSNPTZCY^WUT>Y',8UKMNB[$<]'.T5.B:+T4Z']NW$^*YK*<CY?S*D
MF4PW$N+6LPE!SI&Q7;$<]6I5AL.A<V9*K9[;)K/;<U711+&KVM>JGG4?K'?,
METRFVVA=D-HM=)Y:R\1K&=;Q>I[7V5J9KQRIX&QTJ6GG/#_/K?#SY$SK_$YY
MBWS!15$S5,_"2I/%K-U<A2D@M4ZT=G5%BD@8V)6KJFYKT:G\C5;JB:_F1>NJ
M^!;<D]8^,\YX?D,%R;B7'J7(M\4N-O8:G#BWUGI(B306XH6[+U66!7(SN?Z(
M9FLD29[5>QTQQCIH$JPPJB7/NI6[AV%O_8'L%08^S:3J-4R;.L5T^1RZN9G1
M\TOUCSJ(7EF, B52ZWJ=?5=65D5K"1VBD=P1H1FD@D8BF=9.W7XU,S$5:E25
M[(8W2R31I*Z1\C&R+HKOT,1'(UJ1Z+T55<J]4[3]2N3<?]O.6H>E?%^+<6RE
MJGB,=9R=_+8Z/(SY"YD*4%^5(GSKI4IPLL-K0-HK$]R,=.ZP^5Z.9(?I/JE^
MT6@Z75M1G6=PON!;QIW7^=OK&-:Q">@HT%Y'KP-R>Q<:7\GC)Z6K<VSXE&S/
MGXZ$FFN0I4O3E(GR.38^K2M03TFK'5MU(K#6*JKV^XB[F(J]51'-7:J]5:J+
MU\5U7[B>%<8XIR?#YKAE:2AQGE'&<?FX:3Y'2K16ZUZ35&22?RR0Q3PR^7DE
M3>^NZ)RJ_7>[V?;FN;82HUS7.O<O/N=+Q&</=N,G:S#QK5MYIOQ3-;OE5@BB
MG/'.)V8@>5%:Z^4145CYQ%OR3DI%5>1%@)L:MA]#+-8E.RW9W51%="_]DC5\
M4:CO[$141S====-"S]"LMZ=NSMO@OJG!59Q#D=9*GS)T376<-:W;J>2@DT1[
M88IMK;T+7M;/3?*CD5S&(<RZS:+;>W6B+]J(BP6^L=88>"?TG *"JI(UPVI2
MCH[4FA;1HL![D5%V\5,LE:]6HYY]0K;AD]D/9P9TW,6^S5.#C]3Y%(R-^:<Y
M'SOZ.[2=>W#&[ZVJCY')HJZM;JJ(J&8>L/$\'Z%<4;Z*WZM"YZQV+++F;NHC
M)_ET;4<M'$T9^J(Z2)[;V0GBVK(LM:KN5L,K5L"&)G+@
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M4B:W!S&(0@FUU34UNBI"
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MB<9>]0UP%%624\MD*-I,9VV?+&\AAAPN0B=.E/MK&ZE.RZM/LMLL27MN)6]
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722^1P14ZR5/I)DU[*^&FOW&IT5(3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g172766noticepg02a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg02a.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (0+& P$1  (1 0,1 ?_$ )<  0 !! (# 0
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M@_ZPZ:J?S#*^BZVQMCX,LP,B $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $
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M%F%4+.NJ8M0/X!J%]9_)4#+UGZ!55^LZ9>L_2GTCH>,IP @! " $ ( 0 @!
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MAM61T<L,=\7:J^WML=/WCT[AM61T<L,_-WCD>\0 @! " $ ( 0 @! " $ (
M0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @!
M" $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ (
1 0 @! " $ ( 0 @! " /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g172766noticepg02b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg02b.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1  V P$1  (1 0,1 ?_$ (P   (" P #
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M D"*#G <8"+KD?H/C76SKS>+K8"QSE!NR?+5OM8J54I">?&J57U)J=$#2O\
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0Y]4XN9QS)B]"&>@,] ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g172766noticepg03b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg03b.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!$@%  P$1  (1 0,1 ?_$ )H  0 " @,! 0$
M       '" 8) P0% 0(* 0$                     $   !@(! 0,$# <*
M"P8' 0 " P0%!@<!"  )$1(3(105&)06UK<X6'B8V#E9FC%1(B,7EPI!D9+2
M-C=7U[@983)"LR0T=-1G=WEQ,R55=BB!8F-D93IZ&A$!
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M,6 !QV!#@0LYSW0X_!C\&.!Q\!P' I1I[_+?J _]0.Q?[/>L7 NOP' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' JGOA\!G=3Y(^R?O,S3@19TH?JP>GO\
MCR@_>_9N![O4:^"=(O\ G5IW_;-U]X%[%W^NK/\ :E'^='P.KP' <#416>H6
MZ-,;B;N6C#%&H4YUHWEO* SZRF.P7:\&ZXXE &6 (JRE3%'$L:B2B +I ZQX
MU<-)A:KRDRHR5@T> 9'@(5=)Z8O4']3 SI/%6KK9G2(UW41 G9@([,.VI#JJ
M.P13[]#'Z'\Q(%8&6/WQ8:12K$C\Q"VBR'"#)V,&\"0;-Z9.PU?R[<F.ZW0/
M3G8K4S=IQ9)U,]7MP2IK'#J7NQEK]O@:"S:_F$?KBV6.7MW=9DKD% [-*96G
M<$Y TRHH1(C30Q35[ID[JZ""H2R=7I!K+;UAM&G,,U+VBJNUWNSZ[KJPW"KY
MM+I?6%N5M9D3KZ7RAG>8\BE.&Q<@<V3!:Y"4+!8BC# F$AL.Z?.H4SU+KJWU
MEPSV.V;L7L[L)8FS^P\QA;,Z1Z YL6PLMR4J(UZS/:A2\IH1!F)H3H$)JW(5
M:K.##C0 R/  A?7@. X#@4HT]_EOU ?^H'8O]GO6+@77X#@. X#@. X#@. X
M#@. X#@. X#@. X#@. X#@53WP^ SNI\D?9/WF9IP(LZ4/U8/3W^1Y0?O?LW
M ]WJ-?!.D7_.K3O^V;K[P+V+O]=6?[4H_P Z/@=7@. X&C7J?W/=]1]0#HVE
M4M&+%M8^5V!NBGD6O\%M)CJU'<Q#10+&I;$,D<IJ^,==+BH:8J/=TN'H8@%F
M)QX3=B@P':&C39K8/:VRMF;^C$FC6SD$<Y/UG.G#4ZC4&([:>U67 A$YU.N1
M1(Z.BER5E8;57\-0VFM;TC@:>W.B1O*6&DG*1A4)\C %OMWTDNJ2Z^EO4;AK
MWU$&^!.U+=1NP[.TTJS?"<2C8UX709ICTFCCZ[W^UW\B'/"XL!-Z>1I 2!S.
M1MYHT*1"H.R)":%=JE>-FKSL'I5PN<2/9GJ&ALOIDW1>+U$]?-VI=K*_/0S-
ME)""$O<_M,^?TT7.IQ242<2HD^&K1^?+7!((/<."F\3(?V>PUH+C\.B# 4A=
MVLICBD;9BVN0/RN5/[4%K94*'#6_2I>M<ETH>V[!'@JW(Y2I-7J #/&:8(S(
MQ!D? <!P' I1I[_+?J _]0.Q?[/>L7 NOP' <!P' <!P' <!P' <!P' <!P'
M <!P' <!P' JGOA\!G=3Y(^R?O,S3@19TH?JP>GO\CR@_>_9N![O4:^"=(O^
M=6G?]LW7W@7L7?ZZL_VI1_G1\#J\!P' AF>:]T]9UJT;=LYAI+]:&MCC.W:D
MI4-W?D)L'<;,C)4.G"DAM;71&S/67V-DA3""XIU8",8[Y."S/R^!7&W>F-H]
M>K]8$JLZE3GF3VC;U=WW-9&T6;;<+?5]P5-"'FN*ZG;6[PF=1Y?%W:*PV0K$
MB?#68C)%D[QA@&>$!H0S^O\ 1G6&LI31DYB\"?E$SUK1VPW4M*YG:MMV3(H>
M@O$H@BT49SS8DXE#A)T\E3I@%A [&+L("P]Q'X >W' @!1T=^G<85#"F^CY+
M%0UT@G+1 S(!L!L97*J),5E3)PL.;QMC702UX\N1QA]FKJI<1MN#,HBCSQ>$
M4 .>[P-C<<8&R*1V/Q5E K*98PQM$<9RU[FY/2\MI8FY,U-I:YZ>E:]Y>%@$
M20&#5:Q0>K4F8R8<8,P0AY#V> X#@.!2C3W^6_4!_P"H'8O]GO6+@77X#@.
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MZL'I[_(\H/WOV;@7_P" X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X%4]\/@,[J?)'V3]YF:<"+.E#]6#T]_D>4'[W[-P
M+_\  <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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MVHVZ$MD:=S9_=\-KF0'/PGT1K9$7(IX>Y2]QY SI\EJG=OC,;6G &O4I$*;
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MUBA&8D6ISAGI0<"QAH@B-,$ (0 $8,0 !P+ 0!R+.0A#@0ABP$./)CMSG/\
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MA+)H_8-VD,[@U=B41N2P&XGPF2K+QE4HB2).L4H9<Y)96:HDZTY$,T9*GQ5
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MX,<M4)8,BO:PHFQQUFG;E;;%7;H@K8H9KXX,:9L->68@DT16#$IIP76X#@.
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M5>@V_6E &?UA6]JQZR*J1HH&G.*DL+FS:KCS#+C%4"*.)=6X <D@7JR#"5!
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M/5=G2UXRV8*>\*5D62X=LA(3C7!R9V"*$/O8"?> X#@. X#@. X#@. X#@.
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M,D!!DDONA@.@P0C;/V>, PA& ;UU2PB"+&!!$$3!:F!!$'/;@018SV9QG\/
MSO1*U[3E$PZ-Z>365/I$GL1=UB06 0^2]_=B9R&O;8<T$ #,"ER\\$E#!D(
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F/9;X-^PG_P"TO_,;;?\ /!_-'_("0?SJ_P##;_SW_P#%^/P/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g172766noticepg03c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg03c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!(@ [ P$1  (1 0,1 ?_$ (T  0$! 0 " @,
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M[>7=!A'J<1H*'4"@4"@4"@D?VSO%X\@^@V+:-Y6>WEW081ZG$:"AU H% H%
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5U_\ 2[^-_P#YJ\MG_N;_ .C%!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g172766noticepg05c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticepg05c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!? !D P$1  (1 0,1 ?_$ )(  0$!  (" P$
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M;@$ @,*-(WT6FGGYH5D.IJ" T/@$ @$ @$ @$!%F:??84^LAP^ZQU1 ;-P"
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ME 7(1LJ*H9E(O!*?J626GJI8JR:I[0\S4+G*0J4[]3:4XB=/.(>64Q#%$##
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M8+X\TLB8917-&WFXQA5JVJ662!#^^' A_=!:\ @(LS3[["GUD.'W6.J(#9N
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M8QA_O$1@/I 19FGWV%/K(</NL=40&S< @$ @$!EME)Z1O!KS6-03KA@[ 4#
M(#B^^-Q)]H+(WHNZF:9+\IM/:&YUT$S"I5S$"9\46]H=^K"0S*%\F2HFH4[K
M-9@3GG$ES#2BS!.!3"  (<38PW$R)O!;NTMW[E,-A*<H:[=H*%NBWLMO7*Z#
ME6;(HN'1[#6#.S+5=5MR*GEJ=L3/(R%4Z6!#S#RP-+*!1$ "J8! 19FGWV%/
MK(</NL=40&S< @$ @$!EME)Z1O!KS6-03KA@[ 4# ("?,N&=XJ+$O*NG:=:U
M[[4-08RY ,5/L;4CFN+J]OCQ:.L&YH9VMND2YL]P<G1Q4RY$B1+(8\Z;,*0H
M")@" DO3E0V5IFS^/=*TY(R :;QM&+]I*>K^F[I)LRD].L+VPV[HE-6K/(;[
MXR0M*QNK14B Z>7):PDS91)9Y*(-GXY!#3> 0$69I]]A3ZR'#[K'5$!LW (!
M (! 9;92>D;P:\UC4$ZX8.P% P"  /!W0[@AW0$/[(#[FFS#AP&F','L\!CF
M$/\ T(B$!](! 19FGWV%/K(</NL=40&S< @$ @$!EME)Z1O!KS6-03KA@[ 4
M# (! (! ("+,T^^PI]9#A]UCJB V;@$ @$ @,MLI/2-X->:QJ"=<,'8"@8!
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ML\1NO*HF3<J;;D,$,DAK"7;U0^SZ7D5J=EZ%;46FIU2)IB$JK@Y,51#2_9"
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M8K9;U9R3_=W78[2&GRQS@QE[---/E4SB.1U0D-?;FHUZ>RH"+4P!3^T%<!J
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+_P#JN:?_ )$!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g172766noticexxxx.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766noticexxxx.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ #0!S P$1  (1 0,1 ?_$ '$   $% 0
M      <#!08("0H! 0                     0   $! 4# P,# @<
M  0%!@<" Q4( 1,4%@D %Q@1$B0C)1DB-45$"F4FUBB861H1 0
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M9Z.X;K#RJXASV#(+ETV3P +>CENP[6BF_4(Y5X&2_*&6$31"M2SSE8))R0(
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<G[F_#=I:54?#O44+9WSJAI=14_@Z/(^X=!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g172766page10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766page10.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MOI\+VLNN7UQIFFB,A;VQVBX\S=RF3E@N,'Y0>^<=\U;GWUTMY[[^AMKRZ?\
M#?UK^!T7@08\. QJAM&E8VTH"!YDX^=]A*[B<]/09 /%:2NDKZ/^OT,5N[.Z
M_P" 5?$YEBUV&;24NY]7%MM:&&&*11%N.&/F,@'.>C9/H<<1&]W;;2_XV_4T
M>ROYV_"_Z%_P@ENFGW?EM/\ :FN6:[2>-8V24JN1M7Y0,;3P3G.<DFJ>D4EM
MT^]_K<C[3OOI^1HZCHFG:JT;WEL'DC!"2*Q1U!Z@,I!Q[9J;:W*OI8GL-/M-
5+M1;65ND$();:@ZD]2?4^YIW$?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g172766page6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766page6.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M(A)IROW?YB:GH=U?7AGB\2:I8(0 (;?R-@/MOC8Y/UI+0NY=TC:-,B5;RXO
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A0MNY?T_3[?2[&.SM4*PQYQN8L22<DDGDDDDD^]5<1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g172766page8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766page8.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M0[6]NH1#-*I)4 @'!(# 'D @ C/8T@.:UG^S(/$E[-?:C>_:RL9MS9)-(]F
M#G(12H!//S#G/(QBF!N^$K9+3PS:QQWD=XC&203QC:KAI&;IVZXQVI <9XMD
MEA\5W)AU[_A&RZQ;I'5V%\<'&.P(^[Q\W'TIH#LO" "^$]. M&M?W9/EL6))
MR<M\W/S?>YY^;FD!R?BV*U3Q+/)/#9:JTB1_N;FUGF-F,'D>6K!0>O.#SUIH
M#L/"T2P^&-/C2^%\HCXG7.&&3P,\X'09YXYI ,O?#4-UJ$M]!?WUC-.%$WV6
K4*)-HP"00><<9&#P*8&AING6^DZ?#8VBE88A@;F+$DG)))ZDDDD^](#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g172766page9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g172766page9.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M2U337U%8]NIWEB(\DFV=5W?7<IZ8H AT>V2SGNK<:K>W\BA"WVH@[ 0<;2%
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J8Z9&".X(/'!'84 &DZ)!I+7$J3W%S<7!4RSW$F]VVC '8 #G@#N: /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
